Embed Size (px)
Citation preview
ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣΤΗΣ ΕΛΛΗΝΙΚΗΣ ΔΗΜΟΚΡΑΤΙΑΣ
ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ Αρ. Φύλλου 84012 Μαΐου 2011
11793
ΑΠΟΦΑΣΕΙΣΑριθμ. ΔΥΓ3α/Γ.Π. 52241Επικαιροποιημένος Κατάλογος μη συνταγογραφούμε−
νων φαρμάκων (ΜΗΣΥΦΑ).
Ο ΥΠΟΥΡΓΟΣΥΓΕΙΑΣ ΚΑΙ ΚΟΙΝΩΝΙΚΗΣ ΑΛΛΗΛΕΓΓΥΗΣ
Έχοντας υπόψη:1. Τις διατάξεις του άρθρου 1 παρ. 5 και άρθρο 9
παρ. 7 του ν.1965/91 (ΦΕΚ 146/Α/26−9−91).2. Τις διατάξεις της Υπουργικής Απόφασης ΔΥΓ3 (α)
83657/24−1−2006 (ΦΕΚ Β΄/59).3. Την Υπουργική Απόφαση ΔΥΓ3α/127858/5−2−04
(ΦΕΚ Β΄/284).4. Το Π.Δ. 189/2009 (ΦΕΚ Α΄/221).5. Το Π.Δ. 187/2009 (ΦΕΚ Α΄/214).6. Την από 6−4−2011 αριθμ. πρωτ. 25109 εισήγηση του
ΕΟΦ.
7. Την Υπουργική Απόφαση ΔΥΓ3α/Γ.Π 63696 (ΦΕΚ 740/B΄/27/5/2010).
8. Τις διατάξεις του άρθρου 12 του ν.3816 (ΦΕΚ 6/Α΄/26−1−2010).
9. Τις διατάξεις των άρθρων 51, 63 του ν. 3918 (ΦΕΚ 31/Α΄/2−3−2011).
10. Το Π.Δ. 95/2001 του Οργανισμού του Υπουργείου Υγείας και Πρόνοιας.
11. Το Π.Δ. 63/2005 (ΦΕΚ 98/Τ.Α/22−4−2005) «Κωδικο−ποίηση της νομοθεσίας για την Κυβέρνηση και τα Κυ−βερνητικά Όργανα».
12. Το γεγονός ότι με την απόφαση αυτή δεν προκα−λείται δαπάνη σε βάρος του κρατικού προϋπολογισμού, αποφασίζουμε:
Εγκρίνεται ο κάτωθι κατάλογος φαρμακευτικώνπροϊόντων για την χορήγηση των οποίων δεν απαιτείται ιατρική συνταγή (κατηγορία ΜΗΣΥΦΑ) και διατίθενται αποκλειστικά από τα φαρμακεία:
11794 ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ)
AA
01 A01
AA
01A
AA
01A
A01
S
OD
IUM
FLU
OR
IDE
2469
602
01D
UR
AP
HA
T 5
000
TOO
THP
AS
TE1,
10%
(W/W
)B
Tx1T
UB
Ex5
1GC
OLG
ATE
-PA
LMO
LIV
E
2469
602
02D
UR
AP
HA
T 5
000
TOO
THP
AS
TE1,
10%
(W/W
)B
Tx 3
TU
BE
Sx
51G
CO
LGA
TE-P
ALM
OLI
VE
A
01A
A30
S
OD
IUM
FLU
OR
OP
HO
SP
HA
TE,S
OD
IUM
FLU
OR
IDE
1517
402
01FL
UO
CA
RIL
BI-F
LUO
RE
TOO
THP
AS
T(0
.760
+0.3
315)
%TU
BX
50G
SA
NO
FI-S
YN
THE
LAB
O A
1517
402
02FL
UO
CA
RIL
BI-F
LUO
RE
TOO
THP
AS
T(0
.760
+0.3
315)
%TU
BX
100G
SA
NO
FI-S
YN
THE
LAB
O A
1517
403
01FL
UO
CA
RIL
BI-F
LUO
RE
OR
.T.S
OL
(0,1
34+0
,013
)%FL
X20
0ML
SA
NO
FI-S
YN
THE
LAB
O A
A01
AA
30
SO
DIU
M F
LUO
RO
PH
OS
PH
ATE
,SO
DIU
M F
LUO
RID
E,D
L-A
LPH
A-T
OC
OP
HE
RO
L23
9820
101
FLU
OC
AR
IL 2
50 V
ITA
MIN
E E
TOO
THP
AS
T(0
.76+
0.33
15+0
.50)
%TU
B X
125
ML
SA
NO
FI-S
YN
THE
LAB
O A
2398
201
02FL
UO
CA
RIL
250
VIT
AM
INE
ETO
OTH
PA
ST
(0.7
6+0.
3315
+0.5
0)%
TUB
X 7
5 M
LS
AN
OFI
-SY
NTH
ELA
BO
A23
9820
103
FLU
OC
AR
IL 2
50 V
ITA
MIN
E E
TOO
THP
AS
T(0
.76+
0.33
15+0
.50)
%TU
B X
50
ML
SA
NO
FI-S
YN
THE
LAB
O A
2398
201
04FL
UO
CA
RIL
250
VIT
AM
INE
ETO
OTH
PA
ST
(0.7
6+0.
3315
+0.5
0)%
TUB
X 6
ML
SA
NO
FI-S
YN
THE
LAB
O A
A01
AB
A01
AB
11
PO
VID
ON
E-IO
DIN
E01
7940
301
BE
TAD
INE
SO
L.G
A.M
.W1%
FLX
240M
LLA
VIP
HA
RM
AE
14
2620
501
DR
AP
IXS
OL.
GA
.M.W
1%FL
X24
0ML
DO
CTU
M
1545
403
01O
XIS
EP
TO
R.T
.SO
L1%
(W
/V)
FLx2
40 M
LD
EM
O A
BE
E
2464
704
01P
OV
IOD
INE
GA
RG
LE1%
FLx2
50M
LA
LAP
IS A
BE
E
1009
402
01TI
NS
OLE
SO
L.G
A.M
.W1%
(W
/V)
FLx2
40 M
LA
01A
B12
H
EX
ETI
DIN
E14
6290
101
HE
XA
LEN
MO
UTH
.WA
SH
0,1
% W
/VFL
x 2
00 M
LJO
HN
SO
N A
ND
JO
HN
SO
1462
901
02H
EX
ALE
NM
OU
TH.W
AS
H 0
,1%
W/V
FL x
400
ML
JOH
NS
ON
AN
D J
OH
NS
O14
6290
401
HE
XA
LEN
ME
NTA
MO
UTH
.WA
SH
0,1%
W/V
FL x
200
ML
JOH
NS
ON
AN
D J
OH
NS
O14
6290
402
HE
XA
LEN
ME
NTA
MO
UTH
.WA
SH
0,1%
W/V
FL x
400
ML
JOH
NS
ON
AN
D J
OH
NS
OA
01A
B14
B
EN
ZOX
ON
IUM
CH
LOR
IDE
2006
801
01O
RO
CIL
LOZ
1MG
/LO
ZB
TX24
(BLI
ST3
X8)
NO
VA
RTI
S (H
ELL
AS
) A.E
2006
802
01O
RO
CIL
MO
UTH
SP
R0.
2%FL
x30
ML
NO
VA
RTI
S (H
ELL
AS
) A.E
2006
803
01O
RO
CIL
SO
L.G
A.M
.W0.
05%
FLX
200M
LN
OV
AR
TIS
(HE
LLA
S) A
.E20
0680
401
OR
OC
ILS
OFT
.CA
PS
1MG
/CA
PB
Tx24
(BLI
ST
2x12
)N
OV
AR
TIS
(HE
LLA
S) A
.E
ATC
ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ) 11795
ATC
2006
805
01O
RO
CIL
GIN
GIV
.CA
P1M
G/C
AP
BT
x24
(BLI
ST
2x12
)N
OV
AR
TIS
(HE
LLA
S) A
.EA
01A
DA
01A
D02
B
EN
ZYD
AM
INE
HY
DR
OC
HLO
RID
E02
7320
501
TAN
TUM
MO
UTH
.PA
ST
0,5%
W
/WTU
BX
50G
0273
207
01TA
NTU
MM
OU
TH.W
AS
H0,
15%
(W/V
)FL
x 1
50 M
L02
7320
702
TAN
TUM
MO
UTH
.WA
SH
0,15
% (W
/V)
FL x
250
ML
0273
210
01TA
NTU
MLO
Z3M
G/L
OZ
BTX
20(
10
A01
AD
05
SA
LIC
YLI
C A
CID
,EX
TRA
CTU
M R
HE
I07
0370
101
PY
RA
LVE
XO
R.T
.SO
L1%
+5%
W/V
FL x
10
ML
NO
RG
INE
B.V
., TH
E N
ET
A
01A
D11
C
HO
LIN
E S
ALI
CY
LATE
,CE
TALK
ON
IUM
CH
LOR
IDE
1294
901
01M
UN
DIS
AL
GE
L.O
R.T
OP
8.71
%+0
.01%
BTx
1TU
Bx1
5GLA
VIP
HA
RM
AE
A
01A
D11
K
ETO
PR
OFE
N L
YS
INE
2620
701
01S
OLU
-KE
TM
OU
TH.W
AS
H1,
6% (
W/V
)B
OTT
LEx1
50 M
LA
01A
D11
N
IME
SU
LID
E27
9820
101
ER
RE
FLO
GM
OU
TH.W
AS
H0,
1% W
/VFL
x 2
00 M
L.
..
.A
02
AA
02A
A
A02
AA
E
MA
02A
A01
M
AG
NE
SIU
M C
AR
BO
NA
TE22
6190
101
LIM
ON
ATA
CIT
RO
MA
GN
ES
IAC
A/S
ELL
AD
ISP
.TA
B2G
/TA
B (O
RA
NG
E)
BTX
4M
ED
IPLA
NTS
.
2261
902
01LI
MO
NA
TA C
ITR
OM
AG
NE
SIA
CA
/SE
LLA
DIS
P.T
AB
2G/T
AB
(LE
MO
N)
BTX
4M
ED
IPLA
NTS
.
A02
AA
04
MA
GN
ES
IUM
HY
DR
OX
IDE
0626
001
01M
ILK
OF
MA
GN
ES
IAO
RA
L.S
US
P 4
25M
G/5
ML
FLX
340M
LG
LAX
OS
MIT
HK
LIN
E A
EB
A02
AB
E
AA
02A
B04
S
OD
IUM
PO
LYH
YD
RO
XY
ALU
MIN
IUM
MO
NO
CA
RB
ON
ATE
HE
XIT
OL
CO
MP
LEX
0644
301
01P
EP
SA
MA
RTA
B40
0MG
/TA
B x
50
GLA
XO
SM
ITH
KLI
NE
AE
BA
02A
D,
A02
AD
01
ALU
MIN
IUM
HY
DR
OX
IDE
GE
L,M
AG
NE
SIA
MA
GM
A (1
0% M
GO
)04
1480
101
ALU
DR
OX
OR
AL.
SU
SP
(307
+103
)MG
/5M
LFL
x 3
00 M
LP
FIZE
R
..
A02
AD
01
ALU
MIN
IUM
HY
DR
OX
IDE
GE
L,M
AG
NE
SIU
M H
YD
RO
XID
E22
0380
201
RE
GLA
PH
OR
AL.
SU
SP
(330
+137
.5)M
G/5
ML
FLX
200M
LU
CB
A.E
.
A02
AD
01
ALU
MIN
IUM
HY
DR
OX
IDE
-MA
GN
ES
IUM
CA
RB
ON
ATE
CO
-DR
IED
GE
L22
0380
101
RE
GLA
PH
CH
W.T
AB
450M
G/T
AB
60(B
LIS
T 6X
10)
UC
B A
.E.
11796 ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ)
ATC
A02
AD
01
HY
DR
ATE
D A
LUM
INA
-SU
CR
OS
E P
OW
DE
R (1
:1),M
AG
NE
SIU
M H
YD
RO
XID
E,H
YD
RA
TED
ALU
MIN
A-S
UC
RO
SE
PO
WD
ER
(1:1
),MA
GN
ES
IUM
HY
DR
OX
IDE
0414
802
01A
LUD
RO
XC
HW
.TA
B(2
33+8
3,46
)MG
/TA
BB
Tx60
(BLI
ST
6x10
)P
FIZE
R
..
0414
802
02A
LUD
RO
XC
HW
.TA
B(2
33+8
3,46
)MG
/TA
BB
Tx60
(FO
IST
6x10
)P
FIZE
R
..
A02
AD
01
MA
GN
ES
IUM
HY
DR
OX
IDE
,ALU
MIN
IUM
HY
DR
OX
IDE
GE
L04
2640
101
MA
ALO
XTA
B(2
00+2
00)M
G/T
AB
50(B
LIS
T 5X
10)
SA
NO
FI-A
VE
NTI
S A
EB
E
0426
402
01M
AA
LOX
TAB
(400
+400
)MG
/TA
B50
(BLI
ST
5X10
)S
AN
OFI
-AV
EN
TIS
AE
BE
A
02A
D01
M
AG
NE
SIU
M H
YD
RO
XID
E,A
LUM
INIU
M O
XID
E04
2640
302
MA
ALO
XO
RA
L.S
US
P(2
00+1
14) M
G/5
ML
FLx5
00 M
LS
AN
OFI
-AV
EN
TIS
AE
BE
A
02A
D02
M
AG
ALD
RA
TE18
6770
101
RIO
PA
NC
HW
.TA
B40
0MG
/TA
BB
Tx50
(BLI
ST
5x10
)N
YC
OM
ED
HE
LLA
S S
.A.
A
02A
D02
M
AG
ALD
RA
TE A
NH
YD
RO
US
1867
702
01R
IOP
AN
GE
L.O
RA
L80
0MG
/SA
CH
ET
BTx
20 S
AC
HE
TSN
YC
OM
ED
HE
LLA
S S
.A.
A
02A
D04
H
YD
RO
TALC
ITE
2206
201
01TA
LCID
SU
S.S
D10
00M
G/S
ING
LE D
OS
Ex2
0SA
CH
ETS
x10M
LB
AY
ER
22
0620
102
TALC
IDS
US
.SD
1000
MG
/SIN
GLE
DO
SE
x50S
AC
HE
TSx1
0ML
BA
YE
R
2206
202
01TA
LCID
CH
W.T
AB
500M
G/T
AB
20(B
LIS
T 2X
10)
BA
YE
R
2206
202
02TA
LCID
CH
W.T
AB
500M
G/T
AB
50(B
LIS
T 5X
10)
BA
YE
R
2206
202
03TA
LCID
CH
W.T
AB
500M
G/T
AB
100(
BLI
ST
10X
10)
BA
YE
R
A02
AF
A02
AF
D
IME
TIC
ON
E, A
CTI
VA
TED
2413
801
01IN
FAC
OLI
CO
RA
L.S
US
P4%
(W
/V)
FLx5
0 M
LM
ED
IHE
LM
A02
AF0
2
ALU
MIN
IUM
HY
DR
OX
IDE
,MA
GN
ES
IUM
HY
DR
OX
IDE
PA
STE
,DIM
ETI
CO
NE
, AC
TIV
ATE
D
1902
102
01M
AA
LOX
PLU
SO
RA
L.S
US
P(1
14+2
00+2
5)M
G/5
ML
FLx3
55 M
LS
AN
OFI
-AV
EN
TIS
AE
BE
A
02A
F02
A
LUM
INIU
M O
XID
E,M
AG
NE
SIU
M H
YD
RO
XID
E,D
IME
TIC
ON
E19
0210
101
MA
ALO
X P
LUS
TAB
(200
+200
+25)
MG
/TA
Bx5
0 (B
LIS
T 5x
10)
SA
NO
FI-A
VE
NTI
S A
EB
E
1902
101
02M
AA
LOX
PLU
STA
B(2
00+2
00+2
5)M
G/T
AB
BTx
20 (B
LIS
T 2x
10)
SA
NO
FI-A
VE
NTI
S A
EB
E
A02
AF0
2
DIM
ETH
ICO
NE
AC
TIV
ATE
D,A
LUM
INIU
M H
YD
RO
XID
E-M
AG
NE
SIU
M C
AR
BO
NA
TE C
O-D
RIE
D G
EL,
MA
GN
ES
IUM
HY
DR
OX
IDE
04
6180
301
SIM
EC
O L
EM
ON
FLA
VO
UR
CH
W.T
AB
(25+
282+
85)M
G/T
AB
BTX
30(B
L.2
X 1
5)P
FIZE
R
..
0461
803
02S
IME
CO
LE
MO
N F
LAV
OU
RC
HW
.TA
B(2
5+28
2+85
)MG
/TA
BB
TX60
(BL.
4 X
15)
PFI
ZER
.
.04
6180
303
SIM
EC
O L
EM
ON
FLA
VO
UR
CH
W.T
AB
(25+
282+
85)M
G/T
AB
BTX
30(F
OIS
T 3X
10)
PFI
ZER
.
.04
6180
304
SIM
EC
O L
EM
ON
FLA
VO
UR
CH
W.T
AB
(25+
282+
85)M
G/T
AB
BTX
60(F
OIS
T 6X
10)
PFI
ZER
.
.A
02A
F02
D
IME
TIC
ON
E, A
CTI
VA
TED
,MA
GN
ES
IUM
HY
DR
OX
IDE
,ALU
MIN
IUM
HY
DR
OX
IDE
2911
503
01ZA
XA
NO
RA
L.S
US
P(1
25+1
00+3
00)M
G/5
ML
BTx
30S
AC
HE
TSx5
ML
.&.
/
ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ) 11797
ATC
2911
504
01ZA
XA
NO
RA
L.S
US
P(2
50+1
00+3
00)M
G/5
ML
BTx
30S
AC
HE
TSx5
ML
.&.
/A
02A
F02
D
IME
TIC
ON
E,A
LUM
INIU
M H
YD
RO
XID
E,M
AG
NE
SIU
M H
YD
RO
XID
E29
1150
101
ZAX
AN
TAB
(40+
200+
200)
MG
/TA
Bx5
0.&
./
A02
AF0
2
DIM
ETI
CO
NE
,ALU
MIN
IUM
HY
DR
OX
IDE
,MA
GN
ES
IUM
STE
AR
ATE
2911
502
01ZA
XA
NTA
B(2
50+3
00+1
00)M
G/T
AB
x50
.&.
/A
02A
F02
D
IME
TIC
ON
E,A
LUM
INIU
M H
YD
RO
XID
E-M
AG
NE
SIU
M C
AR
BO
NA
TE C
O-D
RIE
D G
EL,
MA
GN
ES
IUM
HY
DR
OX
IDE
04
6180
101
SIM
EC
O M
INT
FLA
VO
UR
CH
W.T
AB
(25+
282+
85)M
G/T
AB
BTX
60(F
OIS
T 6X
10)
PFI
ZER
.
.04
6180
102
SIM
EC
O M
INT
FLA
VO
UR
CH
W.T
AB
(25+
282+
85)M
G/T
AB
BTX
30(F
OIS
T 3X
10)
PFI
ZER
.
.04
6180
103
SIM
EC
O M
INT
FLA
VO
UR
CH
W.T
AB
(25+
282+
85)M
G/T
AB
BTX
60(B
LIS
T 4X
15)
PFI
ZER
.
.04
6180
104
SIM
EC
O M
INT
FLA
VO
UR
CH
W.T
AB
(25+
282+
85)M
G/T
AB
BTX
30(B
LIS
T 2X
15)
PFI
ZER
.
.A
02A
X
A,
A02
AX
A
LUM
INIU
M H
YD
RO
XID
E,M
AG
NE
SIU
M H
YD
RO
XID
E,A
LUM
INIU
M P
HO
SP
HA
TE,G
UA
R G
UM
,DIM
ETI
CO
NE
,SO
RB
ITA
N M
ON
O-O
LEA
TE,P
OLY
SO
RB
ATE
80
23
4050
101
MO
XY
DO
RA
L.S
US
PFL
x 1
00M
L.
.A
02B
A02
BA
A
H2-
A02
BA
02
RA
NIT
IDIN
E H
YD
RO
CH
LOR
IDE
1907
703
01G
ER
TOC
ALM
F.C
.TA
B75
MG
/TA
Bx4
(1 F
OIS
Tx4)
1907
703
02G
ER
TOC
ALM
F.C
.TA
B75
MG
/TA
BB
Tx10
(1 F
OIS
Tx10
)19
0770
303
GE
RTO
CA
LMF.
C.T
AB
75M
G/T
AB
BTx
20 (2
FO
IST
x10)
1907
703
04G
ER
TOC
ALM
F.C
.TA
B75
MG
/TA
BB
Tx30
(3 F
OIS
T x1
0)24
3250
501
YA
RA
F.C
.TA
B75
MG
/TA
BB
TX10
(1FO
ISTX
10)
ME
DO
CH
EM
IE H
ELL
AS
A24
3250
502
YA
RA
F.C
.TA
B75
MG
/TA
BB
TX20
(2FO
ISTX
10)
ME
DO
CH
EM
IE H
ELL
AS
A18
6450
801
ZAN
TAC
F.C
.TA
B75
MG
/TA
BB
Tx12
( B
LIS
TER
S)
GLA
XO
SM
ITH
KLI
NE
AE
B20
5610
501
ZOLI
DE
NF.
C.T
AB
75M
G/T
AB
BTX
10(B
LIS
T1X
10)
UN
I-PH
AR
MA
20
5610
502
ZOLI
DE
NF.
C.T
AB
75M
G/T
AB
BTX
20(B
LIS
T2X
10)
UN
I-PH
AR
MA
20
5610
601
ZOLI
DE
NE
F.TA
B75
MG
/TA
BB
TX12
(STR
IPS
3X4)
UN
I-PH
AR
MA
A
02B
XA
02B
X13
A
LGIN
,CA
LCIU
M C
AR
BO
NA
TE,S
OD
IUM
BIC
AR
BO
NA
TE22
3830
601
GA
VIS
CO
N L
IQU
ID S
AC
HE
TSO
RA
L.S
US
P(5
00+2
67+1
60)M
G/1
0ML
BTx
2 S
AC
HE
TS22
3830
602
GA
VIS
CO
N L
IQU
ID S
AC
HE
TSO
RA
L.S
US
P(5
00+2
67+1
60)M
G/1
0ML
BTx
4 S
AC
HE
TS22
3830
603
GA
VIS
CO
N L
IQU
ID S
AC
HE
TSO
RA
L.S
US
P(5
00+2
67+1
60)M
G/1
0ML
BTx
6 S
AC
HE
TS22
3830
604
GA
VIS
CO
N L
IQU
ID S
AC
HE
TSO
RA
L.S
US
P(5
00+2
67+1
60)M
G/1
0ML
BTx
8 S
AC
HE
TS22
3830
605
GA
VIS
CO
N L
IQU
ID S
AC
HE
TSO
RA
L.S
US
P(5
00+2
67+1
60)M
G/1
0ML
BTx
10 S
AC
HE
TS
11798 ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ)
ATC
2238
306
06G
AV
ISC
ON
LIQ
UID
SA
CH
ETS
OR
AL.
SU
SP
(500
+267
+160
)MG
/10M
LB
Tx12
SA
CH
ETS
2238
306
07G
AV
ISC
ON
LIQ
UID
SA
CH
ETS
OR
AL.
SU
SP
(500
+267
+160
)MG
/10M
LB
Tx14
SA
CH
ETS
2238
306
08G
AV
ISC
ON
LIQ
UID
SA
CH
ETS
OR
AL.
SU
SP
(500
+267
+160
)MG
/10M
LB
Tx16
SA
CH
ETS
2238
306
09G
AV
ISC
ON
LIQ
UID
SA
CH
ETS
OR
AL.
SU
SP
(500
+267
+160
)MG
/10M
LB
Tx18
SA
CH
ETS
2238
306
10G
AV
ISC
ON
LIQ
UID
SA
CH
ETS
OR
AL.
SU
SP
(500
+267
+160
)MG
/10M
LB
Tx20
SA
CH
ETS
2238
305
01G
AV
ISC
ON
PE
PP
ER
MIN
T TA
BLE
TSC
HW
.TA
B(2
50+1
3,5+
80 M
G) T
AB
BTx
4 B
LIS
T22
3830
502
GA
VIS
CO
N P
EP
PE
RM
INT
TAB
LETS
CH
W.T
AB
(250
+13,
5+80
MG
) TA
BB
Tx6
BLI
ST
2238
305
03G
AV
ISC
ON
PE
PP
ER
MIN
T TA
BLE
TSC
HW
.TA
B(2
50+1
3,5+
80 M
G) T
AB
BTx
8 B
LIS
T22
3830
504
GA
VIS
CO
N P
EP
PE
RM
INT
TAB
LETS
CH
W.T
AB
(250
+13,
5+80
MG
) TA
BB
Tx16
BLI
ST
2238
305
05G
AV
ISC
ON
PE
PP
ER
MIN
T TA
BLE
TSC
HW
.TA
B(2
50+1
3,5+
80 M
G) T
AB
BTx
24 B
LIS
T22
3830
506
GA
VIS
CO
N P
EP
PE
RM
INT
TAB
LETS
CH
W.T
AB
(250
+13,
5+80
MG
) TA
BB
Tx32
BLI
ST
2238
305
07G
AV
ISC
ON
PE
PP
ER
MIN
T TA
BLE
TSC
HW
.TA
B(2
50+1
3,5+
80 M
G) T
AB
BTx
48 B
LIS
T22
3830
508
GA
VIS
CO
N P
EP
PE
RM
INT
TAB
LETS
CH
W.T
AB
(250
+13,
5+80
MG
) TA
BB
Tx64
BLI
ST
2238
305
09G
AV
ISC
ON
PE
PP
ER
MIN
T TA
BLE
TSC
HW
.TA
B(2
50+1
3,5+
80 M
G) T
AB
BO
TTLE
x822
3830
510
GA
VIS
CO
N P
EP
PE
RM
INT
TAB
LETS
CH
W.T
AB
(250
+13,
5+80
MG
) TA
BB
OTT
LEx1
2A
02B
X13
A
LGIN
,PO
TAS
SIU
M B
ICA
RB
ON
ATE
2805
901
01G
AV
ISC
ON
AD
VA
NC
EO
RA
L.S
US
P50
0MG
/5M
L +
100M
G/5
ML
FLx8
0ML
2805
901
02G
AV
ISC
ON
AD
VA
NC
EO
RA
L.S
US
P50
0MG
/5M
L +
100M
G/5
ML
FLx1
00M
L28
0590
103
GA
VIS
CO
N A
DV
AN
CE
OR
AL.
SU
SP
500M
G/5
ML
+ 10
0MG
/5M
LFL
x125
ML
2805
901
04G
AV
ISC
ON
AD
VA
NC
EO
RA
L.S
US
P50
0MG
/5M
L +
100M
G/5
ML
FLx1
40M
L28
0590
105
GA
VIS
CO
N A
DV
AN
CE
OR
AL.
SU
SP
500M
G/5
ML
+ 10
0MG
/5M
LFL
x150
ML
2805
901
06G
AV
ISC
ON
AD
VA
NC
EO
RA
L.S
US
P50
0MG
/5M
L +
100M
G/5
ML
FLx1
80M
L28
0590
107
GA
VIS
CO
N A
DV
AN
CE
OR
AL.
SU
SP
500M
G/5
ML
+ 10
0MG
/5M
LFL
x200
ML
2805
901
08G
AV
ISC
ON
AD
VA
NC
EO
RA
L.S
US
P50
0MG
/5M
L +
100M
G/5
ML
FLx2
50M
L28
0590
109
GA
VIS
CO
N A
DV
AN
CE
OR
AL.
SU
SP
500M
G/5
ML
+ 10
0MG
/5M
LFL
x300
ML
2805
901
10G
AV
ISC
ON
AD
VA
NC
EO
RA
L.S
US
P50
0MG
/5M
L +
100M
G/5
ML
FLx4
00M
L28
0590
111
GA
VIS
CO
N A
DV
AN
CE
OR
AL.
SU
SP
500M
G/5
ML
+ 10
0MG
/5M
LFL
x 50
0ML
2805
901
12G
AV
ISC
ON
AD
VA
NC
EO
RA
L.S
US
P50
0MG
/5M
L +
100M
G/5
ML
FLx5
60M
L28
0590
113
GA
VIS
CO
N A
DV
AN
CE
OR
AL.
SU
SP
500M
G/5
ML
+ 10
0MG
/5M
LFL
x600
ML
A02
BX
13
ALG
IN,S
OD
IUM
BIC
AR
BO
NA
TE22
3820
101
GA
VIS
CO
N-L
OR
AL.
SU
SP
(250
+133
,5)M
G/5
ML
FLx1
50 M
L22
3820
102
GA
VIS
CO
N-L
OR
AL.
SU
SP
(250
+133
,5)M
G/5
ML
FLx2
00 M
L22
3820
103
GA
VIS
CO
N-L
OR
AL.
SU
SP
(250
+133
,5)M
G/5
ML
FLx5
00 M
L
ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ) 11799
ATC
2238
201
04G
AV
ISC
ON
-LO
RA
L.S
US
P(2
50+1
33,5
)MG
/5M
LFL
x300
ML
2238
202
01G
AV
ISC
ON
-L (P
EP
PE
RM
INT
FLA
VO
UR
)O
RA
L.S
US
P(2
50+1
33,5
)MG
/5M
LFL
x150
ML
2238
202
02G
AV
ISC
ON
-L (P
EP
PE
RM
INT
FLA
VO
UR
)O
RA
L.S
US
P(2
50+1
33,5
)MG
/5M
LFL
x200
ML
2238
202
03G
AV
ISC
ON
-L (P
EP
PE
RM
INT
FLA
VO
UR
)O
RA
L.S
US
P(2
50+1
33,5
)MG
/5M
LFL
x500
ML
2238
202
04G
AV
ISC
ON
-L (P
EP
PE
RM
INT
FLA
VO
UR
)O
RA
L.S
US
P(2
50+1
33,5
)MG
/5M
LFL
x300
ML
A02
XA
02X
A02
X
CH
AR
CO
AL,
AC
TIV
ATE
D,S
IME
THIC
ON
E E
MU
LSIO
N,C
HA
RC
OA
L, A
CTI
VA
TED
,SIM
ETH
ICO
NE
EM
ULS
ION
18
6370
102
CA
RB
OS
YLA
NE
CA
PS
& G
R.C
AP
(140
+45)
MG
/CA
P (
) & B
Tx[4
8(B
LIS
T 4x
12) &
..
A03 A
03B
(Bel
lado
nna)
, ,
A03
BB
(Bel
lado
nna)
, A
03B
B01
H
YO
SC
INE
BU
TYLB
RO
MID
E00
0840
101
BU
SC
OP
AN
C.T
AB
10M
G/T
AB
BTx
20 (B
LIS
T.1x
20)
BO
EH
RIN
GE
R IN
GE
LHE
I00
0840
503
BU
SC
OP
AN
SU
PP
10M
G/S
UP
BT
x 10
BO
EH
RIN
GE
R IN
GE
LHE
IA
06
KA
06A
K
A06
AA
,A
06A
A01
P
AR
AFF
IN, L
IQU
ID03
3550
101
NU
JOL
OIL
.OR
AL
100%
FLX
240M
LM
ER
CK
SH
AR
P &
DO
HM
1913
401
01P
AR
AFI
NE
OIL
/NI-T
HE
OIL
.OR
AL
100%
FLx2
00 M
LN
I-TH
E
..
.A
06A
BA
06A
B02
B
ISA
CO
DY
L09
0150
101
DU
LCO
LAX
SU
PP
10M
G/S
UP
BTx
6 (F
OIS
T 1x
6)B
OE
HR
ING
ER
ING
ELH
EI
0901
501
03D
ULC
OLA
XS
UP
P10
MG
/SU
PB
Tx10
(FO
IST
2x5)
BO
EH
RIN
GE
R IN
GE
LHE
I09
0150
206
DU
LCO
LAX
GR
.TA
B5M
G/T
AB
BTx
40B
OE
HR
ING
ER
ING
ELH
EI
A06
AB
05
CA
STO
R O
IL10
6180
101
CA
STO
R O
IL A
RO
MA
TIC
OIL
.SO
L.O
R99
,4%
W/W
FLX
50G
NI-T
HE
.
..
1061
801
02C
AS
TOR
OIL
AR
OM
ATI
CO
IL.S
OL.
OR
99,4
% W
/WFL
X30
GN
I-TH
E
..
.A
06A
B06
S
EN
NA
2633
201
01E
X-L
AX
C.T
AB
12M
G/T
AB
BTx
20 (1
BLI
STE
Rx2
0)N
OV
AR
TIS
(HE
LLA
S) A
.E23
2800
101
SE
NN
A/A
RK
OP
HA
RM
AC
AP
S22
0MG
/CA
PB
Tx50
()
AR
KO
PH
AR
MA
A
06A
B06
S
EN
NA
DR
Y E
XTR
AC
T
11800 ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ)
ATC
1896
701
01B
EK
UN
ISG
R.T
AB
20M
G/T
AB
BTx
45N
OV
AD
EN
TAL
1896
701
02B
EK
UN
ISG
R.T
AB
20M
G/T
AB
BTx
40 (B
LIS
T 2x
20)
NO
VA
DE
NTA
L 18
9670
103
BE
KU
NIS
GR
.TA
B20
MG
/TA
B x
40
NO
VA
DE
NTA
L A
06A
B06
S
EN
NA
LE
AF
1941
601
01FA
DIC
RE
FOR
M T
EA
HE
RB
.TE
AB
T x
75 G
..
A06
AB
06
SE
NN
A L
EA
F P
OW
DE
R22
1180
101
LAX
-LA
XTA
B50
0MG
/TA
BB
TXFL
X20
..
2211
801
02LA
X-L
AX
TAB
500M
G/T
AB
BTX
20(B
LIS
T 2X
10)
..
1989
601
01R
IXA
TIV
EM
AR
M8.
4%JA
R x
260
g.
.19
8960
102
RIX
ATI
VE
MA
RM
8.4%
JAR
x 1
30g
..
A06
AB
06
TIN
NE
VE
LLY
SE
NN
A P
OD
S23
3350
101
BA
BA
NE
YH
ER
BA
L.TE
A45
MG
BTX
1.X
50G
.. &
.
.A
06A
B56
F
OLI
UM
SE
NN
AE
,FE
NN
EL,
MA
TE (D
RIE
D L
EA
VE
S O
F IL
EX
PA
RA
GU
EN
SIS
),BU
CK
THO
RN
,ELD
ER
LE
AV
ES
20
2830
101
LUS
TYS
HE
RB
ALE
NE
OR
AL.
PD
TIK
O B
x 5
0G.
2028
301
02LU
STY
S H
ER
BA
LEN
EO
RA
L.P
D x
150
G.
A06
AB
56
FO
LIU
M S
EN
NA
E,L
IQU
OR
ICE
2284
201
01M
IDR
O T
EE
HE
RB
.TE
A(7
50+6
0) M
G/G
BTx
80 G
A06
AB
56
SE
NN
A L
EA
F P
OW
DE
R,C
AS
SIA
PU
LP E
XTR
AC
T,TA
MA
RIN
D E
XTR
AC
T,C
OR
IAN
DE
R F
RU
IT P
OW
DE
R
0874
702
01TA
MA
RIN
EM
AR
MFL
x 2
60 G
RG
LAX
OS
MIT
HK
LIN
E A
EB
A06
AB
56
SE
NN
A L
EA
F P
OW
DE
R,T
AM
AR
IND
EX
TRA
CT,
PLU
M P
ULP
,AP
PLE
PU
LP20
2580
101
SA
NTA
MA
RIN
EM
AR
M8%
BTx
260
GA
LAP
IS A
BE
E
A06
AC
A06
AC
51
PLA
NTA
GO
OV
ATA
,ISP
AG
HU
LA H
US
KS
,SE
NN
AE
FO
LIU
M A
NG
US
TIFO
LIA
E22
7260
101
AG
IOLA
X-M
AD
AU
SG
RA
NU
LES
BT
x 25
0 G
RO
TTA
PH
AR
M H
ELL
AS
22
7260
102
AG
IOLA
X-M
AD
AU
SG
RA
NU
LES
BT
x 10
0 G
RO
TTA
PH
AR
M H
ELL
AS
A
06A
DA
06A
D10
S
OD
IUM
BIC
AR
BO
NA
TE,T
AR
TAR
IC A
CID
2916
101
01R
AP
IDE
XG
RA
.OR
.SO
L(2
.200
+1.4
30)/G
/SA
CH
ET
BTx
10 S
AC
HE
TS.&
./
A06
AD
10
TA
RTA
RIC
AC
ID,S
OD
IUM
BIC
AR
BO
NA
TE12
1000
101
CO
UP
-LA
X C
OM
PO
SE
OR
.SO
L.S
D(2
0.03
+22)
G/F
L(25
0G)
FLX
250G
CO
UP
AB
EE
A
06A
GA
06A
G04
G
LYC
ER
OL
1926
601
02G
LIC
ER
OLO
MIC
RO
CLI
SM
I EN
EM
AE
NE
MA
2,25
G/3
ML
BTX
3FLX
3ML
ME
DIP
LAN
TS
.
ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ) 11801
ATC
2438
802
01/
()
EN
EM
A1,
8G/D
OS
EB
TX2F
L.
.24
3880
401
/ (
)E
NE
MA
2,4G
/DO
SE
BTX
2FL
..
2438
803
01/
()
EN
EM
A2,
1G/D
OS
EB
TX2F
L.
.06
6210
601
/E
NE
MA
1,8G
/DO
SE
(2,5
ML)
BTx
2FLx
2,5M
L..
&
..
0662
104
01E
NE
MA
2,4G
/DO
SE
(2,5
ML)
BTx
2 FL
x2,5
ML
.. &
.
.06
6210
501
/E
NE
MA
2,1G
/DO
SE
(2,5
ML)
BTx
2FLx
2,5
ML
.. &
.
.A
06A
XA
06A
X01
G
LYC
ER
OL
1246
701
01G
LYC
ER
INE
SU
PP
OS
ITO
RIE
S/N
I-TH
ES
UP
P64
0MG
/SU
P10
NI-T
HE
.
..
1246
702
01G
LYC
ER
INE
SU
PP
OS
ITO
RIE
S/N
I-TH
ES
UP
P12
80M
G/S
UP
10N
I-TH
E
..
.12
4670
301
GLY
CE
RIN
E S
UP
PO
SIT
OR
IES
/NI-T
HE
SU
PP
2560
MG
/SU
P10
NI-T
HE
.
..
2438
801
01/
SU
PP
2,4G
/SU
PB
TX10
..
2438
805
01/
SU
PP
0.6G
/SU
PP
BTx
10
..
.24
3880
601
/S
UP
P1.
2G/S
UP
PB
Tx10
.
..
0662
101
01/
SU
PP
0,6G
/SU
Px1
0..
&
..
0662
103
01/
SU
PP
2,4G
/SU
Px1
0..
&
..
0662
102
01/
SU
PP
1,2G
/SU
Px1
0..
&
..
A07
, /
A07
A
KA
07A
CA
07A
C01
M
ICO
NA
ZOLE
0919
308
01D
AK
TAR
ING
EL.
OR
.TO
P2%
(W
/W)
FL x
40
GJO
HN
SO
N A
ND
JO
HN
SOA
07B
A07
BC
A07
BC
05
DIO
SM
EC
TITE
2410
701
01S
ME
CTA
PD
.OR
A.S
US
3G/S
AC
HE
TB
Tx30
SA
CH
ET
IPS
EN
A
08,
A08
A,
A08
AB
A08
AB
01
OR
LIS
TAT
2880
002
01A
LLI
CA
PS
60M
G/C
AP
BO
TTLE
(HD
PE
)x42
GLA
XO
GR
OU
P L
TD E
NG
2880
002
02A
LLI
CA
PS
60M
G/C
AP
BO
TTLE
(HD
PE
)x60
GLA
XO
GR
OU
P L
TD E
NG
2880
002
03A
LLI
CA
PS
60M
G/C
AP
BO
TTLE
(HD
PE
)x84
GLA
XO
GR
OU
P L
TD E
NG
11802 ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ)
ATC
2880
002
04A
LLI
CA
PS
60M
G/C
AP
BO
TTLE
(HD
PE
)x90
GLA
XO
GR
OU
P L
TD E
NG
A11
B
A11
J,
A11
JC
B,
A11
JC
TH
IAM
INE
MO
NO
NIT
RA
TE,R
ETI
NO
L P
ALM
ITA
TE,R
IBO
FLA
VIN
,DE
AN
OL
BIT
AR
TRA
TE,P
YR
IDO
XIN
E H
YD
RO
CH
LOR
IDE
,AS
CO
RB
IC A
CID
,DL-
ALF
A-T
OC
OP
04
8010
101
PH
AR
MA
TON
GE
RIA
TRIC
SO
FT.C
AP
Sx3
0(B
LIS
T 3x
10)
BO
EH
RIN
GE
R IN
GE
LHE
IA
13 A13
AA
13A
A13
A
DIE
THY
LAM
INO
ETH
AN
OL
MA
LATE
AC
ID04
9830
101
DU
RO
BIO
NO
R.S
OL.
SD
500M
G/1
0ML
AM
P(O
RA
L)B
TX20
AM
P10
ML
OLV
OS
SC
IEN
CE
AE
A
16 A16
AA
16A
A
AA
16A
A01
L
EV
OC
AR
NIT
INE
2742
702
01A
MIN
OC
ER
OR
AL.
SO
L2G
/10M
L V
IAL
BTx
10 V
IALS
x 1
0 M
LV
ER
ISFI
ELD
(UK
) LTD
, U
2476
101
01A
VE
PTO
LO
RA
L.S
OL
1G/1
0ML(
SIN
GLE
DO
SE
)B
TX10
(FLX
10M
L) &
.
2496
201
01B
ITO
BIO
NIL
OR
AL.
SO
L1G
/10M
L V
IAL
BTx
10 F
L x
10 M
LS
.J.A
. PH
AR
M
2496
202
01B
ITO
BIO
NIL
OR
AL.
SO
L20
0MG
/ML(
2G
/10M
L)B
Tx10
x 1
0 M
Lx2G
S.J
.A. P
HA
RM
27
3600
101
CA
RN
IBE
NO
R.S
OL.
SD
1G/1
0ML
BTx
10 F
Lx10
ML
BE
NN
ETT
20
8180
201
CA
RN
ILO
RA
L.S
OL
1G/1
0ML
VIA
L O
RA
LB
Tx10
AM
PS
OR
ALx
1gr
..
2081
802
02C
AR
NIL
OR
AL.
SO
L1G
/10M
L V
IAL
OR
AL
BTx
10 V
IALS
OR
ALx
1G.
.23
5970
101
CA
RN
IDO
SE
OR
.SO
L.S
D1G
/10M
LB
Tx10
FLx
10 M
L27
6480
101
CA
RN
IPR
OL
EFF
.GR
AN
1G/S
AC
HB
Tx15
(SA
CH
ETS
)27
6480
102
CA
RN
IPR
OL
EFF
.GR
AN
1G/S
AC
HB
Tx30
(SA
CH
ETS
)28
5200
101
CA
RN
ISA
CE
FF.G
RA
N10
00M
G/S
AC
HE
TB
Tx30
SA
CH
ETS
x5 G
IAM
ATI
CA
MO
N.
2893
101
01C
AR
NIV
IT (
)O
RA
L.S
OL
2G/1
0ML
(S.D
.)B
Tx10
FLx
10 M
LV
IOFA
R
2304
801
01C
OR
UB
INO
R.S
OL.
SD
1G/1
0ML
BTX
10FL
X10
ML
IAS
IS P
HA
RM
AC
.HE
LLA
S27
6770
101
DU
OC
AR
NIC
OR
AL.
SO
L20
0MG
/ML
(2 G
/10M
L)B
Tx10
x10
MLx
2 G
IAS
IMO
LTD
, EN
GLA
ND
27
6490
101
EN
ER
GO
CA
RN
ILE
FF.G
RA
N1G
/SA
CH
BT
x 15
(SA
CH
ETS
)E
NE
RG
ON
27
6490
102
EN
ER
GO
CA
RN
ILE
FF.G
RA
N1G
/SA
CH
BT
x 30
(SA
CH
ETS
)E
NE
RG
ON
12
L-
ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ) 11803
ATC
2366
001
01E
NS
IAL
OR
.SO
L.S
D1G
/10M
L FL
BTx
10FL
x10M
L.
..
.22
9510
101
FRU
TEN
OR
OR
AL.
SO
L1G
/10M
L S
ING
LE D
OS
EB
Tx10
FLx1
0ML
RA
FAR
M A
.E.B
.E.
22
9510
201
FRU
TEN
OR
OR
.SO
L.S
D2G
/10M
L V
IAL
(200
MG
/ML)
x10
(VIA
LSx1
0ML)
RA
FAR
M A
.E.B
.E.
24
7850
101
GR
OW
AR
TO
RA
L.S
OL
1G/1
0ML
VIA
LB
Tx10
VIA
LS (1
0 M
L).
.22
9150
101
INE
STO
MO
R.S
OL.
SD
1G/1
0ML
BTx
10
FL x
10
ML
HE
LP
2291
503
01IN
ES
TOM
OR
AL.
SO
L2G
/10M
L V
IAL
BTx
10 V
IALS
x10
ML
HE
LP
2050
702
01IN
TELE
CTA
OR
.SO
L.S
D1G
/10M
LB
Tx10
x1
0 M
LU
NI-P
HA
RM
A
2050
705
01IN
TELE
CTA
()
OR
.SO
L.S
D2G
/10M
LB
Tx10
VIA
LS x
10 M
LU
NI-P
HA
RM
A
2050
706
01IN
TELE
CTA
()
EFF
.GR
AN
2000
MG
/SA
CH
ET
BTx
10 S
AC
HE
TS x
5 G
UN
I-PH
AR
MA
20
5070
602
INTE
LEC
TA (
)E
FF.G
RA
N20
00M
G/S
AC
HE
TB
Tx30
SA
CH
ETS
x 5
GU
NI-P
HA
RM
A
2435
101
01K
OP
TILA
NO
RA
L.S
OL
100M
G/M
LB
TX10
FLX
10M
LC
OU
P A
BE
E
2566
601
01LE
VA
LAS
TIN
EO
RA
L.S
OL
1G/1
0ML
BTX
10FL
X10
ML
BIO
ME
DIC
A-C
HE
MIC
A A
E25
6660
201
LEV
ALA
STI
NE
()
EFF
.GR
AN
1000
MG
/SA
CH
ET
BTx
30 S
AC
HE
TSx5
GB
IOM
ED
ICA
-CH
EM
ICA
AE
2455
201
01LE
VA
MIN
OR
AL.
SO
L1G
/10M
L V
IAL
BTx
10 V
IALS
x 1
0 M
LG
EN
EP
HA
RM
AE
25
5300
101
LEV
AR
SO
RA
L.S
OL
1000
MG
/10M
LB
Tx10
FLx
10 M
LA
RS
ME
DE
ND
I .
2858
301
01LE
VIC
IN (
)E
FF.G
RA
N10
00M
G/S
AC
HE
TB
Tx30
SA
CH
ETS
x5G
TAN
IC
2235
901
01LE
VO
CA
RN
ILO
RA
L.S
OL
1G/1
0ML
FL (S
ING
LE D
OS
EB
Tx10
FL
x 10
ML
BIO
SP
RA
Y A
BE
E
2557
701
01LE
VO
SA
NO
R.S
OL.
SD
1000
MG
/10M
LB
Tx10
FL
x 10
ML
SA
NU
S O
.E.
.24
5660
101
LIS
EFO
RO
R.S
OL.
SD
1G/1
0ML
VIA
LB
Tx 1
0 V
IALS
x10
ML
VO
CA
TE
2456
602
01LI
SE
FOR
OR
AL.
SO
L2G
/10M
L V
IAL
BT
x 10
VIA
LS x
10M
LV
OC
ATE
24
5660
301
LIS
EFO
R (
)E
FF.G
RA
N10
00M
G/S
AC
HE
TB
Tx30
SA
CH
ETS
VO
CA
TE
2539
801
01LI
STO
VE
RO
RA
L.S
OL
1G/1
0ML
BTX
10FL
X10
ML
BIO
SY
NTH
ES
IS A
.E.
27
4910
101
LOC
AR
GR
A.O
R.S
OL
1G/S
AC
HE
TB
Tx10
SA
CH
ETS
ME
DIC
US
A.E
.
2749
101
02LO
CA
RG
RA
.OR
.SO
L1G
/SA
CH
ET
BTx
30 S
AC
HE
TSM
ED
ICU
S A
.E.
27
4910
201
LOC
AR
OR
AL.
SO
L3G
/10M
L (3
0%) B
OTL
LEB
OTT
LEx2
0 M
LM
ED
ICU
S A
.E.
27
4910
202
LOC
AR
OR
AL.
SO
L3G
/10M
L (3
0%) B
OTL
LEB
OTT
LEx1
00 M
LM
ED
ICU
S A
.E.
24
5250
101
LOFO
STI
NO
R.S
OL.
SD
1G/1
0ML
BTx
10V
IALS
x10M
LFA
RM
ED
IA A
E
2452
502
01LO
FOS
TIN
OR
AL.
SO
L20
0MG
/ML(
2G
/10M
L)B
Tx10
x10
MLx
2GFA
RM
ED
IA A
E
2827
801
01LY
ZIP
OR
AL.
SO
L2G
/10M
L V
IAL
BT
x 10
VIA
LS x
10M
L.
.27
7080
101
ME
DIC
AR
DIN
OR
AL.
SO
L2G
/10M
L V
IAL
( 2
00m
g/M
L)B
Tx 1
0 V
IALS
x 1
0 M
LFA
RM
ED
IA A
E
2337
501
01M
ER
LIT
OR
.SO
L.S
D1G
/10M
LB
Tx10
FLx
10 M
LLE
OV
AN
.
&
2381
501
01M
EV
AM
YS
TO
R.S
OL.
SD
1G/1
0ML
BTx
10FL
x10M
LM
ED
-ON
E
..
..
.22
8170
201
MIN
AR
TIN
EO
RA
L.S
OL
1G/1
0ML
VIA
L (S
ING
LE D
OSB
Tx10
FLx1
0ML
11804 ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ)
ATC
2281
702
02M
INA
RTI
NE
OR
AL.
SO
L1G
/10M
L V
IAL
(SIN
GLE
DO
SBTx
10 A
MP
(PP
)23
1630
101
MIN
OA
OR
AL.
SO
L1G
/10
ML(
1 )
BTx
10 V
IALS
x10
ML
2331
101
01O
SK
AN
AO
RA
L.S
OL
1G/1
0ML
SIN
GLE
DO
SE
BTx
10V
IALS
x10M
L20
5780
101
PH
AC
OV
ITO
R.S
OL.
SD
1G/1
0ML
BTX
10FL
X10
ML
BR
OS
.
..
2767
901
01R
IDO
VE
TE
FF.G
RA
N1G
/SA
CH
ET
BTx
15 (S
AC
HE
TS)
2767
901
02R
IDO
VE
TE
FF.G
RA
N1G
/SA
CH
ET
BTx
30 (S
AC
HE
TS)
2268
502
01S
OLU
DA
MIN
OR
.SO
L.S
D1G
/SIN
GLE
DO
SE
BTx
10 (F
L x
10 M
L)19
0380
201
SU
PE
RA
MIN
OR
.SO
L.S
D1G
/10M
L F
L.B
TX10
(FLX
10M
L)V
IAN
EX
A.E
.
1903
803
01S
UP
ER
AM
INO
RA
L.S
OL
2G/1
0ML
VIA
LB
T x
10 F
L x
10 M
LV
IAN
EX
A.E
.
2463
902
01TR
IAN
OR
.SO
L.S
D1G
/10M
LB
Tx 5
x 1
0 M
L(A
MB
ER
DE
MO
AB
EE
24
6390
202
TRIA
NO
R.S
OL.
SD
1G/1
0ML
BTx
10x1
0ML(
AM
BE
RD
EM
O A
BE
E
2463
902
03TR
IAN
OR
.SO
L.S
D1G
/10M
LB
Tx5x
10M
L(P
LAS
TIC
DE
MO
AB
EE
24
6390
204
TRIA
NO
R.S
OL.
SD
1G/1
0ML
BTx
10x1
0ML(
PLA
STI
CD
EM
O A
BE
E
2290
301
01TR
INA
LIN
OR
.SO
L.S
D1G
/10M
L(S
ING
LE D
OS
E)
BTx
10
FL x
10
ML
..
2849
301
01V
IGO
RU
P (
)E
FF.G
RA
N10
00M
G/S
AC
HE
TB
Tx30
(SA
CH
ETS
x5G
)H
ER
EM
CO
A
16A
A01
L
EV
OC
AR
NIT
INE
TA
RTR
ATE
2816
001
01C
AR
NIT
OP
PD
.OR
A.S
OL
1000
MG
/SA
CH
ET
BT
x 30
SA
CH
ETS
SA
NO
PH
AR
M A
E
2756
301
01E
RG
OG
EN
EF.
TAB
1000
MG
/TA
BB
Tx12
(STR
IPS
3x4
).&
./
2756
301
02E
RG
OG
EN
EF.
TAB
1000
MG
/TA
BB
Tx28
(STR
IPS
7x4
).&
./
2050
703
01IN
TELE
CTA
EFF
.GR
AN
1000
MG
/SA
CH
ET
BTx
10 S
AC
HE
TS x
5 G
UN
I-PH
AR
MA
20
5070
302
INTE
LEC
TAE
FF.G
RA
N10
00M
G/S
AC
HE
TB
Tx30
SA
CH
ETS
x 5
GU
NI-P
HA
RM
A
2050
703
03IN
TELE
CTA
EFF
.GR
AN
1000
MG
/SA
CH
ET
BTx
10 S
AC
HE
TS x
UN
I-PH
AR
MA
20
5070
304
INTE
LEC
TAE
FF.G
RA
N10
00M
G/S
AC
HE
TB
Tx30
SA
CH
ETS
xU
NI-P
HA
RM
A
2761
902
01LE
CA
RN
AP
D.O
RA
.SO
L10
00M
G/S
AC
HE
TB
T x
30 S
AC
HE
TSB
EN
NE
TT
2765
801
01LE
VO
CU
OR
PD
.OR
A.S
OL
1000
MG
/SA
CH
ET
BT
x 30
SA
CH
ETS
NE
XU
S M
ED
ICA
LS A
.E.
28
5050
101
RE
VO
TON
INE
EF.
TAB
1000
MG
/TA
BB
Tx30
P
HA
RM
A L
INE
A.E
.
2850
501
02R
EV
OTO
NIN
EE
F.TA
B10
00M
G/T
AB
BTx
30 (B
OTT
LES
3x1
0)P
HA
RM
A L
INE
A.E
.
2793
301
01X
AR
ITIC
PD
.OR
A.S
OL
2000
MG
/SA
CH
ET
x30
SA
CH
ETS
S.J
.A. P
HA
RM
B
A
B01
A
B01
A
AB
01A
C
A,
B01
AC
06
AC
ETY
LSA
LIC
YLA
TE L
YS
INE
ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ) 11805
ATC
1035
106
01E
GIC
ALM
PD
.OR
.SD
288(
160)
MG
/SA
CH
ET
BTX
30 S
AC
HE
TSS
AN
OFI
-AV
EN
TIS
AE
BE
10
3510
701
EG
ICA
LMP
D.O
R.S
D54
0(30
0)M
G/S
AC
HE
TB
Tx30
SA
CH
ETS
SA
NO
FI-A
VE
NTI
S A
EB
E
1035
108
01E
GIC
ALM
PD
.OR
.SD
180
(100
)MG
/SA
CH
ET
X 2
0 S
AC
HE
TSS
AN
OFI
-AV
EN
TIS
AE
BE
10
3510
802
EG
ICA
LMP
D.O
R.S
D18
0 (1
00)M
G/S
AC
HE
TB
T X
30
SA
CH
ETS
SA
NO
FI-A
VE
NTI
S A
EB
E
1035
110
01E
GIC
ALM
PD
.OR
.SD
135(
75)M
G/S
AC
HE
TB
TX30
SA
CH
ETS
SA
NO
FI-A
VE
NTI
S A
EB
E
B01
AC
06
AC
ETY
LSA
LIC
YLI
C A
CID
0416
704
01A
SP
IRIN
TAB
100M
G/T
AB
x20(
BLI
ST2
x10)
BA
YE
R
0156
903
01B
UFF
ER
INTA
B32
4MG
/TA
BB
Tx20
NO
VA
RTI
S (H
ELL
AS
) A.E
2834
501
01C
AR
DIO
RA
L (
10(
1))
SO
FT.C
AP
S75
MG
/CA
PB
Tx30
(BLI
ST3
x10)
IBS
A F
AR
MA
CE
UTI
CI I
TA19
2550
501
SA
LOS
PIR
TAB
325M
G/T
AB
BTX
20 (B
LIS
T.2X
10)
UN
I-PH
AR
MA
19
2550
901
SA
LOS
PIR
EF.
TAB
100M
G/T
AB
10U
NI-P
HA
RM
A
1925
509
02S
ALO
SP
IRE
F.TA
B10
0MG
/TA
B12
(FO
IL3X
4)U
NI-P
HA
RM
A
1925
510
01S
ALO
SP
IRE
F.TA
B32
5MG
/TA
B10
UN
I-PH
AR
MA
19
2551
002
SA
LOS
PIR
EF.
TAB
325M
G/T
AB
BTX
12(F
OIL
3X4)
UN
I-PH
AR
MA
19
2551
301
SA
LOS
PIR
EFF
.GR
AN
100M
G/D
OS
E S
AC
HE
TB
Tx10
SA
CH
ETS
UN
I-PH
AR
MA
19
2551
401
SA
LOS
PIR
EFF
.GR
AN
325M
G/D
OS
E S
AC
HE
T10
SA
CH
ETS
UN
I-PH
AR
MA
19
2551
501
SA
LOS
PIR
TAB
75M
G/T
AB
BTX
20(B
LIS
T2X
10)
UN
I-PH
AR
MA
19
2551
601
SA
LOS
PIR
TAB
100M
G/T
AB
20(B
LIS
T2X
10)
UN
I-PH
AR
MA
23
0970
101
DIS
PR
ILC
HW
.TA
B30
0MG
/TA
BB
TX10
(STR
IP 1
X10
)V
IAN
EX
A.E
.
2309
701
02D
ISP
RIL
CH
W.T
AB
300M
G/T
AB
BTX
12(S
TRIP
S 2
X6)
VIA
NE
X A
.E.
23
0970
103
DIS
PR
ILC
HW
.TA
B30
0MG
/TA
BB
TX20
( STR
IPS
2X
10)
VIA
NE
X A
.E.
23
0970
104
DIS
PR
ILC
HW
.TA
B30
0MG
/TA
BB
TX24
(STR
IPS
4X
6)V
IAN
EX
A.E
.
2309
701
05D
ISP
RIL
CH
W.T
AB
300M
G/T
AB
BTX
48(S
TRIP
S 8
X6)
VIA
NE
X A
.E.
23
0970
201
DIS
PR
ILD
ISP
.TA
B30
0MG
/TA
BB
TX10
(STR
IP 1
X10
)V
IAN
EX
A.E
.
2309
702
02D
ISP
RIL
DIS
P.T
AB
300M
G/T
AB
BTX
12(S
TRIP
S 2
X6)
VIA
NE
X A
.E.
23
0970
203
DIS
PR
ILD
ISP
.TA
B30
0MG
/TA
BB
TX20
(STR
IPS
2X
10)
VIA
NE
X A
.E.
23
0970
204
DIS
PR
ILD
ISP
.TA
B30
0MG
/TA
BB
TX24
(STR
IPS
4X
6)V
IAN
EX
A.E
.
2309
702
05D
ISP
RIL
DIS
P.T
AB
300M
G/T
AB
BTX
48(S
TRIP
S 8
X6)
VIA
NE
X A
.E.
C
C05 C
05A
C05
AX
C05
AX
11806 ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ)
ATC
1972
201
01B
EN
OS
TAN
PR
OC
TOR
EC
T.C
RE
AM
TUB
x 2
8 G
BE
NO
STA
N
C05
CC
05C
XC
05C
X
CO
AS
TAL
PIN
E'S
DR
Y B
AR
K E
XTR
AC
T O
R P
INU
S P
INA
STE
R O
R P
INU
S M
AR
ITIM
A23
3920
101
PY
CN
OG
EN
OL
TAB
20M
G/T
AB
BTx
60 (B
LIS
T 4x
15)
VIL
CO
A.E
.
2339
201
02P
YC
NO
GE
NO
LTA
B20
MG
/TA
BB
Tx30
(BLI
ST
2x15
)V
ILC
O A
.E.
23
3920
201
PY
CN
OG
EN
OL
TAB
50M
G/T
AB
BTx
60 (B
LIS
T 4x
15)
VIL
CO
A.E
.
2339
202
02P
YC
NO
GE
NO
LTA
B50
MG
/TA
BB
Tx30
(BLI
ST
2x15
)V
ILC
O A
.E.
D
D01 D
01A
D01
AC
D01
AC
01
CLO
TRIM
AZO
LE11
2200
401
CA
NE
STE
NC
RE
AM
1%TU
Bx2
0GB
AY
ER
11
2200
601
CA
NE
STE
NC
UT.
SO
L1%
FL x
20
ML
BA
YE
R
D01
AC
02
MIC
ON
AZO
LE N
ITR
ATE
0919
306
01D
AK
TAR
INP
D.E
XT.
US
2% (
W/W
)FL
x20
GJO
HN
SO
N A
ND
JO
HN
SO
1599
702
01U
NTA
NO
PD
.EX
T.U
S2%
FLX
25G
RA
FAR
M A
.E.B
.E.
D
01A
C08
K
ETO
CO
NA
ZOLE
1815
501
02A
BB
AM
ED
.SH
AM
P2%
W/W
FLX
120M
LM
ED
ICH
RO
M A
.E.
18
1550
103
AB
BA
ME
D.S
HA
MP
2% W
/WFL
X18
0ML
ME
DIC
HR
OM
A.E
.
0918
702
01A
QU
AR
IUS
ME
D.S
HA
MP
2% (
W/V
)FL
x60M
LD
EM
O A
BE
E
0918
702
02A
QU
AR
IUS
ME
D.S
HA
MP
2% (
W/V
)FL
x120
ML
DE
MO
AB
EE
20
0560
101
BO
TAD
ER
MM
ED
.SH
AM
P2%
W/W
FLx1
20 M
LB
IOS
PR
AY
AB
EE
20
0560
102
BO
TAD
ER
MM
ED
.SH
AM
P2%
W/W
FLx1
80 M
LB
IOS
PR
AY
AB
EE
20
3170
301
EB
ER
SE
PT
ME
D.S
HA
MP
2% W
/VFL
X60
ML
BR
OS
.
..
2031
703
02E
BE
RS
EP
TM
ED
.SH
AM
P2%
W/V
FLX
120M
LB
RO
S
..
.25
5160
101
FLID
AP
HE
NM
ED
.SH
AM
P2%
(W/V
)FL
x120
ML
ZWIT
TER
PH
AR
MA
CE
UT
2551
601
02FL
IDA
PH
EN
ME
D.S
HA
MP
2% (W
/V)
FLx1
80 M
LZW
ITTE
R P
HA
RM
AC
EU
T18
5090
302
FUN
GO
RA
LM
ED
.SH
AM
P2%
W/W
FLx1
20 M
LJO
HN
SO
N A
ND
JO
HN
SO
1850
904
01FU
NG
OR
AL
ME
D.S
HA
MP
1% W
/WFL
x60
ML
JOH
NS
ON
AN
D J
OH
NS
O18
5090
402
FUN
GO
RA
LM
ED
.SH
AM
P1%
W/W
FLx1
00 M
LJO
HN
SO
N A
ND
JO
HN
SO
1850
904
03FU
NG
OR
AL
ME
D.S
HA
MP
1% W
/WS
AC
HE
Tx6
ML
JOH
NS
ON
AN
D J
OH
NS
O
ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ) 11807
ATC
1850
904
04FU
NG
OR
AL
ME
D.S
HA
MP
1% W
/WFL
x200
ML
JOH
NS
ON
AN
D J
OH
NS
O09
6140
301
ILG
EM
ME
D.S
HA
MP
2%FL
X60
ML
RA
FAR
M A
.E.B
.E.
09
6140
302
ILG
EM
ME
D.S
HA
MP
2%FL
X12
0ML
RA
FAR
M A
.E.B
.E.
26
3260
101
KE
TOC
ON
AZO
LE/B
EV
OM
ED
.SH
AM
P20
MG
/G (2
%)
FL x
120
ML
BE
VO
A.E
.
2632
601
02K
ETO
CO
NA
ZOLE
/BE
VO
ME
D.S
HA
MP
20M
G/G
(2%
)B
TxB
OTT
LEx1
80M
LB
EV
O A
.E.
22
6360
201
KE
TOC
ON
AZO
LE/G
EN
EP
HA
RM
ME
D.S
HA
MP
2%FL
x60M
LG
EN
EP
HA
RM
AE
22
6360
202
KE
TOC
ON
AZO
LE/G
EN
EP
HA
RM
ME
D.S
HA
MP
2%FL
x120
ML
GE
NE
PH
AR
M A
E
2263
602
03K
ETO
CO
NA
ZOLE
/GE
NE
PH
AR
MM
ED
.SH
AM
P2%
BTX
84FL
X12
0ML
GE
NE
PH
AR
M A
E
2263
602
04K
ETO
CO
NA
ZOLE
/GE
NE
PH
AR
MM
ED
.SH
AM
P2%
FL x
180
ML
GE
NE
PH
AR
M A
E
2564
901
01LI
BR
OM
AN
ME
D.S
HA
MP
2% (W
/V)
BO
TTLE
x12
0 M
LD
EK
AZ
..
.20
8870
101
NE
O-E
GM
OL
ME
D.S
HA
MP
2%(W
/W)
FLx6
0ML
TAR
GE
T P
HA
RM
A
2088
701
02N
EO
-EG
MO
LM
ED
.SH
AM
P2%
(W/W
)FL
x 1
20M
LTA
RG
ET
PH
AR
MA
20
8870
103
NE
O-E
GM
OL
ME
D.S
HA
MP
2%(W
/W)
FLx1
80M
LTA
RG
ET
PH
AR
MA
26
5620
101
NY
OX
EP
ME
D.S
HA
MP
2% (
W/V
)FL
x120
ML
..
2656
201
02N
YO
XE
PM
ED
.SH
AM
P2%
(W
/V)
FLx1
80 M
L.
.20
1390
101
AD
EN
OS
AN
ME
D.S
HA
MP
2% W
/WFL
X60
ML
IAS
IS P
HA
RM
AC
.HE
LLA
S20
1390
102
AD
EN
OS
AN
ME
D.S
HA
MP
2% W
/WFL
X12
0ML
IAS
IS P
HA
RM
AC
.HE
LLA
S20
1390
103
AD
EN
OS
AN
ME
D.S
HA
MP
2% W
/WFL
X18
0ML
IAS
IS P
HA
RM
AC
.HE
LLA
SD
01A
ED
01A
E15
T
ER
BIN
AFI
NE
HY
DR
OC
HLO
RID
E26
5970
101
AN
AP
LAS
CU
T.S
OL
1% W
/WFL
x30M
L.&
./
2659
702
01A
NA
PLA
SG
EL
10M
G/G
(1%
)TU
Bx1
5G.&
./
2659
702
02A
NA
PLA
SG
EL
10M
G/G
(1%
)TU
Bx3
0G.&
./
2662
002
01C
HE
MID
ER
MS
PR
.SO
L1%
(W/W
)B
Tx1
FLx1
5 M
L+IA
SIS
PH
AR
MA
C.H
ELL
AS
2662
002
02C
HE
MID
ER
MS
PR
.SO
L1%
(W/W
)B
Tx1
FLx3
0 M
L+IA
SIS
PH
AR
MA
C.H
ELL
AS
2662
002
03C
HE
MID
ER
MS
PR
.SO
L1%
(W/W
)B
Tx1
FLx5
0 M
L+IA
SIS
PH
AR
MA
C.H
ELL
AS
2639
302
01E
ALK
CU
T.S
OL
1%
W/W
BTx
1BO
TTLE
x30M
L.
.26
3930
202
EA
LKC
UT.
SO
L1%
W
/WB
Tx1B
OTT
LEx3
0ML
+.
.26
3930
203
EA
LKC
UT.
SO
L1%
W
/WB
Tx1B
OTT
LEx5
0ML
..
2639
302
04E
ALK
CU
T.S
OL
1%
W/W
BTx
1BO
TTLE
x50M
L+.
.26
3930
205
EA
LKC
UT.
SO
L1%
W
/WB
Tx1B
OTT
LEx6
0ML+
..
2639
302
06E
ALK
CU
T.S
OL
1%
W/W
BTx
1BO
TTLE
x100
ML+
..
2634
702
01FL
IXID
SP
R.S
OL
1% (W
/W)
BT
x 1
FL x
15
ML
+
11808 ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ)
ATC
2634
702
02FL
IXID
SP
R.S
OL
1% (W
/W)
BT
x 1
FL x
30
ML
+26
3470
203
FLIX
IDS
PR
.SO
L1%
(W/W
)B
T x
1 FL
x 5
0 M
L +
2655
401
01FR
EZY
LIN
SP
R.S
OL
1% W
/WB
T X
1 F
L X
30
ML
FRE
ZYD
ER
M A
BE
E
2655
401
02FR
EZY
LIN
SP
R.S
OL
1% W
/WB
T X
1 F
L X
15
ML
FRE
ZYD
ER
M A
BE
E
2040
606
01LA
MIS
IL D
ER
MG
EL
GE
L1%
W
/WTU
B x
5 g
NO
VA
RTI
S (H
ELL
AS
) A.E
2040
606
02LA
MIS
IL D
ER
MG
EL
GE
L1%
W
/WTU
B x
15
gN
OV
AR
TIS
(HE
LLA
S) A
.E20
4060
603
LAM
ISIL
DE
RM
GE
LG
EL
1%
W/W
TUB
x 3
0 g
NO
VA
RTI
S (H
ELL
AS
) A.E
2040
607
01LA
MIS
IL O
NC
EC
UT.
SO
L1%
(W/W
) (1
0MG
/1G
)TU
B x
4 G
NO
VA
RTI
S (H
ELL
AS
) A.E
2663
201
01LI
ZAM
ITP
EX
SP
R.S
OL
1% W
/VB
Tx1
FLx1
5 M
L.
.26
6320
102
LIZA
MIT
PE
XS
PR
.SO
L1%
W/V
BTx
1 FL
x30
ML
..
2663
201
03LI
ZAM
ITP
EX
SP
R.S
OL
1% W
/VB
Tx1
FLx1
5 M
L.
.26
3110
101
PA
VLI
NO
XC
UT.
SO
L1%
BTx
1FLx
30M
LM
ED
ICU
S A
.E.
26
5930
101
SE
RA
LON
SP
R.S
OL
1% W
/WB
Tx1F
Lx30
ML+
ME
DO
CH
EM
IE H
ELL
AS
A26
5930
102
SE
RA
LON
SP
R.S
OL
1% W
/WB
Tx1F
Lx50
ML+
ME
DO
CH
EM
IE H
ELL
AS
A26
8060
101
SO
LUTE
RB
CU
T.S
OL
1% W
/WB
Tx 1
FL
x 30
ML
2680
601
02S
OLU
TER
BC
UT.
SO
L1%
W/W
BTx
1BO
TTLE
x60M
L26
8060
103
SO
LUTE
RB
CU
T.S
OL
1% W
/WB
Tx1B
OTT
LEx1
00M
L25
1810
201
TER
BIG
RA
MC
UT.
SO
L1%
BTX
1BO
T X
30M
LLA
VIP
HA
RM
AE
26
5610
101
TER
BIN
SP
R.S
OL
1% W
/WB
T X
1 F
L X
30
ML
+G
AB
RIE
L H
EA
LTH
26
5610
102
TER
BIN
SP
R.S
OL
1% W
/WB
T X
1 F
L X
15
ML
GA
BR
IEL
HE
ALT
H
2600
402
01TE
RB
INA
FIN
E/T
AR
GE
TS
PR
.SO
L1%
(W
/V)
BT
x 1
FL x
15
ML+
TAR
GE
T P
HA
RM
A
2600
402
02TE
RB
INA
FIN
E/T
AR
GE
TS
PR
.SO
L1%
(W
/V)
BT
x 1
FL x
30
ML+
TAR
GE
T P
HA
RM
A
2601
702
01TE
RB
IPR
OL
SP
R.S
OL
1%
(W
/W)
BTx
1FLx
15M
L+P
RO
EL
A.E
.26
0170
202
TER
BIP
RO
LS
PR
.SO
L1%
(
W/W
)B
Tx1F
Lx30
ML+
PR
OE
L A
.E.
2655
501
01TE
RFI
NIL
SP
R.S
OL
1% W
/WB
Tx1F
Lx15
ML+
BIO
ME
DIC
A-C
HE
MIC
A A
E26
5550
102
TER
FIN
ILS
PR
.SO
L1%
W/W
BTx
1FLx
30M
L+B
IOM
ED
ICA
-CH
EM
ICA
AE
2655
301
01TH
ATE
RO
NS
PR
.SO
L1%
W/W
BT
x 1
FL x
30
ML
+A
LAP
IS A
BE
E
2655
301
02TH
ATE
RO
NS
PR
.SO
L1%
W/W
BT
x 1
FL x
15
ML
+A
LAP
IS A
BE
E
2040
604
01LA
MIS
ILC
UT.
SO
L1%
FLX
30M
LN
OV
AR
TIS
(HE
LLA
S) A
.E20
4060
501
LAM
ISIL
SP
R.S
OL
1%FL
X30
ML(
NO
VA
RTI
S (H
ELL
AS
) A.E
2040
605
02LA
MIS
ILS
PR
.SO
L1%
FLX
15M
L(N
OV
AR
TIS
(HE
LLA
S) A
.ED
02 D02
A
*02008401205110048*
ATC
D02
AB
D02
AB
W
HIT
E S
OFT
PA
RA
FFIN
,ZIN
C O
XID
E11
4500
101
VA
SE
LIN
E O
XY
DE
DE
ZIN
C/N
I-TH
EO
INTM
EN
T(9
0+10
)%B
TX1T
UB
X18
GN
I-TH
E
..
.11
4500
102
VA
SE
LIN
E O
XY
DE
DE
ZIN
C/N
I-TH
EO
INTM
EN
T(9
0+10
)%B
TX12
TUB
X18
GN
I-TH
E
..
.D
02A
C
MD
02A
C
WH
ITE
SO
FT P
AR
AFF
IN11
9000
101
VA
SE
LIN
E P
UR
E/N
I-TH
EO
INTM
EN
T10
0%V
AS
EX
50G
NI-T
HE
.
..
1190
001
02V
AS
ELI
NE
PU
RE
/NI-T
HE
OIN
TME
NT
100%
BTX
12V
AS
ES
X50
GN
I-TH
E
..
.11
9000
103
VA
SE
LIN
E P
UR
E/N
I-TH
EO
INTM
EN
T10
0%V
AS
EX
100G
NI-T
HE
.
..
1190
001
04V
AS
ELI
NE
PU
RE
/NI-T
HE
OIN
TME
NT
100%
BTX
12V
AS
ES
X10
0GN
I-TH
E
..
.11
9000
105
VA
SE
LIN
E P
UR
E/N
I-TH
EO
INTM
EN
T10
0%B
TX1T
UB
X17
GN
I-TH
E
..
.11
9000
106
VA
SE
LIN
E P
UR
E/N
I-TH
EO
INTM
EN
T10
0%B
TX12
TUB
X17
GN
I-TH
E
..
.11
9000
107
VA
SE
LIN
E P
UR
E/N
I-TH
EO
INTM
EN
T10
0%B
TX24
TUB
X17
GN
I-TH
E
..
.11
9000
108
VA
SE
LIN
E P
UR
E/N
I-TH
EO
INTM
EN
T10
0%B
TX1T
UB
X25
GN
I-TH
E
..
.11
9000
109
VA
SE
LIN
E P
UR
E/N
I-TH
EO
INTM
EN
T10
0%B
TX12
TUB
X25
GN
I-TH
E
..
.D
02A
XD
02A
X
YE
AS
T C
ELL
EX
TRA
CT,
SH
AR
E L
IVE
R O
IL22
3410
201
PR
EP
AR
ATI
ON
HO
INTM
EN
T(1
+3)%
TUB
x 2
5 G
PFI
ZER
.
.22
3410
202
PR
EP
AR
ATI
ON
HO
INTM
EN
T(1
+3)%
TUB
x 5
0 G
PFI
ZER
.
.D
04,
,,
.D
04A
,,
,.
D04
AA
D04
AA
13
DIM
ETI
ND
EN
E M
ALE
ATE
0228
301
01FE
NIS
TIL
GE
L0,
1% (W
/W)
x30
GN
OV
AR
TIS
(HE
LLA
S) A
.E02
2830
801
FEN
ISTI
LE
MU
L.E
XT.
U0,
1% (
W/V
)TU
Bx1
00 M
LN
OV
AR
TIS
(HE
LLA
S) A
.E02
2830
802
FEN
ISTI
LE
MU
L.E
XT.
U0,
1% (
W/V
)FL
x8 M
LN
OV
AR
TIS
(HE
LLA
S) A
.ED
06 D06
AD
06A
XD
06A
X04
H
OR
SE
LIV
ER
CA
TALA
SE
,NE
OM
YC
IN S
ULF
ATE
1313
001
01P
ULV
O-4
7A
ER
.TO
P(1
0811
UC
+2,2
3MG
)/GFL
x74G
AB
BO
TT L
AB
OR
ATO
RIE
S13
1300
102
PU
LVO
-47
AE
R.T
OP
(108
11 U
C+2
,23M
G)/G
FLx1
48G
AB
BO
TT L
AB
OR
ATO
RIE
SD
06B
ΦΕΚ 840 ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ) 11809
11810 ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ)
ATC
D06
BB
-D
06B
B03
A
CIC
LOV
IR19
3180
102
AB
DU
CE
CR
EA
M5%
W
/WTU
BX
2GIA
SIS
PH
AR
MA
C.H
ELL
AS
1951
301
02C
AR
GO
SIL
CR
EA
M5%
TUB
X2G
GE
NE
PH
AR
M A
E
2062
701
02C
YC
LOV
IRA
N/M
ED
ICH
RO
MC
RE
AM
5%TU
BX
2GM
ED
ICH
RO
M A
.E.
24
1870
101
ER
PA
CLO
VIR
CR
EA
M5%
TUB
x 2
GA
LAP
IS A
BE
E
2086
902
01E
TAS
ISE
NC
RE
AM
5%TU
B X
2G
RA
FAR
M A
.E.B
.E.
21
0650
301
HA
GE
VIR
CR
EA
M5%
W/W
TUB
X2G
CO
SM
OP
HA
RM
20
5390
201
HE
LPO
SO
LC
RE
AM
5%TU
BX
2GH
ELP
23
6050
101
NE
LDIM
CR
EA
M5%
BTX
2GV
ILC
O A
.E.
19
2490
302
UN
IPLE
XC
RE
AM
5%TU
BX
2GU
NI-P
HA
RM
A
2426
601
01V
ER
PIR
CR
EA
M5%
TUB
x2G
2231
801
02V
IRU
STE
RIL
CR
EA
M5%
W/W
TUB
x2 G
RB
IOS
PR
AY
AB
EE
20
6970
301
ZIC
OTE
NC
RE
AM
5%TU
BX
2GIT
F H
ELL
AS
A.E
.
2387
401
01ZI
DO
VIM
MC
RE
AM
5%B
T X
1TU
B X
2G
..
1880
203
02ZO
VIR
AX
CR
EA
M5%
(W/W
)TU
B x
2
GG
LAX
OS
MIT
HK
LIN
E A
EB
1984
501
01ZO
VIR
AX
CR
EA
M5%
TUB
X2G
.22
9290
101
ZOV
IRA
XC
RE
AM
5%TU
BX
2G/
D06
BB
06
PE
NC
ICLO
VIR
2738
801
01FE
NIV
IRC
RE
AM
1% (W
/W)
TUB
x 2
GN
OV
AR
TIS
(HE
LLA
S) A
.E27
3880
102
FEN
IVIR
CR
EA
M1%
(W/W
)TU
B x
5 G
NO
VA
RTI
S (H
ELL
AS
) A.E
2738
801
03FE
NIV
IRC
RE
AM
1% (W
/W)
PU
MP
x 2
GN
OV
AR
TIS
(HE
LLA
S) A
.E27
3880
104
FEN
IVIR
CR
EA
M1%
(W/W
)B
T (T
UB
x 2
G +
NO
VA
RTI
S (H
ELL
AS
) A.E
D06
BB
11
DO
CO
SA
NO
L26
7540
101
HE
ALI
PC
RE
AM
10%
(w
/w)
BTx
TUB
x2G
JEN
SO
N P
HA
RM
AC
EU
TI
2675
401
02H
EA
LIP
CR
EA
M10
% (
w/w
)B
TxTU
Bx5
GJE
NS
ON
PH
AR
MA
CE
UTI
26
7540
103
HE
ALI
PC
RE
AM
10%
(w
/w)
BTx
TUB
x15G
JEN
SO
N P
HA
RM
AC
EU
TI
D08 D
08A
D08
AC
D08
AC
02
CH
LOR
HE
XID
INE
GLU
CO
NA
TE03
6390
301
HIB
ITA
NE
CU
T.S
OL
0,5%
(W/V
)FL
x500
ML
CA
NA
.E
.03
6390
302
HIB
ITA
NE
CU
T.S
OL
0,5%
(W/V
)FL
x250
ML
CA
NA
.E
.
ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ) 11811
ATC
0363
905
01H
IBIT
AN
EC
RE
AM
1%TU
Bx5
0GC
AN
A
.E.
0363
906
01H
IBIT
AN
EM
ED
.L.S
OA
P4%
(W
/V)
FLx1
40M
LC
AN
A
.E.
0363
906
02H
IBIT
AN
EM
ED
.L.S
OA
P4%
(W
/V)
FLx1
000M
LC
AN
A
.E.
0363
906
03H
IBIT
AN
EM
ED
.L.S
OA
P4%
(W
/V)
FLx2
50M
LC
AN
A
.E.
2420
101
01LI
FO-S
CR
UB
CU
T.S
OL
4%FL
X10
0ML
..
D08
AD
D08
AD
W
HIT
E S
OFT
PA
RA
FFIN
,BO
RIC
AC
ID12
1040
101
VA
SE
LIN
E B
OR
IQU
E/N
I-TH
EO
INTM
EN
T(9
0+10
)%B
TX1T
UB
X18
GN
I-TH
E
..
.12
1040
102
VA
SE
LIN
E B
OR
IQU
E/N
I-TH
EO
INTM
EN
T(9
0+10
)%B
TX12
TUB
X18
GN
I-TH
E
..
.D
08A
ED
08A
E05
C
HLO
RO
XY
LEN
OL
2828
301
01D
ETT
OLS
EP
TC
UT.
SO
L4,
8% (W
/V)
FL x
108
ML
2828
301
02D
ETT
OLS
EP
TC
UT.
SO
L4,
8% (W
/V)
EIO
2828
301
03D
ETT
OLS
EP
TC
UT.
SO
L4,
8% (W
/V)
FL x
125
ML
2828
301
04D
ETT
OLS
EP
TC
UT.
SO
L4,
8% (W
/V)
FL x
250
ML
2828
301
05D
ETT
OLS
EP
TC
UT.
SO
L4,
8% (W
/V)
FL x
500
ML
2828
301
06D
ETT
OLS
EP
TC
UT.
SO
L4,
8% (W
/V)
FL x
1 L
2828
301
07D
ETT
OLS
EP
TC
UT.
SO
L4,
8% (W
/V)
FL x
750
ML
D08
AG
D08
AG
02
PO
VID
ON
E-IO
DIN
E01
7941
001
BE
TAD
INE
CR
EA
M5%
TUB
X 3
0GLA
VIP
HA
RM
AE
D
08A
G03
E
THA
NO
L (9
5 P
ER
CE
NT)
,IOD
INE
,SO
DIU
M IO
DID
E18
6550
101
/RE
VIF
AR
TIN
CT
FLX
100M
LR
EV
IFA
R A
.E.
D
08A
G03
I
OD
INE
2344
801
01IO
DIN
E S
OLU
TIO
N/E
CO
FAR
MC
UT.
SO
L7%
FLx5
0ML
EC
O-F
AR
M A
E
2210
801
01 2
%/M
ED
IPLA
NTS
TIN
CT
2%FL
X65
ML
ME
DIP
LAN
TS
.22
1080
102
2%
/ME
DIP
LAN
TSTI
NC
T2%
FLX
75M
LM
ED
IPLA
NTS
.
2210
801
03 2
%/M
ED
IPLA
NTS
TIN
CT
2%FL
X10
0ML
ME
DIP
LAN
TS
.24
2260
101
/C
UT.
SO
L2%
FL X
50M
L..
&
..
D08
AG
03
IO
DIN
E,P
OTA
SS
IUM
IOD
IDE
,IOD
INE
2347
602
01IO
DIN
E/B
IOS
PR
AY
AB
EE
CU
T.S
OL
2,30
%FL
X50
ML
BIO
SP
RA
Y A
BE
E
D08
AK
04
ME
RB
RO
MIN
2344
901
01M
ER
BR
OM
IN (
)/EC
OF
CU
T.S
OL
2%FL
x30M
LE
CO
-FA
RM
AE
11812 ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ)
ATC
2210
901
01M
ER
BR
OM
IN 2
%/M
ED
IPLA
NTS
CU
T.S
OL
2% W
/VFL
X50
ML
ME
DIP
LAN
TS
.22
1090
102
ME
RB
RO
MIN
2%
/ME
DIP
LAN
TSC
UT.
SO
L2%
W/V
FLX
100M
LM
ED
IPLA
NTS
.
2422
701
01M
ER
CU
RO
CH
RO
ME
/C
UT.
SO
L2%
FLX
100M
L..
&
..
D08
AX
D08
AX
01
HY
DR
OG
EN
PE
RO
XID
E27
1610
101
BIO
SE
PT
SP
R.S
OL
3% (
W/V
)FL
x 1
00 M
LB
IOS
PR
AY
AB
EE
23
5730
101
CR
YS
TAC
IDE
CR
EA
M1%
W/W
TUB
x5 G
2357
301
02C
RY
STA
CID
EC
RE
AM
1% W
/WTU
B10
G23
5730
103
CR
YS
TAC
IDE
CR
EA
M1%
W/W
TUB
x25
G23
5730
104
CR
YS
TAC
IDE
CR
EA
M1%
W/W
TUB
x40
G23
4470
101
HY
DR
OG
EN
PE
RO
XID
E /E
CO
FAR
MC
UT.
SO
L3%
FLX
200M
L(.
)E
CO
-FA
RM
AE
23
4470
102
HY
DR
OG
EN
PE
RO
XID
E /E
CO
FAR
MC
UT.
SO
L3%
FLX
500M
L(.
)E
CO
-FA
RM
AE
22
1070
101
OX
YG
EN
ATE
D W
ATE
R 3
%/M
ED
IPLA
NTS
CU
T.S
OL
3% (W
/V)
FLx1
00 M
LM
ED
IPLA
NTS
.
2210
701
02O
XY
GE
NA
TED
WA
TER
3%
/ME
DIP
LAN
TSC
UT.
SO
L3%
(W/V
)FL
x240
ML
ME
DIP
LAN
TS
.22
1070
103
OX
YG
EN
ATE
D W
ATE
R 3
%/M
ED
IPLA
NTS
CU
T.S
OL
3% (W
/V)
FLx5
00 M
LM
ED
IPLA
NTS
.
2210
701
04O
XY
GE
NA
TED
WA
TER
3%
/ME
DIP
LAN
TSC
UT.
SO
L3%
(W/V
)FL
x100
0 M
LM
ED
IPLA
NTS
.
2210
701
05O
XY
GE
NA
TED
WA
TER
3%
/ME
DIP
LAN
TSC
UT.
SO
L3%
(W/V
)FL
x100
ML
ME
DIP
LAN
TS
.22
1070
106
OX
YG
EN
ATE
D W
ATE
R 3
%/M
ED
IPLA
NTS
CU
T.S
OL
3% (W
/V)
FLx2
40 M
LM
ED
IPLA
NTS
.
2210
701
07O
XY
GE
NA
TED
WA
TER
3%
/ME
DIP
LAN
TSC
UT.
SO
L3%
(W/V
)FL
x500
ML
ME
DIP
LAN
TS
.22
1070
108
OX
YG
EN
ATE
D W
ATE
R 3
%/M
ED
IPLA
NTS
CU
T.S
OL
3% (W
/V)
FLx1
000
ML
ME
DIP
LAN
TS
.D
08A
X01
H
YD
RO
GE
N P
ER
OX
IDE
SO
LUTI
ON
(30
PE
RC
EN
T)24
2250
101
/C
UT.
SO
L3%
FLx1
00 M
L..
&
..
2422
501
02/
CU
T.S
OL
3%FL
x250
ML
.. &
.
.24
2250
103
/C
UT.
SO
L3%
FLx5
00 M
L..
&
..
2422
501
04/
CU
T.S
OL
3%FL
x100
0 M
L..
&
..
D08
AX
08
ETH
AN
OL
(96
PE
RC
EN
T)26
8560
101
95°
FIR
SCU
T.S
OL
95%
V/V
FL x
240
ML
2685
601
02 9
5° F
IRSC
UT.
SO
L95
% V
/VFL
x 4
20 M
LD
08A
X08
E
THY
L A
LCO
HO
L 96
%23
7930
101
ME
DIP
LCU
T.S
OL
70%
V/V
BO
TTLE
X20
0ML
ME
DIP
LAN
TS
.23
7930
102
ME
DIP
LCU
T.S
OL
70%
V/V
BO
TTLE
X30
0ML
ME
DIP
LAN
TS
.23
7930
103
ME
DIP
LCU
T.S
OL
70%
V/V
BO
TTLE
X50
0ML
ME
DIP
LAN
TS
.23
7930
201
ME
DIP
LCU
T.S
OL
96%
V/V
BO
TTLE
X20
0ML
ME
DIP
LAN
TS
.
ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ) 11813
ATC
2379
302
02 M
ED
IPLC
UT.
SO
L96
% V
/VB
OTT
LEX
300M
LM
ED
IPLA
NTS
.
2379
302
03 M
ED
IPLC
UT.
SO
L96
% V
/VB
OTT
LEX
500M
LM
ED
IPLA
NTS
.
D08
AX
53
IS
OP
RO
PY
L A
LCO
HO
L,B
EN
ZALK
ON
IUM
CH
LOR
IDE
2416
401
01C
UTA
SE
PT
FC
UT.
SO
L(6
3+0,
025)
%FL
X25
0ML
PH
AR
MA
CH
EM
IE,
2416
401
02C
UTA
SE
PT
FC
UT.
SO
L(6
3+0,
025)
%FL
X1L
PH
AR
MA
CH
EM
IE,
2416
401
03C
UTA
SE
PT
FC
UT.
SO
L(6
3+0,
025)
%FL
X5L
PH
AR
MA
CH
EM
IE,
2416
401
04C
UTA
SE
PT
FC
UT.
SO
L(6
3+0,
025)
%FL
X50
ML
PH
AR
MA
CH
EM
IE,
2416
402
01C
UTA
SE
PT
GC
UT.
SO
L63
%+0
.025
%FL
X25
0ML
PH
AR
MA
CH
EM
IE,
2416
402
02C
UTA
SE
PT
GC
UT.
SO
L63
%+0
.025
%FL
X1L
PH
AR
MA
CH
EM
IE,
2416
402
03C
UTA
SE
PT
GC
UT.
SO
L63
%+0
.025
%FL
X5L
PH
AR
MA
CH
EM
IE,
D08
AX
53
IS
OP
RO
PY
L A
LCO
HO
L,N
-PR
OP
YL
ALC
OH
OL
2685
401
01C
HIR
O D
ES
CU
T.S
OL
(63,
14+1
4,3)
% W
/W.
x 1
50M
L.
2685
401
02C
HIR
O D
ES
CU
T.S
OL
(63,
14+1
4,3)
% W
/W.
x 5
00M
L.
2685
401
03C
HIR
O D
ES
CU
T.S
OL
(63,
14+1
4,3)
% W
/W.
x10
00M
L.
2685
401
04C
HIR
O D
ES
CU
T.S
OL
(63,
14+1
4,3)
% W
/W.
x50
00M
L.
D11 D
11A
D11
AC
D11
AC
06
PO
VID
ON
E-IO
DIN
E01
7940
801
BE
TAD
INE
ME
D.S
HA
MP
4%FL
X10
0ML
LAV
IPH
AR
M A
E
2464
709
01P
OV
IOD
INE
ME
D.S
HA
MP
4% W
/VB
TXFL
X10
0ML
ALA
PIS
AB
EE
D
11A
C30
R
EFI
NE
D C
OA
L TA
R26
8730
101
NE
UTR
OG
EN
A T
/GE
LM
ED
.SH
AM
P5
MG
/ML
BO
TTLE
x 1
5 M
LJO
HN
SO
N A
ND
JO
HN
SO
2687
301
02N
EU
TRO
GE
NA
T/G
EL
ME
D.S
HA
MP
5 M
G/M
LB
OTT
LE x
125
ML
JOH
NS
ON
AN
D J
OH
NS
O26
8730
103
NE
UTR
OG
EN
A T
/GE
LM
ED
.SH
AM
P5
MG
/ML
BO
TTLE
x 2
50 M
LJO
HN
SO
N A
ND
JO
HN
SO
D11
AF
D11
AF
S
ALI
CY
LIC
AC
ID18
9720
101
AD
AP
TOP
LAS
TC
OR
N.P
AD
40%
BTx
30P
AQ
x5S
TRIP
SV
ICA
N
.18
9720
102
AD
AP
TOP
LAS
TC
OR
N.P
AD
40%
BTx
1PA
Qx2
STR
IPS
VIC
AN
.
1897
201
03A
DA
PTO
PLA
ST
CO
RN
.PA
D40
%1
PA
Qx5
STR
IPS
VIC
AN
.
1897
202
01A
DA
PTO
PLA
ST
(CA
LLO
US
CA
PS
)C
OR
N.P
AD
160M
G/C
OR
N P
AD
(40%
W/W1
SA
CH
ETx
2CO
RN
.PA
D.
VIC
AN
.
2266
401
01C
ALL
IFU
GO
-ME
DIP
LAN
TSC
UT.
SO
L10
%FL
X10
ML
ME
DIP
LAN
TS
.24
0920
102
HA
NS
AP
LAS
T C
ALL
OU
S P
LAS
TER
TTS
570M
G/3
8CM
BTX
3B
EIE
RS
DO
RF
.
11814 ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ)
ATC
1921
401
01ZI
NO
CO
RN
.PA
D40
%B
TX4P
AD
+4TH
ER
.DIS
C.
SS
L .
.19
2140
102
ZIN
OC
OR
N.P
AD
40%
BTX
2PA
D+2
THE
R.D
ISC
.S
SL
..
1921
403
01ZI
NO
IMP
.GA
UZE
6.4M
G/E
E (4
0% W
/W)
BTX
6S
SL
..
1921
404
01ZI
NO
IMP
.GA
UZE
38,0
1MG
/EE
(40%
W/W
)B
TX2
SS
L .
.D
11A
F
SA
LIC
YLI
C A
CID
,CA
MP
HO
R15
6750
101
2 D
RO
PC
UT.
SO
L12
.5%
+3.1
1%FL
X10
ML
SS
L .
.D
11A
XD
11A
X
EU
CA
LYP
TUS
OIL
,PE
PP
ER
MIN
T O
IL,C
AJU
PU
T O
IL,M
EN
THO
L,N
ATU
RA
L W
INTE
RG
RE
EN
FLA
VO
UR
,JU
NIP
ER
OIL
,CLO
VE
OIL
20
3440
101
OLB
AS
OIL
CU
T.S
OL
W/W
FL X
10
ML
.D
11A
X
EX
PR
ES
SE
D J
UIC
E F
RO
M P
UR
PLE
CO
NE
FLO
WE
R23
6720
201
EC
HIN
AC
INO
INTM
EN
T16
%
W/W
BT
x 1
TUB
x 2
0 G
RO
TTA
PH
AR
M H
ELL
AS
23
6720
202
EC
HIN
AC
INO
INTM
EN
T16
%
W/W
BT
x 1
TUB
x 5
0 G
RO
TTA
PH
AR
M H
ELL
AS
D
11A
X01
M
INO
XID
IL19
7730
201
AX
ELA
NC
UT.
SO
L5%
W/V
FLx6
0ML
1977
301
01A
XE
LAN
CU
T.S
OL
2%FL
x60M
L19
6550
101
BO
TAFE
XC
UT.
SO
L2%
BTx
1FLx
60M
L.
.19
6550
2B
OTA
FEX
CU
T.S
OL
5%B
Tx1F
Lx60
ML
..
2791
201
01D
ILA
INE
()
CU
T.S
OL
5% W
/VFL
x60M
L+A
PP
LIC
ATO
RH
ELP
09
4580
501
EB
ER
SE
DIN
CU
T.S
OL
2% W
/VFL
X60
ML
BR
OS
.
..
2513
001
01H
AIR
WA
YC
UT.
SO
L5%
FL x
60
ML
GA
BR
IEL
HE
ALT
H
2513
002
01H
AIR
WA
YG
EL
2%FL
x 6
0 M
LG
AB
RIE
L H
EA
LTH
19
6370
101
LOTO
RIN
LOT
2% (W
/V)
FLx6
0ML
UN
I-PH
AR
MA
23
9170
101
MIN
OD
RIL
CU
T.S
OL
5%B
TxFL
x60M
L23
9170
201
MIN
OD
RIL
GE
L2%
BTX
FLX
60M
L26
6190
101
MIN
OX
IDIL
/TA
RG
ET
CU
T.S
OL
5% W
/VFL
x60M
LTA
RG
ET
PH
AR
MA
25
9550
101
NH
ER
EA
CU
T.S
OL
5% W
/VFL
x60M
LZW
ITTE
R P
HA
RM
AC
EU
T19
0500
501
OX
OFE
NIL
CU
T.S
OL
2% (W
/V)
FLx
60 M
LB
IOS
PR
AY
AB
EE
19
6030
101
RE
GA
INE
CU
T.S
OL
2% (W
/V)
FL x
60
ML
JOH
NS
ON
AN
D J
OH
NS
O19
6030
201
RE
GA
INE
GE
L2%
(W/W
)FL
X60
ML
JOH
NS
ON
AN
D J
OH
NS
O19
6030
301
RE
GA
INE
CU
T.S
OL
5% W
/VFL
x 6
0 M
LJO
HN
SO
N A
ND
JO
HN
SO
2727
301
01V
IUS
CU
T.S
OL
5% W
/VB
T x
1 B
OTT
LE x
60M
L.
.D
11A
O
IL O
F H
YO
SC
YA
MU
S/H
EN
BA
NE
OIL
2854
501
01K
ELO
SO
FTC
RE
AM
50%
(W/W
)B
T x
TUB
10g
DE
KA
Z .
..
ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ) 11815
ATC
2854
501
02K
ELO
SO
FTC
RE
AM
50%
(W/W
)B
T x
TUB
25g
DE
KA
Z .
..
LL0
3
AL0
3
AL0
3
AL0
3
EX
PR
ES
SE
D J
UIC
E F
RO
M P
UR
PLE
CO
NE
FLO
WE
R23
6720
101
EC
HIN
AC
INO
R.S
O.D
80%
W/W
BTx
BO
TTLE
x 5
0 M
LR
OTT
AP
HA
RM
HE
LLA
S
2367
201
02E
CH
INA
CIN
OR
.SO
.D80
% W
/WB
Tx B
OTT
LE x
100
ML
RO
TTA
PH
AR
M H
ELL
AS
M
M01 M
01A
M01
AE
M01
AE
01
IB
UP
RO
FEN
2452
801
01A
DV
ILC
.TA
B20
0MG
/TA
BB
Tx20
( B
LIS
TER
S)
PFI
ZER
.
.24
5280
201
AD
VIL
SO
FT.C
AP
S20
0MG
/CA
PB
Tx10
(BLI
ST
1x10
)P
FIZE
R
..
2452
802
02A
DV
ILS
OFT
.CA
PS
200M
G/C
AP
BTx
20 (B
LIS
T 2x
10)
PFI
ZER
.
.20
7670
101
ALG
OFR
EN
EFF
.GR
AN
200M
G/S
AC
HE
TB
TX20
SA
CH
ETS
.&.
/20
7670
401
ALG
OFR
EN
EF.
TAB
200M
G/T
AB
BTX
20(F
OIS
T2X
10)
.&.
/20
7670
901
ALG
OFR
EN
F.C
.TA
B20
0MG
/TA
BB
Tx30
(BLI
ST
3x10
).&
./
2076
709
02A
LGO
FRE
NF.
C.T
AB
200M
G/T
AB
BTx
20 (B
LIS
T 2x
10)
.&.
/01
4910
201
BR
UFE
NC
.TA
B20
0MG
/TA
BB
TX30
(BLI
ST3
X10
)A
BB
OTT
LA
BO
RA
TOR
IES
2075
001
01N
UR
OFE
NC
.TA
B20
0MG
/TA
BB
Tx12
(BLI
STE
R 1
x12)
2075
001
02N
UR
OFE
NC
.TA
B20
0MG
/TA
BB
Tx20
(BLI
STE
R 2
x10)
2075
001
03N
UR
OFE
NC
.TA
B20
0MG
/TA
BB
TX24
(BLI
STE
R 2
x12)
2075
001
04N
UR
OFE
NC
.TA
B20
0MG
/TA
BB
Tx12
(BLI
STE
R 2
x6)
2075
001
05N
UR
OFE
NC
.TA
B20
0MG
/TA
BB
Tx1
BO
TTLE
(HD
PE
)x12
2075
001
06N
UR
OFE
NC
.TA
B20
0MG
/TA
BB
Tx1
BO
TTLE
(HD
PE
)x20
2075
001
07N
UR
OFE
NC
.TA
B20
0MG
/TA
BB
Tx1
BO
TTLE
(HD
PE
)x24
2075
005
01N
UR
OFE
NS
OFT
.CA
PS
200M
G/C
AP
BTx
2 (B
LIS
T 1
x 2)
2075
005
02N
UR
OFE
NS
OFT
.CA
PS
200M
G/C
AP
BTx
4 (B
LIS
T 1
x 4)
2075
005
03N
UR
OFE
NS
OFT
.CA
PS
200M
G/C
AP
BTx
6 (B
LIS
T 1
x 6)
2075
005
04N
UR
OFE
NS
OFT
.CA
PS
200M
G/C
AP
BTx
8 (B
LIS
T 1
x 8)
2075
005
05N
UR
OFE
NS
OFT
.CA
PS
200M
G/C
AP
BTx
10 (B
LIS
T 1
x 10
)
11816 ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ)
ATC
2075
005
06N
UR
OFE
NS
OFT
.CA
PS
200M
G/C
AP
BTx
12 (B
LIS
T 1
x 12
)20
7500
507
NU
RO
FEN
SO
FT.C
AP
S20
0MG
/CA
PB
Tx16
(BLI
ST
2 x
8)
2075
005
08N
UR
OFE
NS
OFT
.CA
PS
200M
G/C
AP
BTx
20 (B
LIS
T 2
x 10
)20
7500
509
NU
RO
FEN
SO
FT.C
AP
S20
0MG
/CA
PB
Tx24
(BLI
ST
2 x
12)
2075
005
10N
UR
OFE
NS
OFT
.CA
PS
200M
G/C
AP
BTx
30 (B
LIS
T 3
x 10
)20
7500
511
NU
RO
FEN
SO
FT.C
AP
S20
0MG
/CA
PB
Tx40
(BLI
ST
4 x
10)
2075
005
12N
UR
OFE
NS
OFT
.CA
PS
200M
G/C
AP
BTx
48 (B
LIS
T 4
x 12
)20
7500
513
NU
RO
FEN
SO
FT.C
AP
S20
0MG
/CA
PB
Tx72
(BLI
ST
6 x
12)
2075
005
14N
UR
OFE
NS
OFT
.CA
PS
200M
G/C
AP
BTx
96 (B
LIS
T 8
x 12
)20
7500
601
NU
RO
FEN
(LE
MO
N)
OR
.DIS
P.T
A20
0MG
/TA
BB
Tx 4
(BLI
ST
1 x
4)20
7500
602
NU
RO
FEN
(LE
MO
N)
OR
.DIS
P.T
A20
0MG
/TA
BB
Tx 6
(BLI
ST
1 x
6)20
7500
603
NU
RO
FEN
(LE
MO
N)
OR
.DIS
P.T
A20
0MG
/TA
BB
Tx 1
0 (B
LIS
T 2
x 5)
2075
006
04N
UR
OFE
N (L
EM
ON
)O
R.D
ISP
.TA
200M
G/T
AB
BTx
12
(BLI
ST
2 x
6)20
7500
605
NU
RO
FEN
(LE
MO
N)
OR
.DIS
P.T
A20
0MG
/TA
BB
Tx 2
0 (B
LIS
T 4
x 5)
2075
006
06N
UR
OFE
N (L
EM
ON
)O
R.D
ISP
.TA
200M
G/T
AB
BTx
24
(BLI
ST
4 x
6)20
7500
607
NU
RO
FEN
(LE
MO
N)
OR
.DIS
P.T
A20
0MG
/TA
BB
Tx 3
0 (B
LIS
T 5
x 6)
2075
006
08N
UR
OFE
N (L
EM
ON
)O
R.D
ISP
.TA
200M
G/T
AB
BTx
36
(BLI
ST
6 x
6)20
7500
609
NU
RO
FEN
(LE
MO
N)
OR
.DIS
P.T
A20
0MG
/TA
BB
Tx 4
0 (B
LIS
T 8
x 5)
2075
006
10N
UR
OFE
N (L
EM
ON
)O
R.D
ISP
.TA
200M
G/T
AB
BTx
48
(BLI
ST
8 x
6)20
7500
701
NU
RO
FEN
(MIN
T)O
R.D
ISP
.TA
200M
G/T
AB
BTx
4 (B
LIS
T 1
x 4)
2075
007
02N
UR
OFE
N (M
INT)
OR
.DIS
P.T
A20
0MG
/TA
BB
Tx 6
(BLI
ST
1 x
6)20
7500
703
NU
RO
FEN
(MIN
T)O
R.D
ISP
.TA
200M
G/T
AB
BTx
10 (B
LIS
T 2
x 5)
2075
007
04N
UR
OFE
N (M
INT)
OR
.DIS
P.T
A20
0MG
/TA
BB
Tx 1
2 (B
LIS
T 2
x 6)
2075
007
05N
UR
OFE
N (M
INT)
OR
.DIS
P.T
A20
0MG
/TA
BB
Tx 2
0 (B
LIS
T 4
x 5)
2075
007
06N
UR
OFE
N (M
INT)
OR
.DIS
P.T
A20
0MG
/TA
BB
Tx 2
4 (B
LIS
T 4
x 6)
2075
007
07N
UR
OFE
N (M
INT)
OR
.DIS
P.T
A20
0MG
/TA
BB
Tx 3
0 (B
LIS
T 5
x 6)
2075
007
08N
UR
OFE
N (M
INT)
OR
.DIS
P.T
A20
0MG
/TA
BB
Tx 3
6 (B
LIS
T 6
x 6)
2075
007
09N
UR
OFE
N (M
INT)
OR
.DIS
P.T
A20
0MG
/TA
BB
Tx 4
0 (B
LIS
T 8
x 5)
2075
007
10N
UR
OFE
N (M
INT)
OR
.DIS
P.T
A20
0MG
/TA
BB
Tx 4
8 (B
LIS
T 8
x 6)
2075
007
11N
UR
OFE
N (M
INT)
OR
.DIS
P.T
A20
0MG
/TA
BB
Tx 1
8M
01A
E01
I
BU
PR
OFE
N S
OD
IUM
DIH
YD
RA
TE20
7501
201
NU
RO
FEN
C.T
AB
256M
G/T
AB
BTx
4 (
BLI
ST
PV
C)
2075
012
02N
UR
OFE
NC
.TA
B25
6MG
/TA
BB
Tx6
( B
LIS
T P
VC
)
ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ) 11817
ATC
2075
012
03N
UR
OFE
NC
.TA
B25
6MG
/TA
BB
Tx12
( B
LIS
T P
VC
)20
7501
204
NU
RO
FEN
C.T
AB
256M
G/T
AB
BTx
24 (
BLI
ST
PV
C)
2075
012
05N
UR
OFE
NC
.TA
B25
6MG
/TA
BB
Tx4
2075
012
06N
UR
OFE
NC
.TA
B25
6MG
/TA
BB
Tx 6
2075
012
07N
UR
OFE
NC
.TA
B25
6MG
/TA
BB
Tx12
2075
012
08N
UR
OFE
NC
.TA
B25
6MG
/TA
BB
Tx24
2075
012
09N
UR
OFE
NC
.TA
B25
6MG
/TA
BB
Tx4
2075
012
10N
UR
OFE
NC
.TA
B25
6MG
/TA
BB
Tx6
2075
012
11N
UR
OFE
NC
.TA
B25
6MG
/TA
BB
Tx12
2075
012
12N
UR
OFE
NC
.TA
B25
6MG
/TA
BB
Tx24
2075
012
13N
UR
OFE
NC
.TA
B25
6MG
/TA
BB
OTT
LEx2
4M
01A
E09
F
LUR
BIP
RO
FEN
2802
401
01S
TRE
PFE
NLO
Z8,
75M
G/L
OZ
BTx
16 (B
LIS
T 2x
8)28
0240
102
STR
EP
FEN
LOZ
8,75
MG
/LO
ZB
Tx24
(BLI
ST
2x12
)M
01A
XM
01A
X
DE
VIL
'S C
LAW
RO
OT
2669
801
01A
LLY
AF.
C.T
AB
240M
G/T
AB
BTx
40 (B
LIS
T 2x
20)
- &
26
6980
102
ALL
YA
F.C
.TA
B24
0MG
/TA
BB
Tx10
0 (B
LIS
T 5x
20)
- &
26
6990
101
FLE
XI
F.C
.TA
B48
0MG
/TA
BB
Tx50
(BLI
ST
2x25
)-
&
2669
901
02FL
EX
IF.
C.T
AB
480M
G/T
AB
BTx
100
(4B
LIS
T.x2
5)-
&
2785
601
01H
AR
PA
DO
LC
AP
S43
5MG
/CA
PB
Tx45
CA
PS
AR
KO
PH
AR
MA
27
8560
102
HA
RP
AD
OL
CA
PS
435M
G/C
AP
BTx
150
CA
PS
AR
KO
PH
AR
MA
M
01A
X
HA
RP
AG
OP
HY
TUM
PR
OC
UM
BE
NS
RA
DE
X D
RY
EX
TRA
CT
2700
701
01K
HE
LMA
RH
EU
MA
TIC
PA
INC
AP
S25
0MG
/CA
PB
Tx60
KH
ELM
A H
ELL
AS
A.E
.
M01
AX
05
GLU
CO
SA
MIN
E H
YD
RO
CH
LOR
IDE
2839
801
01E
FFE
R-A
CTI
VE
F.TA
B1,
884(
1,5)
G/T
AB
BTx
30 (3
TU
B x
10)
ALA
PIS
AB
EE
28
7770
101
GIO
RA
LE
F.TA
B15
00M
G/T
AB
BT
x 30
(TU
B.2
x 1
5)B
IOM
ED
ICA
-CH
EM
ICA
AE
2594
802
01G
LUC
OS
AM
ILE
F.TA
B(1
,5) G
/TA
BB
T x
30V
ER
ISFI
ELD
(UK
) LTD
, U
2594
802
02G
LUC
OS
AM
ILE
F.TA
B(1
,5) G
/TA
BB
T x
30V
ER
ISFI
ELD
(UK
) LTD
, U
2594
803
01G
LUC
OS
AM
ILO
RA
L.S
OL
150M
G/M
LB
Tx 1
BO
TTLE
x 30
0ML
VE
RIS
FIE
LD (U
K) L
TD, U
29
0790
201
GLU
MIN
AL
EF.
TAB
1500
MG
/TA
BB
Tx2
TUB
ES
x15
TAB
SV
OC
ATE
29
0290
101
LAS
AN
OL
EF.
TAB
1500
MG
/TA
BB
Tx30
(TU
BE
S2x
15)
SA
NO
PH
AR
M A
E
2786
302
01LI
PA
THR
EC
EF.
TAB
1,5G
/TA
BB
Tx30
VE
RIS
FIE
LD (U
K) L
TD, U
11818 ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ)
ATC
2786
302
02LI
PA
THR
EC
EF.
TAB
1,5G
/TA
BB
Tx30
VE
RIS
FIE
LD (U
K) L
TD, U
28
9520
101
PA
IN-F
RE
EE
F.TA
B15
00M
G/T
AB
BTx
30.
.27
6910
101
VO
LTA
FLE
X G
LUC
OS
AM
INE
F.C
.TA
B62
5MG
/TA
BB
Tx60
( B
LIS
TER
S)
NO
VA
RTI
S (H
ELL
AS
) A.E
2769
101
02V
OLT
AFL
EX
GLU
CO
SA
MIN
EF.
C.T
AB
625M
G/T
AB
BTx
90 (
BO
TTLE
)N
OV
AR
TIS
(HE
LLA
S) A
.E27
6910
103
VO
LTA
FLE
X G
LUC
OS
AM
INE
F.C
.TA
B62
5MG
/TA
BB
Tx18
0( B
LIS
TER
S)
NO
VA
RTI
S (H
ELL
AS
) A.E
2769
101
04V
OLT
AFL
EX
GLU
CO
SA
MIN
EF.
C.T
AB
625M
G/T
AB
BTx
30 (
BLI
STE
RS
)N
OV
AR
TIS
(HE
LLA
S) A
.E28
9100
101
ZAC
OS
TEO
EF.
TAB
1500
MG
/TA
BB
Tx30
(TU
B 2
x15)
2782
701
01ZA
NTR
ISTA
B62
5MG
/TA
BB
Tx40
(BLI
ST)
LAB
OR
ATO
IRE
S E
XP
AN
S27
8270
102
ZAN
TRIS
TAB
625M
G/T
AB
BTx
60 (B
LIS
T)LA
BO
RA
TOIR
ES
EX
PA
NS
2782
701
03ZA
NTR
ISTA
B62
5MG
/TA
BB
Tx18
0 (B
LIS
T)LA
BO
RA
TOIR
ES
EX
PA
NS
2782
701
04ZA
NTR
ISTA
B62
5MG
/TA
BB
Tx60
LAB
OR
ATO
IRE
S E
XP
AN
S27
8270
105
ZAN
TRIS
TAB
625M
G/T
AB
BTx
180
LAB
OR
ATO
IRE
S E
XP
AN
S27
8270
106
ZAN
TRIS
TAB
625M
G/T
AB
x20
(BLI
ST)
LAB
OR
ATO
IRE
S E
XP
AN
SM
01A
X05
G
LUC
OS
AM
INE
SU
LFA
TE26
3610
101
AN
AR
THR
ILP
D.O
RA
.SO
L1,
884(
1,50
)G/S
AC
HE
TB
Tx 2
0 S
AC
HE
TS26
3610
102
AN
AR
THR
ILP
D.O
RA
.SO
L1,
884(
1,50
)G/S
AC
HE
TB
Tx 3
0 S
AC
HE
TS27
0860
101
BE
ST
PD
.OR
A.S
OL
1,88
4(1,
5)G
/SA
CH
ET
BTx
20 S
AC
HE
TSU
NI-P
HA
RM
A
2844
201
01D
OLE
NIO
F.C
.TA
B15
00M
G/T
AB
BTx
BO
TTLE
S H
DP
Ex
30B
LUE
BIO
PH
AR
MA
CE
UT
2844
201
02D
OLE
NIO
F.C
.TA
B15
00M
G/T
AB
BTx
BO
TTLE
S H
DP
Ex
90B
LUE
BIO
PH
AR
MA
CE
UT
2622
501
01D
ON
AM
INP
D.O
RA
.SO
L1,
884(
1,5)
G/S
AC
HE
TB
Tx20
SA
CH
ETS
x 1
,5g
GE
NE
PH
AR
M A
E
2622
501
02D
ON
AM
INP
D.O
RA
.SO
L1,
884(
1,5)
G/S
AC
HE
TB
Tx30
SA
CH
ETS
x 1
,5g
GE
NE
PH
AR
M A
E
2213
901
01D
ON
AR
OT
PD
.OR
.SD
1,88
4(1,
5)G
/SA
CH
ET
BT
x 20
SA
CH
ETS
RO
TTA
PH
AR
M H
ELL
AS
22
1390
102
DO
NA
RO
TP
D.O
R.S
D1,
884(
1,5)
G/S
AC
HE
TB
T x
30 S
AC
HE
TSR
OTT
AP
HA
RM
HE
LLA
S
2635
401
01D
ON
AR
THR
ILP
D.O
RA
.SO
L1,
884(
1,50
)G/S
AC
HE
TB
Tx20
SA
CH
ETS
RA
FAR
M A
.E.B
.E.
26
3540
102
DO
NA
RTH
RIL
PD
.OR
A.S
OL
1,88
4(1,
50)G
/SA
CH
ET
BTx
30 S
AC
HE
TSR
AFA
RM
A.E
.B.E
.
2635
401
03D
ON
AR
THR
ILP
D.O
RA
.SO
L1,
884(
1,50
)G/S
AC
HE
TB
Tx40
SA
CH
ETS
RA
FAR
M A
.E.B
.E.
26
2260
101
ELI
ME
RP
D.O
RA
.SO
L1,
884
(1,5
)G/S
AC
HE
TB
Tx20
SA
CH
ETS
x 1,
5 G
NE
XU
S M
ED
ICA
LS A
.E.
26
2260
102
ELI
ME
RP
D.O
RA
.SO
L1,
884
(1,5
)G/S
AC
HE
TB
Tx30
SA
CH
ETS
x 1,
5 G
NE
XU
S M
ED
ICA
LS A
.E.
27
5490
101
EN
ER
GO
RO
TP
D.O
RA
.SO
L1,
884(
1,5)
G/S
AC
HE
TB
Tx20
SA
CH
ETS
2754
901
02E
NE
RG
OR
OT
PD
.OR
A.S
OL
1,88
4(1,
5)G
/SA
CH
ET
BTx
30 S
AC
HE
TS27
1260
101
GLU
CA
SU
LFP
D.O
RA
.SO
L1,
884(
1,5)
G/S
AC
HE
TB
T x
20 S
AC
HE
TS27
1260
102
GLU
CA
SU
LFP
D.O
RA
.SO
L1,
884(
1,5)
G/S
AC
HE
TB
T x
30 S
AC
HE
TS26
1870
101
GLU
CO
ZAN
TP
D.O
RA
.SO
L1,
884(
1,5)
G/S
AC
HE
TB
Tx20
SA
CH
ETS
VIV
AX
PH
AR
MA
CE
UTI
CA
ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ) 11819
ATC
2618
701
02G
LUC
OZA
NT
PD
.OR
A.S
OL
1,88
4(1,
5)G
/SA
CH
ET
BTx
30 S
AC
HE
TSV
IVA
X P
HA
RM
AC
EU
TIC
A27
0710
101
GLU
KO
TRA
LP
D.O
RA
.SO
L1,
884(
1,5)
G/S
AC
HE
TB
T x
20 S
AC
HE
TS27
0710
102
GLU
KO
TRA
LP
D.O
RA
.SO
L1,
884(
1,5)
G/S
AC
HE
TB
T x
30 S
AC
HE
TS29
0790
101
GLU
MIN
AL
PD
.OR
A.S
OL
1,88
4 (1
,5)G
/SA
CH
ET
BT
x 20
SA
CH
ETS
VO
CA
TE
2907
901
02G
LUM
INA
LP
D.O
RA
.SO
L1,
884
(1,5
)G/S
AC
HE
TB
T x
30 S
AC
HE
TSV
OC
ATE
27
3400
101
GLU
NA
RO
TP
D.O
RA
.SO
L1,
884(
1,5)
G/S
AC
HE
TB
Tx20
SA
CH
ETS
SA
NU
S O
.E.
.27
3400
102
GLU
NA
RO
TP
D.O
RA
.SO
L1,
884(
1,5)
G/S
AC
HE
TB
Tx30
SA
CH
ETS
SA
NU
S O
.E.
.29
0910
101
GLU
VE
DU
SP
D.O
RA
.SO
L1,
884
(1,5
)G/S
AC
HE
TB
Tx20
SA
CH
ETS
PH
AR
MA
LIN
E A
.E.
29
0910
102
GLU
VE
DU
SP
D.O
RA
.SO
L1,
884
(1,5
)G/S
AC
HE
TB
Tx30
SA
CH
ETS
PH
AR
MA
LIN
E A
.E.
27
1320
101
LAR
AN
ED
PD
.OR
A.S
OL
1,88
4(1,
5)g/
SA
CH
ET
BTx
20 S
AC
HE
TSE
UR
ON
ED
O.E
.
2713
201
02LA
RA
NE
DP
D.O
RA
.SO
L1,
884(
1,5)
g/S
AC
HE
TB
Tx30
SA
CH
ETS
EU
RO
NE
D O
.E.
28
1330
101
ME
DO
MIN
(
)P
D.O
RA
.SO
L1,
884G
(1,5
g)/S
AC
HE
TB
Tx20
SA
CH
ETS
ME
D-O
NE
.
..
..
2813
301
02M
ED
OM
IN
()
PD
.OR
A.S
OL
1,88
4G (1
,5g)
/SA
CH
ET
BTx
30 S
AC
HE
TSM
ED
-ON
E
..
..
.27
0370
101
MIN
ED
ON
PD
.OR
A.S
OL
1,88
4(1,
5)G
/SA
CH
ET
BT
x 20
SA
CH
ETS
HE
LP
2703
701
02M
INE
DO
NP
D.O
RA
.SO
L1,
884(
1,5)
G/S
AC
HE
TB
T x
30 S
AC
HE
TSH
ELP
27
1720
101
NE
RIT
AP
D.O
RA
.SO
L1,
884
(1,5
)G/S
AC
HE
TB
T x
20 S
AC
HE
TSD
ELE
GA
NT
HO
LDIN
GS
L27
1720
102
NE
RIT
AP
D.O
RA
.SO
L1,
884
(1,5
)G/S
AC
HE
TB
T x
30 S
AC
HE
TSD
ELE
GA
NT
HO
LDIN
GS
L27
0700
101
PA
INO
FFP
D.O
RA
.SO
L1,
884(
1,5)
G/S
AC
HE
TB
T x
20 S
AC
HE
TSR
AFA
RM
A.E
.B.E
.
2707
001
02P
AIN
OFF
PD
.OR
A.S
OL
1,88
4(1,
5)G
/SA
CH
ET
BT
x 30
SA
CH
ETS
RA
FAR
M A
.E.B
.E.
26
8330
101
RE
CO
SIN
EP
D.O
RA
.SO
L1,
884(
1,5)
G/S
AC
HE
TB
Tx20
SA
CH
ETS
2683
301
02R
EC
OS
INE
PD
.OR
A.S
OL
1,88
4(1,
5)G
/SA
CH
ET
BTx
30 S
AC
HE
TS28
7860
101
SA
CR
UM
PD
.OR
A.S
OL
1,5G
/SA
CH
ET
BTx
20 S
AC
HE
TSA
LAP
IS A
BE
E
2878
601
02S
AC
RU
MP
D.O
RA
.SO
L1,
5G/S
AC
HE
TB
Tx30
SA
CH
ETS
ALA
PIS
AB
EE
27
0430
101
SA
MIC
LAR
PD
.OR
A.S
OL
1,88
4(1,
5)G
/SA
CH
ET
BTx
20 S
AC
HE
TS27
0430
102
SA
MIC
LAR
PD
.OR
A.S
OL
1,88
4(1,
5)G
/SA
CH
ET
BTx
30 S
AC
HE
TS27
1330
101
SU
FIG
AL
PD
.OR
A.S
OL
1,88
4(1,
5)G
/SA
CH
ET
BT
x 20
SA
CH
ETS
..
2713
301
02S
UFI
GA
LP
D.O
RA
.SO
L1,
884(
1,5)
G/S
AC
HE
TB
T x
30 S
AC
HE
TS.
.27
3350
101
TAR
ED
ON
PD
.OR
A.S
OL
1,88
4(1,
5)G
/SA
CH
ET
BT
x 20
SA
CH
ET
ME
DIC
US
A.E
.
2733
501
02TA
RE
DO
NP
D.O
RA
.SO
L1,
884(
1,5)
G/S
AC
HE
TB
T x
30 S
AC
HE
TM
ED
ICU
S A
.E.
27
3080
101
VIA
RTR
ILP
D.O
RA
.SO
L1,
884(
1,5)
G/S
AC
HE
TB
T x
20 S
AC
HE
TS27
3080
102
VIA
RTR
ILP
D.O
RA
.SO
L1,
884(
1,5)
G/S
AC
HE
TB
T x
30 S
AC
HE
TS27
1760
101
VIR
EM
AX
PD
.OR
A.S
OL
1,88
4(1,
5)G
/SA
CH
ET
BTx
20 S
AC
HE
TS.
.27
1760
102
VIR
EM
AX
PD
.OR
A.S
OL
1,88
4(1,
5)G
/SA
CH
ET
BTx
30 S
AC
HE
TS.
.
11820 ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ)
ATC
2752
201
01X
AN
ALI
FEP
D.O
RA
.SO
L1,
5G/S
AC
HE
TB
Tx20
SA
CH
ETS
TAR
GE
T P
HA
RM
A
2752
201
02X
AN
ALI
FEP
D.O
RA
.SO
L1,
5G/S
AC
HE
TB
Tx30
SA
CH
ETS
TAR
GE
T P
HA
RM
A
M01
AX
05
GLU
CO
SA
MIN
E S
ULF
ATE
SO
DIU
M S
ALT
2817
701
01A
RTH
RO
LOC
PD
.OR
A.S
OL
1,88
4 (1
,5)G
/SA
CH
ET
BTx
20 S
AC
HE
TSB
ALU
28
1770
102
AR
THR
OLO
CP
D.O
RA
.SO
L1,
884
(1,5
)G/S
AC
HE
TB
Tx30
SA
CH
ETS
BA
LU
2594
801
01G
LUC
OS
AM
ILP
D.O
RA
.SO
L1,
884(
1,5)
G/S
AC
HE
TB
Tx20
SA
CH
ETS
VE
RIS
FIE
LD (U
K) L
TD, U
25
9480
102
GLU
CO
SA
MIL
PD
.OR
A.S
OL
1,88
4(1,
5)G
/SA
CH
ET
BTx
30 S
AC
HE
TSV
ER
ISFI
ELD
(UK
) LTD
, U
2598
501
01G
LUS
AM
ON
PD
.OR
A.S
OL
1884
(1,5
)G/S
AC
HE
TB
Tx 2
0 (S
AC
HE
TS)
FAR
ME
DIA
AE
25
9850
102
GLU
SA
MO
NP
D.O
RA
.SO
L18
84(1
,5)G
/SA
CH
ET
BTx
30
(SA
CH
ETS
)FA
RM
ED
IA A
E
2775
501
01G
LYC
EFO
RT
UP
PD
.OR
A.S
OL
1,88
4(1,
5G/S
AC
HE
T)B
T x
20 S
AC
HE
TS.
.27
7550
102
GLY
CE
FOR
T U
PP
D.O
RA
.SO
L1,
884(
1,5G
/SA
CH
ET)
BT
x 30
SA
CH
ETS
..
M02
,M
02A
,M
02A
AM
02A
A
ETO
FEN
AM
ATE
,BE
NZY
L N
ICO
TIN
ATE
2321
101
01TH
ER
MO
-RO
IPLO
NC
RE
AM
10%
+1%
TUB
X10
0GM
EN
AR
INI H
ELL
AS
A.E
.
M02
AA
N
IME
SU
LID
E24
4240
501
DO
LOS
TOP
GE
L3%
W/W
TUB
x50G
.&.
/24
4240
502
DO
LOS
TOP
GE
L3%
W/W
TUB
x30G
.&.
/24
2900
501
LALI
DE
GE
L3%
BT
X1T
BX
30G
ME
DO
CH
EM
IE H
ELL
AS
A24
2900
502
LALI
DE
GE
L3%
BTX
1TB
X50
GM
ED
OC
HE
MIE
HE
LLA
S A
2429
005
03LA
LID
EG
EL
3%B
TX1T
B X
100G
ME
DO
CH
EM
IE H
ELL
AS
A20
0920
501
ME
SU
LID
GE
L3%
W/W
TUB
x30
GB
OE
HR
ING
ER
ING
ELH
EI
2009
205
02M
ES
ULI
DG
EL
3% W
/WTU
B x
50G
BO
EH
RIN
GE
R IN
GE
LHE
I20
0920
503
ME
SU
LID
GE
L3%
W/W
TUB
x10
0GB
OE
HR
ING
ER
ING
ELH
EI
2009
205
04M
ES
ULI
DG
EL
3% W
/WTU
Bx1
5GB
OE
HR
ING
ER
ING
ELH
EI
M02
AA
05
BE
NZY
DA
MIN
E H
YD
RO
CH
LOR
IDE
0273
204
01TA
NTU
MC
RE
AM
5%TU
BX
30G
0273
204
02TA
NTU
MC
RE
AM
5%TU
BX
100G
0273
208
01TA
NTU
MG
EL
5% W
/WTU
BX
50G
M02
AA
06
ETO
FEN
AM
ATE
1786
501
01C
ELA
NA
TG
EL
5%TB
X10
0G/
2047
201
01E
TOFE
NO
L-M
ED
ICH
RO
MG
EL
10%
TUB
X10
0GM
ED
ICH
RO
M A
.E.
ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ) 11821
ATC
2403
002
01FE
NA
MG
EL
10%
TUB
X10
0G18
6410
101
HE
RP
ON
ILG
EL
5%TU
BX
100G
HE
LP
1864
102
01H
ER
PO
NIL
GE
L10
%TU
BX
100G
HE
LP
1831
901
01IR
IFO
NE
GE
L5%
W/W
TUB
X10
0G18
3190
102
IRIF
ON
EG
EL
5%W
/WTU
BX
50G
1837
302
01K
OV
OTH
ER
MG
EL
10%
TUB
X10
0GA
LAP
IS A
BE
E
1763
101
01M
ELF
ER
UT
GE
L10
%TU
BX
100G
RA
FAR
M A
.E.B
.E.
22
6830
101
RA
DE
RM
ING
EL
5% W
/WTU
BX
100G
VIO
FAR
22
6830
201
RA
DE
RM
ING
EL
10%
W/W
TUB
X10
0GV
IOFA
R
0889
301
01R
EU
MIN
AG
EL
5%TU
BX
100G
RD
EM
O A
BE
E
0889
302
01R
EU
MIN
AG
EL
10%
TUB
X10
0GD
EM
O A
BE
E
1521
701
01R
OIP
LON
GE
L5%
W/W
TUB
x100
GM
EN
AR
INI H
ELL
AS
A.E
.
1521
702
01R
OIP
LON
GE
L10
%TU
Bx1
00 G
ME
NA
RIN
I HE
LLA
S A
.E.
15
2170
501
RO
IPLO
NS
PR
10%
FLx5
0 M
LM
EN
AR
INI H
ELL
AS
A.E
.
1521
706
01R
OIP
LON
EM
UL.
EX
T.U
10%
W/W
FLx1
00G
(.
)M
EN
AR
INI H
ELL
AS
A.E
.
1901
302
01V
ELL
OD
YR
ING
GE
L10
% W
/WTU
BX
100G
RE
ME
DIN
A A
BE
E
M02
AA
07
PIR
OX
ICA
M18
3710
301
BLE
DU
RA
NG
EL
0.5%
W/W
TUB
X50
GA
LAP
IS A
BE
E
1803
703
01C
ON
ZILA
GE
L0.
5%TU
BX
50G
..
1587
207
01FE
LDE
NE
GE
L0,
5% (W
/W)
TUB
x50
GP
FIZE
R
..
1826
503
01P
AIN
RE
LIP
T-D
GE
L0,
5% W
/WTU
BX
50G
.&
1777
103
01P
ED
IFA
NG
EL
0.5%
TUB
X50
GV
ILC
O A
.E.
17
7010
401
PR
OP
ON
OL
GE
L0.
5%U
BX
50G
HE
LP
1810
105
01R
UV
AM
ED
GE
L0.
5%TU
BX
50G
CO
UP
AB
EE
17
5270
301
ZER
OS
PA
SM
GE
L0.
5%TU
BX
50G
M02
AA
07
PIR
OX
ICA
M C
INN
AM
ATE
2217
303
01S
INA
RTR
OL
CR
EA
M1,
5% (
W/W
)TU
Bx5
0 G
M02
AA
11
BE
ND
AZA
C10
6240
202
VE
RS
ALB
AC
RE
AM
3%TU
Bx8
0 G
M02
AA
12
NA
PR
OX
EN
1193
505
01N
AP
RO
SY
NG
EL
10%
TUB
X50
GM
02A
A13
I
BU
PR
OFE
N20
7670
801
ALG
OFR
EN
CR
EA
M10
%TU
BX
100G
.&.
/
11822 ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ)
ATC
M02
AA
15
DIC
LOFE
NA
C D
IETH
YLA
MM
ON
IUM
1266
205
01D
ELI
MO
NG
EL
1%TU
BX
100G
2613
501
01D
ICLO
FEN
AC
/BE
VO
GE
L1%
BTx
TUB
x100
GB
EV
O A
.E.
24
2290
101
DIF
EN
DG
EL
1%TU
BX
100G
ME
DIC
US
A.E
.
1640
107
01E
VIN
OP
ON
GE
L1%
TUB
X10
0GB
RO
S
..
.16
0160
601
FLE
FAR
MIN
GE
L1%
TUB
X10
0GB
IOS
PR
AY
AB
EE
16
0160
602
FLE
FAR
MIN
GE
L1%
TUB
X30
BIO
SP
RA
Y A
BE
E
2453
601
01R
ELI
PA
ING
EL
1%TU
BX
100G
..
1932
804
01R
HE
UM
AV
EK
GE
L1%
TUB
X10
0G19
3280
402
RH
EU
MA
VE
KG
EL
1%B
TX1T
UB
X50
G17
7490
601
RU
VO
MIN
OX
GE
L1%
TUB
X10
0GR
AFA
RM
A.E
.B.E
.
2366
601
01S
FIN
AC
GE
L1%
TUB
X10
0G25
9460
101
TOP
ALG
ON
GE
L1,
16%
(1%
)TU
BX
100G
LAV
IPH
AR
M A
E
1731
305
01V
ILO
NIT
GE
L1%
(W/W
)TU
Bx1
00 G
1731
305
03V
ILO
NIT
GE
L1%
(W/W
)TU
Bx3
0 G
1731
305
04V
ILO
NIT
GE
L1%
(W/W
)TU
Bx5
0 G
1228
807
01V
OLT
AR
EN
EM
ULG
EL
GE
L1%
W/W
TUB
(ALU
) x 1
00 G
RN
OV
AR
TIS
(HE
LLA
S) A
.E12
2880
702
VO
LTA
RE
N E
MU
LGE
LG
EL
1% W
/WB
Tx 1
PU
MP
NO
VA
RTI
S (H
ELL
AS
) A.E
1228
807
03V
OLT
AR
EN
EM
ULG
EL
GE
L1%
W/W
BT
x 1
PU
MP
NO
VA
RTI
S (H
ELL
AS
) A.E
1228
807
04V
OLT
AR
EN
EM
ULG
EL
GE
L1%
W/W
BT
x 1
PU
MP
NO
VA
RTI
S (H
ELL
AS
) A.E
1228
807
05V
OLT
AR
EN
EM
ULG
EL
GE
L1%
W/W
TUB
(LA
MIN
ATE
DN
OV
AR
TIS
(HE
LLA
S) A
.E12
2880
706
VO
LTA
RE
N E
MU
LGE
LG
EL
1% W
/WTU
B (L
AM
INA
TED
NO
VA
RTI
S (H
ELL
AS
) A.E
1228
807
07V
OLT
AR
EN
EM
ULG
EL
GE
L1%
W/W
TUB
(LA
MIN
ATE
DN
OV
AR
TIS
(HE
LLA
S) A
.E16
2820
601
VU
RD
ON
GE
L1%
W/W
TUB
x 1
00 G
HE
LP
M02
AA
15
DIC
LOFE
NA
C E
PO
LAM
INE
2311
901
01D
ICLO
PLA
ST
ME
D.P
LAS
T1,
29%
(180
MG
/PLA
ST)
BT
x 1
x 5
2311
901
02D
ICLO
PLA
ST
ME
D.P
LAS
T1,
29%
(180
MG
/PLA
ST)
BTx
2
523
1190
103
DIC
LOP
LAS
TM
ED
.PLA
ST
1,29
% (1
80M
G/P
LAS
T)B
T x
1 x
223
1190
104
DIC
LOP
LAS
TM
ED
.PLA
ST
1,29
% (1
80M
G/P
LAS
T)B
T x
1 x
M02
AA
15
DIC
LOFE
NA
C S
OD
IUM
2755
602
01A
CTI
SU
NY
CU
T.S
OL
1,5%
W/W
BTx
1 B
OTT
LEx3
0 M
L27
5560
202
AC
TIS
UN
YC
UT.
SO
L1,
5% W
/WB
Tx1
BO
TTLE
x60
ML
2422
903
01D
IFE
ND
CU
T.S
OL
1,5%
(W
/W)
BT
x 1
BO
TTLE
x 1
5ML
ME
DIC
US
A.E
.
ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ) 11823
ATC
2422
903
02D
IFE
ND
CU
T.S
OL
1,5%
(W
/W)
BT
x 1
BO
TTLE
x 3
0ML
ME
DIC
US
A.E
.
2422
903
03D
IFE
ND
CU
T.S
OL
1,5%
(W
/W)
BT
x 1
BO
TTLE
x 6
0ML
ME
DIC
US
A.E
.
2755
301
01IN
FLA
FOR
TEC
UT.
SO
L1,
5% W
/WB
OTT
LEx3
0 M
LV
ER
ISFI
ELD
(UK
) LTD
, U
2755
301
02IN
FLA
FOR
TEC
UT.
SO
L1,
5% W
/WB
OTT
LEx6
0 M
LV
ER
ISFI
ELD
(UK
) LTD
, U
2655
801
01M
INIF
LAM
GE
L1%
(W/W
)B
TxTU
Bx5
0 G
UN
I-PH
AR
MA
26
5580
102
MIN
IFLA
MG
EL
1% (W
/W)
BTx
TUB
x100
GU
NI-P
HA
RM
A
2595
901
01P
EN
NS
AID
CU
T.S
OL
1,5%
(W
/W)
BO
TTLE
x15M
LV
IAN
EX
A.E
.
2595
901
02P
EN
NS
AID
CU
T.S
OL
1,5%
(W
/W)
BO
TTLE
x30M
LV
IAN
EX
A.E
.
2595
901
03P
EN
NS
AID
CU
T.S
OL
1,5%
(W
/W)
BO
TTLE
x60M
LV
IAN
EX
A.E
.
2595
901
04P
EN
NS
AID
CU
T.S
OL
1,5%
(W
/W)
BO
TTLE
x120
ML
VIA
NE
X A
.E.
25
9590
105
PE
NN
SA
IDC
UT.
SO
L1,
5% (
W/W
)B
OTT
LEx1
50M
LV
IAN
EX
A.E
.
M02
AA
23
IN
DO
ME
TAC
IN22
6600
101
HA
STE
LG
EL
1%W
/WTU
BX
50G
SA
MB
RO
OK
&
0031
201
01IN
TOB
UTA
ZG
EL
1%TU
BX
50G
DE
MO
AB
EE
03
2240
201
RE
UM
AD
OLO
RG
EL
1%TU
BX
50G
BR
OS
.
..
M02
AA
25
AC
EC
LOFE
NA
C27
1680
101
AC
EC
LOFE
NA
C/H
ELP
CR
EA
M1,
5% W
/WB
Tx1
TUB
x 6
0 G
HE
LP
2246
602
01B
IOFE
NA
CC
RE
AM
1,5%
W/W
BT
x TU
B x
60
GG
ALE
NIC
A
2247
102
01S
OV
IPA
NC
RE
AM
1,5%
W/W
TUB
x 6
0 G
NO
VIS
PH
AR
MA
CE
UTI
CA
M02
AA
26
NIM
ES
ULI
DE
2539
701
01N
IME
GE
LG
EL
3%B
TxTB
x30
GA
LAP
IS A
BE
E
2539
701
02N
IME
GE
LG
EL
3%B
TxTB
x50
GA
LAP
IS A
BE
E
2539
701
03N
IME
GE
LG
EL
3%B
TxTB
x100
GA
LAP
IS A
BE
E
2602
901
01N
IME
SU
LID
E/
GE
L3%
BTx
TUB
x30G
..
2602
901
02N
IME
SU
LID
E/
GE
L3%
BTx
TUB
x50G
..
2602
901
03N
IME
SU
LID
E/
GE
L3%
BTx
TUB
x100
G.
.M
02A
BM
02A
B
SO
FT E
XTR
AC
T O
F C
AY
EN
NE
PE
PP
ER
2701
901
01M
ED
.PLA
ST
4,8M
G/P
LAS
T(18
x12c
m)
SA
CH
ET
x 1
PLA
STE
RB
EIE
RS
DO
RF
A.G
. W. G
E27
0190
102
ME
D.P
LAS
T4,
8MG
/PLA
ST(
18x1
2cm
)S
AC
HE
T x
2 P
LAS
TER
SB
EIE
RS
DO
RF
A.G
. W. G
EM
02A
B01
C
AP
SA
ICIN
2746
801
01A
RTH
RA
LGO
NC
RE
AM
0,02
5% W
/WTU
B x
45
GLA
VIP
HA
RM
HE
LLA
S A
E
2746
802
01A
RTH
RA
LGO
NC
RE
AM
0,07
5% W
/WTU
B x
45
GLA
VIP
HA
RM
HE
LLA
S A
E
11824 ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ)
ATC
2764
301
01C
AP
SE
RC
RE
AM
0,08
%B
T x
1 TU
B x
45
GR
VE
RIS
FIE
LD (U
K) L
TD, U
27
6430
102
CA
PS
ER
CR
EA
M0,
08%
BT
x 1
TUB
x 5
0 G
RV
ER
ISFI
ELD
(UK
) LTD
, U
2764
301
03C
AP
SE
RC
RE
AM
0,08
%B
T x
1 TU
B x
100
GR
VE
RIS
FIE
LD (U
K) L
TD, U
23
9910
101
GE
LCE
NC
RE
AM
0,03
%TU
Bx3
0GIN
TRA
ME
D
..
.27
6440
101
SE
NS
OC
AP
SC
RE
AM
0,08
%B
T x
1 TU
B x
45
GR
..
2764
401
02S
EN
SO
CA
PS
CR
EA
M0,
08%
BT
x 1
TUB
x 1
00 G
..
2592
502
01A
NTI
KH
CR
EA
M0,
075
% W
/W. x
20
GB
EIE
RS
DO
RF
A.G
. W. G
E25
9250
202
AN
TIK
HC
RE
AM
0,07
5 %
W/W
. x 5
0 G
BE
IER
SD
OR
F A
.G. W
. GE
2592
502
03A
NTI
KH
CR
EA
M0,
075
% W
/W. x
100
GB
EIE
RS
DO
RF
A.G
. W. G
EM
02A
B01
C
AP
SIC
UM
LIQ
UID
EX
TRA
CT
2607
101
01S
ALO
NP
AS
HO
TM
ED
.PLA
ST
0.46
3MG
/CM
2B
TX1
PLA
STE
Rx2
34cm
2V
IAN
EX
A.E
.
2607
101
02S
ALO
NP
AS
HO
TM
ED
.PLA
ST
0.46
3MG
/CM
2B
TX2
PLA
STE
Rx2
34cm
2V
IAN
EX
A.E
.
2607
101
03S
ALO
NP
AS
HO
TM
ED
.PLA
ST
0.46
3MG
/CM
2B
TX4
PLA
STE
Rx2
34cm
2V
IAN
EX
A.E
.
2607
101
04S
ALO
NP
AS
HO
TM
ED
.PLA
ST
0.46
3MG
/CM
2S
AC
HE
T X
1 P
LAS
TER
VIA
NE
X A
.E.
M
02A
CM
02A
C
CA
MP
HO
R,D
IETH
YLA
MIN
O S
ALI
CY
LATE
,OLE
OR
ES
INA
CA
PS
ICI
0204
201
01P
ON
OS
TOP
OIN
TME
NT
2.5%
+10%
+1%
W/W
TUB
X40
GN
I-TH
E
..
.M
02A
C
ME
THY
L S
ALI
CY
LATE
,EU
GE
NO
L,M
EN
THO
L09
9880
101
CO
UN
TER
PA
INC
RE
AM
100M
G +
13M
G +
54M
GTU
BX
30G
PH
AR
MA
SW
ISS
HE
LLA
S
0998
801
07C
OU
NTE
RP
AIN
CR
EA
M10
0MG
+ 1
3MG
+ 5
4MG
TUB
X10
0GP
HA
RM
AS
WIS
S H
ELL
AS
M
02A
C
ME
THY
L S
ALI
CY
LATE
,GLY
CO
L S
ALI
CY
LATE
,ME
NTH
OL,
CA
MP
HO
R,B
EN
ZYL
NIC
OTI
NA
TE
2404
601
01A
IR S
ALO
NP
AS
AE
R.T
OP
(1,7
5+1,
75+3
,20+
3,00
+0,0
04B
OTT
LEX
80M
LV
IAN
EX
A.E
.
2404
601
02A
IR S
ALO
NP
AS
AE
R.T
OP
(1,7
5+1,
75+3
,20+
3,00
+0,0
04B
OTT
LE X
120M
LV
IAN
EX
A.E
.
M02
AC
M
ETH
YL
SA
LIC
YLA
TE,M
EN
THO
L,C
AM
PH
OR
,TO
CO
PH
ER
YL
AC
ETA
TE24
4350
101
SA
LON
PA
SM
ED
.PLA
ST
(1,3
2+1,
20+0
,26+
0,42
)MG
/Cx1
PO
UC
HE
x10p
last
erV
IAN
EX
A.E
.
2443
501
02S
ALO
NP
AS
ME
D.P
LAS
T(1
,32+
1,20
+0,2
6+0,
42)M
G/C
1PO
UC
HE
x2pl
aste
rsV
IAN
EX
A.E
.
2443
501
03S
ALO
NP
AS
ME
D.P
LAS
T(1
,32+
1,20
+0,2
6+0,
42)M
G/C
1PO
UC
HE
x4pl
aste
rsV
IAN
EX
A.E
.
2443
501
04S
ALO
NP
AS
ME
D.P
LAS
T(1
,32+
1,20
+0,2
6+0,
42)M
G/C
BTx
1PO
UC
HE
x2pl
aste
rsV
IAN
EX
A.E
.
2443
501
05S
ALO
NP
AS
ME
D.P
LAS
T(1
,32+
1,20
+0,2
6+0,
42)M
G/C
x2P
OU
CH
Ex2
plas
ters
VIA
NE
X A
.E.
M
02A
C
SA
LIC
YLI
C A
CID
,DIE
THY
LAM
INE
,MY
RTE
CA
INE
0086
401
01A
LGE
SA
L S
UR
AC
TIV
EO
INTM
EN
T10
%+1
% (W
/W)
TUB
x40
GP
HA
RM
AS
ELE
CT
INTE
RN
0086
401
02A
LGE
SA
L S
UR
AC
TIV
EO
INTM
EN
T10
%+1
% (W
/W)
TUB
x100
GP
HA
RM
AS
ELE
CT
INTE
RN
M02
AX
,
ATC
M02
AX
10
CA
MP
HO
R,M
EN
THO
L,C
LOV
E O
IL,C
AJU
PU
T O
IL19
4740
101
TIG
ER
BA
LM (R
ED
)O
INTM
EN
TV
AS
E x
19 G
(RE
D)
OLV
OS
SC
IEN
CE
AE
19
4740
201
TIG
ER
BA
LM (W
HIT
E)
OIN
TME
NT
(80+
110+
15+1
29)m
g/G
VA
SE
x 1
9 G
(WH
ITE
)O
LVO
S S
CIE
NC
E A
E
M02
AX
10
EU
CA
LYP
TUS
OIL
,ME
NTH
OL,
CA
MP
HO
R,B
EN
ZYL
NIC
OTI
NA
TE,M
INK
GR
EA
SE
,BO
G (M
UD
) EX
TRA
CT,
SP
AN
ISH
PE
PP
ER
EX
TRA
CT
22
4090
101
EH
RLI
CH
OIN
TME
NT
TUB
X75
G.
.22
4090
102
EH
RLI
CH
OIN
TME
NT
TUB
X12
0G.
.22
4090
103
EH
RLI
CH
OIN
TME
NT
JAR
X12
0G.
.22
4090
104
EH
RLI
CH
OIN
TME
NT
JAR
X24
0G.
.M
02A
X10
P
EP
PE
RM
INT
OIL
2263
901
01C
HIN
A-O
EL,
OIL
OIL
.OR
AL
100%
FLX
10M
LB
IO-D
IAT-
BE
RLI
N G
MB
H,
2263
901
02C
HIN
A-O
EL,
OIL
OIL
.OR
AL
100%
FLX
25M
LB
IO-D
IAT-
BE
RLI
N G
MB
H,
2263
901
03C
HIN
A-O
EL,
OIL
OIL
.OR
AL
100%
FLX
100M
LB
IO-D
IAT-
BE
RLI
N G
MB
H,
M02
AX
10
TH
IOC
OLC
HIC
OS
IDE
2355
701
01H
ALI
VE
RC
RE
AM
0,25
%TU
BX
40G
0625
404
01M
US
CO
-RIL
CR
EA
MC
R.E
XT.
US
0,2
5%TU
BX
40G
SA
NO
FI-A
VE
NTI
S A
EB
E
0625
405
01M
US
CO
-RIL
GE
LG
EL.
EX
T.U
S 0
.25%
TUB
X40
GS
AN
OFI
-AV
EN
TIS
AE
BE
28
7870
101
RE
LIE
FC
RE
AM
0,25
%TU
BX
40G
IAS
IS P
HA
RM
AC
.HE
LLA
S28
7870
401
RE
LIE
FG
EL
0,25
%B
T x
TUB
x 3
0 G
IAS
IS P
HA
RM
AC
.HE
LLA
S28
7870
402
RE
LIE
FG
EL
0,25
%B
T x
TUB
x 6
0 G
IAS
IS P
HA
RM
AC
.HE
LLA
SN
N02
A
N02
BN
02B
AN
02B
A01
A
CE
TYLS
ALI
CY
LATE
LY
SIN
E12
6440
401
DR
AS
PIR
-FA
RA
NP
D.O
R.S
D90
0 (5
00)M
G/S
AC
HE
TB
TX20
SA
CH
ETS
1035
104
01E
GIC
ALM
PD
.OR
.SD
900(
500)
MG
/SA
CH
ET
BTX
20 S
AC
HE
TSS
AN
OFI
-AV
EN
TIS
AE
BE
10
3510
402
EG
ICA
LMP
D.O
R.S
D90
0(50
0)M
G/S
AC
HE
TB
TX2
SA
CH
ETS
SA
NO
FI-A
VE
NTI
S A
EB
E
1035
104
03E
GIC
ALM
PD
.OR
.SD
900(
500)
MG
/SA
CH
ET
BTx
30 S
AC
HE
TSS
AN
OFI
-AV
EN
TIS
AE
BE
N
02B
A01
A
CE
TYLS
ALI
CY
LIC
AC
ID04
1670
301
AS
PIR
INTA
B50
0MG
/TA
B20
(BLI
ST2
X10
)B
AY
ER
04
1670
501
AS
PIR
INC
HW
.TA
B50
0MG
/TA
BB
Tx10
(BLI
ST
5x2)
BA
YE
R
0416
709
01A
SP
IRIN
EF.
TAB
500M
G/T
AB
BTx
12B
AY
ER
04
1670
902
AS
PIR
INE
F.TA
B50
0MG
/TA
BB
Tx24
(2 F
OIS
Tx12
)B
AY
ER
ΦΕΚ 840 ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ) 11825
11826 ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ)
ATC
0416
710
01A
SP
IRIN
GR
AN
ULE
S50
0MG
/SA
CH
ET
BTx
10
SA
CH
ETS
BA
YE
R
0156
901
01B
UFF
ER
INTA
B50
0MG
/TA
Bx2
0N
OV
AR
TIS
(HE
LLA
S) A
.E19
2550
601
SA
LOS
PIR
TAB
500M
G/T
AB
20 (B
LIS
T. 2
X10
)U
NI-P
HA
RM
A
1925
507
01S
ALO
SP
IRE
FF.G
RA
N50
0MG
/DO
SE
SA
CH
ET
BTx
10 S
AC
HE
TSU
NI-P
HA
RM
A
1925
511
01S
ALO
SP
IRE
F.TA
B50
0MG
/TA
B10
UN
I-PH
AR
MA
19
2551
102
SA
LOS
PIR
EF.
TAB
500M
G/T
AB
BTX
12((
BLI
ST3
X4)
UN
I-PH
AR
MA
N
02B
A51
A
CE
TYLS
ALI
CY
LIC
AC
ID,A
SC
OR
BIC
AC
ID29
0710
101
AS
PR
O-C
EF.
TAB
(400
+240
)MG
/TA
BB
TX10
BA
YE
R
2222
101
01S
ALO
SP
IR-C
500
EF.
TAB
(500
+300
)MG
/TA
Bx1
2(FO
IST3
x4)
UN
I-PH
AR
MA
N
02B
A51
A
CE
TYLS
ALI
CY
LIC
AC
ID,C
AFF
EIN
E11
6600
101
KA
LMA
LIN
E A
CTA
B(5
00+3
0)M
G/T
AB
BTx
100
(BLI
ST
2x50
)C
OU
P A
BE
E
1166
001
02K
ALM
ALI
NE
AC
TAB
(500
+30)
MG
/TA
BB
Tx20
0 (B
LIS
T 2x
100)
CO
UP
AB
EE
11
6600
103
KA
LMA
LIN
E A
CTA
B(5
00+3
0)M
G/T
AB
BTx
8 (B
LIS
T)C
OU
P A
BE
E
1166
001
04K
ALM
ALI
NE
AC
TAB
(500
+30)
MG
/TA
BB
Tx20
0 (B
LIS
T 25
x8)
CO
UP
AB
EE
11
6600
105
KA
LMA
LIN
E A
CTA
B(5
00+3
0)M
G/T
AB
BTx
16 (B
LIS
T 2x
8)C
OU
P A
BE
E
1841
102
01K
ALM
OD
INE
TAB
(500
+30)
MG
/TA
B8
( B
LIS
TER
)C
OU
P A
BE
E
1841
102
02K
ALM
OD
INE
TAB
(500
+30)
MG
/TA
BB
TX20
0 (B
LIS
T.10
0X2)
CO
UP
AB
EE
N
02B
A51
A
CE
TYLS
ALI
CY
LIC
AC
ID,M
AG
NE
SIU
M H
YD
RO
XID
E,A
LUM
INIU
M H
YD
RO
XID
E G
EL,
DR
IED
23
1410
101
PO
NO
TEX
'AD
ELC
O'
TAB
(500
+100
+27)
MG
/TA
B20
AD
ELC
O A
.E.
.23
1410
102
PO
NO
TEX
'AD
ELC
O'
TAB
(500
+100
+27)
MG
/TA
BB
TX10
0A
DE
LCO
A.E
. .
N02
BA
51
AC
ETY
LSA
LIC
YLI
C A
CID
,PA
RA
CE
TAM
OL,
CA
FFE
INE
1884
001
03S
PLE
NTI
RTA
B(4
00+2
00+5
0)M
G/T
AB
x10
( B
LIS
TER
)U
NI-P
HA
RM
A
1884
001
06S
PLE
NTI
RTA
B(4
00+2
00+5
0)M
G/T
AB
x50
(BLI
ST
5x10
)U
NI-P
HA
RM
A
1884
001
08S
PLE
NTI
RTA
B(4
00+2
00+5
0)M
G/T
AB
BTx
30 (B
LIS
T 3x
10)
UN
I-PH
AR
MA
18
8400
201
SP
LEN
TIR
C.T
AB
(400
+200
+50)
MG
/TA
BB
TX10
(1B
LIS
TX10
)U
NI-P
HA
RM
A
1884
002
02S
PLE
NTI
RC
.TA
B(4
00+2
00+5
0)M
G/T
AB
BTX
20(2
BLI
STX
10)
UN
I-PH
AR
MA
18
8400
301
SP
LEN
TIR
EF.
TAB
(400
+200
+50)
MG
/TA
BB
Tx12
(FO
IST3
x4)
UN
I-PH
AR
MA
00
0280
102
TAB
(400
+200
+50)
MG
/TA
BB
Tx16
(BLI
ST2
x8)
LAV
IPH
AR
M A
E
0002
801
08TA
B(4
00+2
00+5
0)M
G/T
AB
BTx
10(B
LIS
T1x1
0)LA
VIP
HA
RM
AE
00
0280
110
TAB
(400
+200
+50)
MG
/TA
BB
LIS
T x
2 TA
BLA
VIP
HA
RM
AE
00
0280
111
TAB
(400
+200
+50)
MG
/TA
BB
Tx20
(BLI
ST2
x10)
LAV
IPH
AR
M A
E
0002
801
12TA
B(4
00+2
00+5
0)M
G/T
AB
BTx
30 (B
LIS
T3x1
0)LA
VIP
HA
RM
AE
N
02B
E
A
ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ) 11827
ATC
N02
BE
01
PA
RA
CE
TAM
OL
1854
102
01A
PO
TEL
TAB
500M
G/T
AB
x20
(BLI
ST
10x2
)U
NI-P
HA
RM
A
1854
103
01A
PO
TEL
SU
PP
125M
G/S
UP
5U
NI-P
HA
RM
A
1854
104
01A
PO
TEL
SU
PP
250M
G/S
UP
5U
NI-P
HA
RM
A
1854
105
01A
PO
TEL
SU
PP
500M
G/S
UP
5U
NI-P
HA
RM
A
1854
107
01A
PO
TEL
EF.
TAB
500M
G/T
AB
10U
NI-P
HA
RM
A
1854
107
02A
PO
TEL
EF.
TAB
500M
G/T
AB
12 (F
OIS
T 3X
4)U
NI-P
HA
RM
A
1854
108
01A
PO
TEL
EFF
.GR
AN
160M
G/S
AC
HE
T10
SA
CH
ET
UN
I-PH
AR
MA
18
5410
901
AP
OTE
LE
FF.G
RA
N50
0MG
/SA
CH
ET
BTX
10 S
AC
HE
TSU
NI-P
HA
RM
A
1854
110
01A
PO
TEL
EFF
.GR
AN
80M
G/S
AC
HE
T10
SA
CH
ETS
UN
I-PH
AR
MA
18
5411
101
AP
OTE
LO
R.S
O.D
100M
G/M
LFL
X30
ML+
UN
I-PH
AR
MA
1854
112
01A
PO
TEL
ELI
X12
0MG
/5M
LFL
X60
ML
UN
I-PH
AR
MA
18
5411
401
AP
OTE
LC
.TA
B50
0MG
/TA
BB
TX20
(BLI
ST
2X10
)U
NI-P
HA
RM
A
1854
115
01A
PO
TEL
SY
R12
0MG
/5M
LFL
x 1
20 M
LU
NI-P
HA
RM
A
1854
116
01A
PO
TEL
EF.
TAB
1G/T
AB
BTx
8 (F
OIS
T 2
x4)
UN
I-PH
AR
MA
18
5411
602
AP
OTE
LE
F.TA
B1G
/TA
BB
TxTU
BU
NI-P
HA
RM
A
0232
801
01D
EP
ON
TAB
500M
G/T
AB
BTx
20(B
LIS
T2x1
0)B
RIS
TOL-
MY
ER
S S
QU
IBB
0232
802
02D
EP
ON
EF.
TAB
500
MG
/TA
B x
10
BR
ISTO
L-M
YE
RS
SQ
UIB
B02
3280
203
DE
PO
NE
F.TA
B 5
00M
G/T
AB
x20
(2 T
UB
ES
x10)
BR
ISTO
L-M
YE
RS
SQ
UIB
B02
3280
401
DE
PO
NS
UP
P20
0MG
/SU
Px6
( F
OIL
S)
BR
ISTO
L-M
YE
RS
SQ
UIB
B02
3280
501
DE
PO
NS
UP
P60
0MG
/SU
PP
x6 (
FO
ILS
)B
RIS
TOL-
MY
ER
S S
QU
IBB
0232
806
01D
EP
ON
SY
R12
0MG
/5M
LFL
x60M
LB
RIS
TOL-
MY
ER
S S
QU
IBB
0232
806
02D
EP
ON
SY
R12
0MG
/5M
LFL
x120
ML
BR
ISTO
L-M
YE
RS
SQ
UIB
B02
3280
603
DE
PO
NS
YR
120M
G/5
ML
FLx1
50M
LB
RIS
TOL-
MY
ER
S S
QU
IBB
0232
806
04D
EP
ON
SY
R12
0MG
/5M
LFL
x120
ML
BR
ISTO
L-M
YE
RS
SQ
UIB
B02
3280
901
DE
PO
NF.
C.T
AB
500M
G/T
AB
BTx
16 (B
LIS
TER
2x8
)B
RIS
TOL-
MY
ER
S S
QU
IBB
0232
809
02D
EP
ON
F.C
.TA
B50
0MG
/TA
BB
Tx20
(BLI
STE
R 2
x10)
BR
ISTO
L-M
YE
RS
SQ
UIB
B02
3280
801
DE
PO
N M
AX
IMU
ME
F.TA
B1G
/TA
BB
T x
8 (
STR
IPS
)B
RIS
TOL-
MY
ER
S S
QU
IBB
0232
808
02D
EP
ON
MA
XIM
UM
EF.
TAB
1G/T
AB
BTx
TU
B x
8 T
AB
BR
ISTO
L-M
YE
RS
SQ
UIB
B02
3281
001
DE
PO
N (O
DIS
)O
R.D
ISP
.TA
500M
G/T
AB
BTx
8B
RIS
TOL-
MY
ER
S S
QU
IBB
0232
810
03D
EP
ON
(OD
IS)
OR
.DIS
P.T
A50
0MG
/TA
BB
Tx10
BR
ISTO
L-M
YE
RS
SQ
UIB
B02
3281
005
DE
PO
N (O
DIS
)O
R.D
ISP
.TA
500M
G/T
AB
BTx
16B
RIS
TOL-
MY
ER
S S
QU
IBB
0232
810
07D
EP
ON
(OD
IS)
OR
.DIS
P.T
A50
0MG
/TA
BB
Tx10
0B
RIS
TOL-
MY
ER
S S
QU
IBB
11828 ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ)
ATC
0296
901
01D
OLA
LTA
B50
0MG
/TA
BB
TX20
(BLI
ST2
X10
)A
LAP
IS A
BE
E
0296
902
01D
OLA
LS
YR
125
MG
/5M
LFL
X10
0ML
ALA
PIS
AB
EE
02
9690
301
DO
LAL
SU
PP
150M
G/S
UP
BTX
6( F
OIS
T)A
LAP
IS A
BE
E
0296
904
01D
OLA
LS
UP
P25
0MG
/SU
PP
BTX
6( F
OIS
T)A
LAP
IS A
BE
E
2002
904
01LO
NA
RID
TA
B50
0MG
/TA
BB
Tx20
(BLI
ST
2x10
)B
OE
HR
ING
ER
ING
ELH
EI
2002
901
01LO
NA
RID
S
UP
P12
5MG
/SU
P6(
FOIS
T 2X
3)B
OE
HR
ING
ER
ING
ELH
EI
2002
902
01LO
NA
RID
S
UP
P25
0mg/
sup
BTx
6 (F
OIS
T 2x
3)B
OE
HR
ING
ER
ING
ELH
EI
2002
903
01LO
NA
RID
S
UP
P50
0MG
/SU
Px6
(FO
IST
2x3)
BO
EH
RIN
GE
R IN
GE
LHE
I18
9150
601
PA
NA
DO
LS
UP
P25
0MG
/SU
PB
TX5
(FO
IST
1X5)
GLA
XO
SM
ITH
KLI
NE
AE
B18
9150
701
PA
NA
DO
LS
UP
P50
0MG
/SU
PB
TX5
(FO
IST1
X5)
GLA
XO
SM
ITH
KLI
NE
AE
B18
9150
801
PA
NA
DO
LO
RA
L.S
OL
160
MG
/5M
LFL
X60
ML
GLA
XO
SM
ITH
KLI
NE
AE
B18
9150
802
PA
NA
DO
LO
RA
L.S
OL
160
MG
/5M
LFL
x 1
20 M
LG
LAX
OS
MIT
HK
LIN
E A
EB
1891
509
01P
AN
AD
OL
EF.
TAB
500M
G/T
AB
x12
( F
OIS
T)G
LAX
OS
MIT
HK
LIN
E A
EB18
9150
902
PA
NA
DO
LE
F.TA
B50
0MG
/TA
Bx1
6( F
OIS
T)G
LAX
OS
MIT
HK
LIN
E A
EB18
9151
001
PA
NA
DO
LF.
C.T
AB
500M
G/T
AB
BTx
20 (B
LIS
T 2x
10)
GLA
XO
SM
ITH
KLI
NE
AE
B18
9151
601
PA
NA
DO
LO
RA
L.S
US
P12
0MG
/5M
LB
OTT
LEx1
00 M
LG
LAX
OS
MIT
HK
LIN
E A
EB
1891
516
02P
AN
AD
OL
OR
AL.
SU
SP
120M
G/5
ML
BO
TTLE
x300
ML
GLA
XO
SM
ITH
KLI
NE
AE
B18
9151
401
PA
NA
DO
L (U
LTR
A)
F.C
.TA
B1G
/TA
BB
TX8
GLA
XO
SM
ITH
KLI
NE
AE
B18
9151
501
PA
NA
DO
L A
CTI
FAS
TF.
C.T
AB
500M
G/T
AB
BTX
20 (B
LIS
T 2X
10)
GLA
XO
SM
ITH
KLI
NE
AE
B24
2630
201
PA
R 5
00TA
B50
0MG
/TA
BB
TX20
(BLI
ST2
X10
)24
2630
301
PA
R 5
00O
RA
L.S
OL
160M
G/5
ML
FLX
120M
L27
0870
101
PA
RA
CE
TAM
OL/
ITF
PH
AR
MA
KFT
EFF
.GR
AN
1G/S
AC
HE
TB
Tx8
SA
CH
ETS
ITF
HE
LLA
S A
.E.
26
0360
101
PR
OTA
LGO
NS
YR
120M
G/5
ML
FLX
120M
LLA
VIP
HA
RM
AE
26
0360
201
PR
OTA
LGO
NTA
B50
0MG
/TA
BB
TX20
(BLI
ST2
X10
)LA
VIP
HA
RM
AE
18
9151
701
PA
NA
DO
L R
ETA
RD
CO
N.R
.TA
B66
5MG
/TA
BB
Tx12
(BLI
ST.
1x12
)G
LAX
OS
MIT
HK
LIN
E A
EB
N02
BE
51
PA
RA
CE
TAM
OL,
AS
CO
RB
IC A
CID
2227
601
01A
PO
TEL
C-5
00E
F.TA
BE
F.TA
B(5
00+3
00)M
G/T
AB
Tx12
(FO
IST
3 x
4)U
NI-P
HA
RM
A
2345
801
01D
EP
ON
VIT
CE
F.TA
B(3
30+2
00)M
G/T
AB
BT
x 2
TUB
x 1
0B
RIS
TOL-
MY
ER
S S
QU
IBB
2345
802
01D
EP
ON
VIT
CE
F.TA
B(5
00+2
00)M
G/T
AB
BTx
TUB
x8B
RIS
TOL-
MY
ER
S S
QU
IBB
2345
802
02D
EP
ON
VIT
CE
F.TA
B(5
00+2
00)M
G/T
AB
BTx
2 T
UB
S x
8B
RIS
TOL-
MY
ER
S S
QU
IBB
N02
BE
51
PA
RA
CE
TAM
OL,
CA
FFE
INE
2423
702
01A
LGIN
ETA
B(5
00+6
5)M
G/T
AB
BTX
12(1
BLI
STX
12)
AD
ELC
O A
.E.
.23
7990
101
AP
OTE
L E
XTR
AE
F.TA
B(5
00+6
5)M
G/T
AB
BTx
12 (3
STR
IPS
x 4)
UN
I-PH
AR
MA
ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ) 11829
ATC
2379
902
01A
PO
TEL
EX
TRA
TAB
(500
+65)
MG
/TA
BB
Tx10
(BLI
ST
1x10
)U
NI-P
HA
RM
A
2379
902
02A
PO
TEL
EX
TRA
TAB
(500
+65)
MG
/TA
BB
Tx16
(BLI
ST
2x 8
)U
NI-P
HA
RM
A
2379
902
03A
PO
TEL
EX
TRA
TAB
(500
+65)
MG
/TA
BB
Tx12
(BLI
ST
1x12
)U
NI-P
HA
RM
A
2068
201
01P
AN
AD
OL
EX
TRA
TAB
(500
+65)
MG
/TA
BB
Tx10
(BLI
ST
1x10
)G
LAX
OS
MIT
HK
LIN
E A
EB
2068
201
02P
AN
AD
OL
EX
TRA
TAB
(500
+65)
MG
/TA
BB
Tx12
(BLI
ST
1x12
)G
LAX
OS
MIT
HK
LIN
E A
EB
2068
201
03P
AN
AD
OL
EX
TRA
TAB
(500
+65)
MG
/TA
BB
Tx16
(BLI
ST2
x8)
GLA
XO
SM
ITH
KLI
NE
AE
B20
6820
201
PA
NA
DO
L E
XTR
AE
F.TA
B(5
00+6
5)M
G/T
AB
BTx
12(F
OIS
T6x2
)G
LAX
OS
MIT
HK
LIN
E A
EB
2068
202
02P
AN
AD
OL
EX
TRA
EF.
TAB
(500
+65)
MG
/TA
BB
Tx16
(FO
IST8
x2)
GLA
XO
SM
ITH
KLI
NE
AE
BN
05 N05
C
YN
05C
MN
05C
M
PA
SS
IFLO
RA
INC
AR
NA
TA23
0220
101
PA
SS
IFLO
RA
/AR
KO
PH
AR
MA
CA
PS
230M
G/C
AP
BTX
50(
..)
AR
KO
PH
AR
MA
N
05C
M09
P
ETA
SIT
IDIS
RA
DIX
EX
TRA
CTU
M S
ICC
UM
,VA
LER
IAN
E O
FFIC
INA
LIS
RA
DIX
EX
TRA
CTU
M S
ICC
UM
,PA
SS
IFLO
RA
E H
ER
BA
EX
TRA
CTU
M S
PIS
SU
M,M
E25
7750
101
ZELL
ER
RE
LAX
F.C
.TA
B(9
0+90
+90+
60)M
G/T
AB
BTX
20(B
LIS
T1X
20)
PH
AR
MA
CO
N
..
.25
7750
102
ZELL
ER
RE
LAX
F.C
.TA
B(9
0+90
+90+
60)M
G/T
AB
BTX
60(B
LIS
T3X
20)
PH
AR
MA
CO
N
..
.N
05C
M09
V
ALE
RIA
N E
XTR
AC
T23
5350
101
RE
LAX
INE
C.T
AB
500M
G/T
AB
BTX
15(B
LIS
T1X
15)
ALA
PIS
AB
EE
23
5350
102
RE
LAX
INE
C.T
AB
500M
G/T
AB
BTX
30(B
LIS
T2X
15)
ALA
PIS
AB
EE
12
0820
101
VA
LMA
NE
C.T
AB
125M
G/T
AB
BTx
20S
OLV
AY
PH
AR
MA
.
.N
05C
M09
V
ALE
RIA
NA
OFF
ICIN
ALI
S23
9020
101
VA
LER
IAN
/AR
KO
PH
AR
MA
CA
PS
270M
G/C
AP
BTX
50(
)A
RK
OP
HA
RM
A
N07 N
07B
N07
BA
N07
BA
01
NIC
OTI
NE
1927
403
01N
ICO
RE
TTE
TTS
5MG
/16H
BTx
7TE
x10
cm2
JOH
NS
ON
AN
D J
OH
NS
O19
2740
302
NIC
OR
ETT
ETT
S5M
G/1
6HB
Tx14
TEx1
0 cm
2JO
HN
SO
N A
ND
JO
HN
SO
1927
404
01N
ICO
RE
TTE
TTS
10M
G/1
6HB
Tx7T
Ex2
0 cm
2JO
HN
SO
N A
ND
JO
HN
SO
1927
404
02N
ICO
RE
TTE
TTS
10M
G/1
6HB
Tx14
TEx2
0 cm
2JO
HN
SO
N A
ND
JO
HN
SO
1927
405
01N
ICO
RE
TTE
TTS
15M
G/1
6HB
Tx7T
Ex3
0cm
2JO
HN
SO
N A
ND
JO
HN
SO
1927
405
02N
ICO
RE
TTE
TTS
15M
G/1
6HB
Tx14
TEx3
0cm
2JO
HN
SO
N A
ND
JO
HN
SO
1927
406
01N
ICO
RE
TTE
INH
ALA
T10
MG
/UN
ITB
Tx 4
2 JO
HN
SO
N A
ND
JO
HN
SO
11830 ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ)
ATC
1927
406
02N
ICO
RE
TTE
INH
ALA
T10
MG
/UN
ITB
Tx18
JO
HN
SO
N A
ND
JO
HN
SO
1927
406
03N
ICO
RE
TTE
INH
ALA
T10
MG
/UN
ITB
Tx18
JO
HN
SO
N A
ND
JO
HN
SO
1927
418
01N
ICO
RE
TTE
CLE
AR
PA
TCH
TTS
10M
G/1
6HB
Tx7
(13,
5 cm
2)JO
HN
SO
N A
ND
JO
HN
SO
1927
418
02N
ICO
RE
TTE
CLE
AR
PA
TCH
TTS
10M
G/1
6HB
Tx14
(13,
5 cm
2)JO
HN
SO
N A
ND
JO
HN
SO
1927
419
01N
ICO
RE
TTE
CLE
AR
PA
TCH
TTS
15M
G/1
6HB
Tx7
(9 c
m2)
JOH
NS
ON
AN
D J
OH
NS
O19
2741
902
NIC
OR
ETT
E C
LEA
R P
ATC
HTT
S15
MG
/16H
BTx
14 (9
cm
2)JO
HN
SO
N A
ND
JO
HN
SO
1927
419
03N
ICO
RE
TTE
CLE
AR
PA
TCH
TTS
15M
G/1
6HB
Tx28
(9 c
m2)
JOH
NS
ON
AN
D J
OH
NS
O23
2641
001
NIC
OTI
NE
LL C
OO
L M
INT
CH
EW
.GU
M2M
G/G
UM
BT
x 2
NO
VA
RTI
S (H
ELL
AS
) A.E
2326
410
02N
ICO
TIN
ELL
CO
OL
MIN
TC
HE
W.G
UM
2MG
/GU
MB
T x
12N
OV
AR
TIS
(HE
LLA
S) A
.E23
2641
003
NIC
OTI
NE
LL C
OO
L M
INT
CH
EW
.GU
M2M
G/G
UM
BT
x 24
NO
VA
RTI
S (H
ELL
AS
) A.E
2326
410
04N
ICO
TIN
ELL
CO
OL
MIN
TC
HE
W.G
UM
2MG
/GU
MB
T x
36N
OV
AR
TIS
(HE
LLA
S) A
.E23
2641
005
NIC
OTI
NE
LL C
OO
L M
INT
CH
EW
.GU
M2M
G/G
UM
BT
x 48
NO
VA
RTI
S (H
ELL
AS
) A.E
2326
410
06N
ICO
TIN
ELL
CO
OL
MIN
TC
HE
W.G
UM
2MG
/GU
MB
T x
60N
OV
AR
TIS
(HE
LLA
S) A
.E23
2641
007
NIC
OTI
NE
LL C
OO
L M
INT
CH
EW
.GU
M2M
G/G
UM
BT
x 72
NO
VA
RTI
S (H
ELL
AS
) A.E
2326
410
08N
ICO
TIN
ELL
CO
OL
MIN
TC
HE
W.G
UM
2MG
/GU
MB
T x
96N
OV
AR
TIS
(HE
LLA
S) A
.E23
2641
009
NIC
OTI
NE
LL C
OO
L M
INT
CH
EW
.GU
M2M
G/G
UM
BTx
204(
BLI
ST
17x1
2)N
OV
AR
TIS
(HE
LLA
S) A
.E23
2641
010
NIC
OTI
NE
LL C
OO
L M
INT
CH
EW
.GU
M2M
G/G
UM
BT
x 12
0N
OV
AR
TIS
(HE
LLA
S) A
.E23
2640
801
NIC
OTI
NE
LL F
RU
ITC
HE
W.G
UM
2MG
/GU
MB
T x
2N
OV
AR
TIS
(HE
LLA
S) A
.E23
2640
802
NIC
OTI
NE
LL F
RU
ITC
HE
W.G
UM
2MG
/GU
MB
T x
12N
OV
AR
TIS
(HE
LLA
S) A
.E23
2640
803
NIC
OTI
NE
LL F
RU
ITC
HE
W.G
UM
2MG
/GU
MB
T x
24N
OV
AR
TIS
(HE
LLA
S) A
.E23
2640
804
NIC
OTI
NE
LL F
RU
ITC
HE
W.G
UM
2MG
/GU
MB
T x
36N
OV
AR
TIS
(HE
LLA
S) A
.E23
2640
805
NIC
OTI
NE
LL F
RU
ITC
HE
W.G
UM
2MG
/GU
MB
T x
48N
OV
AR
TIS
(HE
LLA
S) A
.E23
2640
806
NIC
OTI
NE
LL F
RU
ITC
HE
W.G
UM
2MG
/GU
MB
T x
60N
OV
AR
TIS
(HE
LLA
S) A
.E23
2640
807
NIC
OTI
NE
LL F
RU
ITC
HE
W.G
UM
2MG
/GU
MB
T x
72N
OV
AR
TIS
(HE
LLA
S) A
.E23
2640
808
NIC
OTI
NE
LL F
RU
ITC
HE
W.G
UM
2MG
/GU
MB
T x
96N
OV
AR
TIS
(HE
LLA
S) A
.E23
2640
809
NIC
OTI
NE
LL F
RU
ITC
HE
W.G
UM
2MG
/GU
MB
Tx20
4(B
LIS
T 17
x12)
NO
VA
RTI
S (H
ELL
AS
) A.E
2326
408
10N
ICO
TIN
ELL
FR
UIT
CH
EW
.GU
M2M
G/G
UM
BT
x 12
0N
OV
AR
TIS
(HE
LLA
S) A
.E23
2641
201
NIC
OTI
NE
LL L
IQU
OR
ICE
CH
EW
.GU
M2M
G/G
UM
BT
x 2
NO
VA
RTI
S (H
ELL
AS
) A.E
2326
412
02N
ICO
TIN
ELL
LIQ
UO
RIC
EC
HE
W.G
UM
2MG
/GU
MB
T x
12N
OV
AR
TIS
(HE
LLA
S) A
.E23
2641
203
NIC
OTI
NE
LL L
IQU
OR
ICE
CH
EW
.GU
M2M
G/G
UM
BT
x 24
NO
VA
RTI
S (H
ELL
AS
) A.E
2326
412
04N
ICO
TIN
ELL
LIQ
UO
RIC
EC
HE
W.G
UM
2MG
/GU
MB
T x
36N
OV
AR
TIS
(HE
LLA
S) A
.E23
2641
205
NIC
OTI
NE
LL L
IQU
OR
ICE
CH
EW
.GU
M2M
G/G
UM
BT
x 48
NO
VA
RTI
S (H
ELL
AS
) A.E
2326
412
06N
ICO
TIN
ELL
LIQ
UO
RIC
EC
HE
W.G
UM
2MG
/GU
MB
T x
60N
OV
AR
TIS
(HE
LLA
S) A
.E
ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ) 11831
ATC
2326
412
07N
ICO
TIN
ELL
LIQ
UO
RIC
EC
HE
W.G
UM
2MG
/GU
MB
T x
72N
OV
AR
TIS
(HE
LLA
S) A
.E23
2641
208
NIC
OTI
NE
LL L
IQU
OR
ICE
CH
EW
.GU
M2M
G/G
UM
BT
x 96
NO
VA
RTI
S (H
ELL
AS
) A.E
2326
412
09N
ICO
TIN
ELL
LIQ
UO
RIC
EC
HE
W.G
UM
2MG
/GU
MB
Tx20
4(B
LIS
T 17
x12)
NO
VA
RTI
S (H
ELL
AS
) A.E
2326
412
10N
ICO
TIN
ELL
LIQ
UO
RIC
EC
HE
W.G
UM
2MG
/GU
MB
T x
120
NO
VA
RTI
S (H
ELL
AS
) A.E
N07
BA
01
NIC
OTI
NE
B-C
YC
LOD
EX
TRIN
CO
MP
LEX
1927
412
01N
ICO
RE
TTE
(MIC
RO
TAB
)S
UB
L.TA
B2M
G/T
AB
BTx
30(B
LIS
T 2x
15)
JOH
NS
ON
AN
D J
OH
NS
O19
2741
202
NIC
OR
ETT
E (M
ICR
OTA
B)
SU
BL.
TAB
2MG
/TA
BB
Tx10
5 (B
LIS
T 7x
15)
JOH
NS
ON
AN
D J
OH
NS
O19
2741
203
NIC
OR
ETT
E (M
ICR
OTA
B)
SU
BL.
TAB
2MG
/TA
BB
Tx36
JOH
NS
ON
AN
D J
OH
NS
O19
2741
204
NIC
OR
ETT
E (M
ICR
OTA
B)
SU
BL.
TAB
2MG
/TA
BB
Tx10
8JO
HN
SO
N A
ND
JO
HN
SO
1927
412
05N
ICO
RE
TTE
(MIC
RO
TAB
)S
UB
L.TA
B2M
G/T
AB
BTx
30(B
LIS
T 3x
10)
JOH
NS
ON
AN
D J
OH
NS
O19
2741
206
NIC
OR
ETT
E (M
ICR
OTA
B)
SU
BL.
TAB
2MG
/TA
BB
Tx10
0(B
LIS
T 10
x10)
JOH
NS
ON
AN
D J
OH
NS
ON
07B
A01
N
ICO
TIN
E B
ITA
RTR
ATE
DIH
YD
RA
TE19
2741
601
NIC
OR
ETT
E M
ICR
OTA
B L
EM
ON
SU
BL.
TAB
2MG
/TA
BB
T x
20
JOH
NS
ON
AN
D J
OH
NS
O19
2741
602
NIC
OR
ETT
E M
ICR
OTA
B L
EM
ON
SU
BL.
TAB
2MG
/TA
BB
T x
30
JOH
NS
ON
AN
D J
OH
NS
O19
2741
603
NIC
OR
ETT
E M
ICR
OTA
B L
EM
ON
SU
BL.
TAB
2MG
/TA
BB
T x
90
JOH
NS
ON
AN
D J
OH
NS
O19
2741
604
NIC
OR
ETT
E M
ICR
OTA
B L
EM
ON
SU
BL.
TAB
2MG
/TA
BB
T x
100
JOH
NS
ON
AN
D J
OH
NS
O19
2741
605
NIC
OR
ETT
E M
ICR
OTA
B L
EM
ON
SU
BL.
TAB
2MG
/TA
BB
T x
150
JOH
NS
ON
AN
D J
OH
NS
ON
07B
A01
N
ICO
TIN
E R
ES
IN26
8750
201
NIC
OP
AS
S 1
,5 M
G F
RE
SH
MIN
T, L
OZE
NLO
Z1,
5MG
/LO
NZ
BTx
12 (B
LIS
T 1x
12)
PIE
RR
E F
AB
RE
HE
LLA
S
2687
502
02N
ICO
PA
SS
1,5
MG
FR
ES
H M
INT,
LO
ZEN
LOZ
1,5M
G/L
ON
ZB
Tx24
(BLI
ST
2x12
)P
IER
RE
FA
BR
E H
ELL
AS
26
8750
203
NIC
OP
AS
S 1
,5 M
G F
RE
SH
MIN
T, L
OZE
NLO
Z1,
5MG
/LO
NZ
BTx
36 (B
LIS
T 3x
12)
PIE
RR
E F
AB
RE
HE
LLA
S
2687
502
04N
ICO
PA
SS
1,5
MG
FR
ES
H M
INT,
LO
ZEN
LOZ
1,5M
G/L
ON
ZB
Tx48
(BLI
ST
4x12
)P
IER
RE
FA
BR
E H
ELL
AS
26
8750
205
NIC
OP
AS
S 1
,5 M
G F
RE
SH
MIN
T, L
OZE
NLO
Z1,
5MG
/LO
NZ
BTx
60 (B
LIS
T 5x
12)
PIE
RR
E F
AB
RE
HE
LLA
S
2687
502
06N
ICO
PA
SS
1,5
MG
FR
ES
H M
INT,
LO
ZEN
LOZ
1,5M
G/L
ON
ZB
Tx72
(BLI
ST
6x12
)P
IER
RE
FA
BR
E H
ELL
AS
26
8750
207
NIC
OP
AS
S 1
,5 M
G F
RE
SH
MIN
T, L
OZE
NLO
Z1,
5MG
/LO
NZ
BTx
84 (B
LIS
T 7x
12)
PIE
RR
E F
AB
RE
HE
LLA
S
2687
502
08N
ICO
PA
SS
1,5
MG
FR
ES
H M
INT,
LO
ZEN
LOZ
1,5M
G/L
ON
ZB
Tx96
(BLI
ST
8x12
)P
IER
RE
FA
BR
E H
ELL
AS
26
8750
209
NIC
OP
AS
S 1
,5 M
G F
RE
SH
MIN
T, L
OZE
NLO
Z1,
5MG
/LO
NZ
BTx
204
(BLI
ST
17x1
2)P
IER
RE
FA
BR
E H
ELL
AS
26
8750
101
NIC
OP
AS
S 1
,5 M
G L
IQU
OR
ICE
MIN
T, L
OLO
Z1,
5MG
/LO
ZB
Tx12
(BLI
ST
1x12
)P
IER
RE
FA
BR
E H
ELL
AS
26
8750
102
NIC
OP
AS
S 1
,5 M
G L
IQU
OR
ICE
MIN
T, L
OLO
Z1,
5MG
/LO
ZB
Tx24
(BLI
ST
2x12
)P
IER
RE
FA
BR
E H
ELL
AS
26
8750
103
NIC
OP
AS
S 1
,5 M
G L
IQU
OR
ICE
MIN
T, L
OLO
Z1,
5MG
/LO
ZB
Tx36
(BLI
ST
3x12
)P
IER
RE
FA
BR
E H
ELL
AS
26
8750
104
NIC
OP
AS
S 1
,5 M
G L
IQU
OR
ICE
MIN
T, L
OLO
Z1,
5MG
/LO
ZB
Tx48
(BLI
ST
4x12
)P
IER
RE
FA
BR
E H
ELL
AS
26
8750
105
NIC
OP
AS
S 1
,5 M
G L
IQU
OR
ICE
MIN
T, L
OLO
Z1,
5MG
/LO
ZB
Tx60
(BLI
ST
5x12
)P
IER
RE
FA
BR
E H
ELL
AS
26
8750
106
NIC
OP
AS
S 1
,5 M
G L
IQU
OR
ICE
MIN
T, L
OLO
Z1,
5MG
/LO
ZB
Tx72
(BLI
ST
6x12
)P
IER
RE
FA
BR
E H
ELL
AS
11832 ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ)
ATC
2687
501
07N
ICO
PA
SS
1,5
MG
LIQ
UO
RIC
E M
INT,
LO
LOZ
1,5M
G/L
OZ
BTx
84 (B
LIS
T 7x
12)
PIE
RR
E F
AB
RE
HE
LLA
S
2687
501
08N
ICO
PA
SS
1,5
MG
LIQ
UO
RIC
E M
INT,
LO
LOZ
1,5M
G/L
OZ
BTx
96 (B
LIS
T 8x
12)
PIE
RR
E F
AB
RE
HE
LLA
S
2687
501
09N
ICO
PA
SS
1,5
MG
LIQ
UO
RIC
E M
INT,
LO
LOZ
1,5M
G/L
OZ
BTx
204
(BLI
ST
17x1
2)P
IER
RE
FA
BR
E H
ELL
AS
19
2740
101
NIC
OR
ETT
EC
HW
.TA
B 2
MG
/TA
Bx1
05JO
HN
SO
N A
ND
JO
HN
SO
1927
401
02N
ICO
RE
TTE
CH
W.T
AB
2M
G/T
AB
x30
JOH
NS
ON
AN
D J
OH
NS
O19
2740
103
NIC
OR
ETT
EC
HW
.TA
B 2
MG
/TA
BB
Tx36
JOH
NS
ON
AN
D J
OH
NS
O19
2740
104
NIC
OR
ETT
EC
HW
.TA
B 2
MG
/TA
BB
Tx10
8JO
HN
SO
N A
ND
JO
HN
SO
1927
410
01N
ICO
RE
TTE
(MIN
T)C
HW
.TA
B2M
G/T
AB
BTx
30JO
HN
SO
N A
ND
JO
HN
SO
1927
410
02N
ICO
RE
TTE
(MIN
T)C
HW
.TA
B2M
G/T
AB
BTx
105
JOH
NS
ON
AN
D J
OH
NS
O19
2741
003
NIC
OR
ETT
E (M
INT)
CH
W.T
AB
2MG
/TA
BB
Tx36
JOH
NS
ON
AN
D J
OH
NS
O19
2741
004
NIC
OR
ETT
E (M
INT)
CH
W.T
AB
2MG
/TA
BB
Tx10
8JO
HN
SO
N A
ND
JO
HN
SO
1927
421
01N
ICO
RE
TTE
FR
ES
HFR
UIT
CH
W.T
AB
2MG
/TA
BB
Tx 3
0(B
LIS
T 2x
15)
JOH
NS
ON
AN
D J
OH
NS
O19
2742
102
NIC
OR
ETT
E F
RE
SH
FRU
ITC
HW
.TA
B2M
G/T
AB
BTx
105(
BLI
ST
7x15
)JO
HN
SO
N A
ND
JO
HN
SO
1927
414
01N
ICO
RE
TTE
FR
ES
HM
INT
CH
W.T
AB
2MG
/TA
BB
Tx30
(BLI
ST
2x15
)JO
HN
SO
N A
ND
JO
HN
SO
1927
414
02N
ICO
RE
TTE
FR
ES
HM
INT
CH
W.T
AB
2MG
/TA
BB
Tx10
5 (B
LIS
T 7x
15)
JOH
NS
ON
AN
D J
OH
NS
O19
2742
301
NIC
OR
ETT
E IC
EM
INT
CH
W.T
AB
2MG
/TA
BB
Tx 3
0 (B
LIS
T 2x
15)
JOH
NS
ON
AN
D J
OH
NS
O19
2742
302
NIC
OR
ETT
E IC
EM
INT
CH
W.T
AB
2MG
/TA
BB
Tx 1
05 (B
LIS
T 7x
15)
JOH
NS
ON
AN
D J
OH
NS
ON
07B
A01
S
(-) -
NIC
OTI
NE
2705
901
01N
ICO
PA
TCH
TTS
7MG
/24H
OU
RS
BT
x 7
SA
CH
ETS
PIE
RR
E F
AB
RE
HE
LLA
S
2705
901
02N
ICO
PA
TCH
TTS
7MG
/24H
OU
RS
BT
x 14
SA
CH
ETS
PIE
RR
E F
AB
RE
HE
LLA
S
2705
901
03N
ICO
PA
TCH
TTS
7MG
/24H
OU
RS
BT
x 21
SA
CH
ETS
PIE
RR
E F
AB
RE
HE
LLA
S
2705
901
04N
ICO
PA
TCH
TTS
7MG
/24H
OU
RS
BT
x 28
SA
CH
ETS
PIE
RR
E F
AB
RE
HE
LLA
S
2705
902
01N
ICO
PA
TCH
TTS
14M
G/2
4HO
UR
SB
T x
7 S
AC
HE
TSP
IER
RE
FA
BR
E H
ELL
AS
27
0590
202
NIC
OP
ATC
HTT
S14
MG
/24H
OU
RS
BT
x 14
SA
CH
ETS
PIE
RR
E F
AB
RE
HE
LLA
S
2705
902
03N
ICO
PA
TCH
TTS
14M
G/2
4HO
UR
SB
T x
21 S
AC
HE
TSP
IER
RE
FA
BR
E H
ELL
AS
27
0590
204
NIC
OP
ATC
HTT
S14
MG
/24H
OU
RS
BT
x 28
SA
CH
ETS
PIE
RR
E F
AB
RE
HE
LLA
S
2705
903
01N
ICO
PA
TCH
TTS
21M
G/2
4HO
UR
SB
T x
7 S
AC
HE
TSP
IER
RE
FA
BR
E H
ELL
AS
27
0590
302
NIC
OP
ATC
HTT
S21
MG
/24H
OU
RS
BT
x 14
SA
CH
ETS
PIE
RR
E F
AB
RE
HE
LLA
S
2705
903
03N
ICO
PA
TCH
TTS
21M
G/2
4HO
UR
SB
T x
21 S
AC
HE
TSP
IER
RE
FA
BR
E H
ELL
AS
27
0590
304
NIC
OP
ATC
HTT
S21
MG
/24H
OU
RS
BT
x 28
SA
CH
ETS
PIE
RR
E F
AB
RE
HE
LLA
S
2715
901
01N
ICO
TIN
ELL
TTS
(NC
H)
TTS
7MG
/24h
rsB
T x
7 T
TS x
10
cm2
NO
VA
RTI
S (H
ELL
AS
) A.E
2715
901
02N
ICO
TIN
ELL
TTS
(NC
H)
TTS
7MG
/24h
rsB
Tx 1
4 TT
S x
10
cm2
NO
VA
RTI
S (H
ELL
AS
) A.E
2715
901
03N
ICO
TIN
ELL
TTS
(NC
H)
TTS
7MG
/24h
rsB
Tx 2
1 TT
S x
10
cm2
NO
VA
RTI
S (H
ELL
AS
) A.E
ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ) 11833
ATC
2715
901
04N
ICO
TIN
ELL
TTS
(NC
H)
TTS
7MG
/24h
rsB
Tx 2
8 TT
S x
10
cm2
NO
VA
RTI
S (H
ELL
AS
) A.E
2715
902
01N
ICO
TIN
ELL
TTS
(NC
H)
TTS
14M
G/2
4hrs
BT
x 7
TTS
x 2
0 cm
2N
OV
AR
TIS
(HE
LLA
S) A
.E27
1590
202
NIC
OTI
NE
LL T
TS (N
CH
)TT
S14
MG
/24h
rsB
Tx 1
4 TT
S x
20
cm2
NO
VA
RTI
S (H
ELL
AS
) A.E
2715
902
03N
ICO
TIN
ELL
TTS
(NC
H)
TTS
14M
G/2
4hrs
BTx
21
TTS
x 2
0 cm
2N
OV
AR
TIS
(HE
LLA
S) A
.E27
1590
204
NIC
OTI
NE
LL T
TS (N
CH
)TT
S14
MG
/24h
rsB
Tx 2
8 TT
S x
20
cm2
NO
VA
RTI
S (H
ELL
AS
) A.E
2715
903
01N
ICO
TIN
ELL
TTS
(NC
H)
TTS
21M
G/2
4hrs
BT
x 7
TTS
x 3
0 cm
2N
OV
AR
TIS
(HE
LLA
S) A
.E27
1590
302
NIC
OTI
NE
LL T
TS (N
CH
)TT
S21
MG
/24h
rsB
T x
14 T
TS x
30
cm2
NO
VA
RTI
S (H
ELL
AS
) A.E
2715
903
03N
ICO
TIN
ELL
TTS
(NC
H)
TTS
21M
G/2
4hrs
BT
x 21
TTS
x 3
0 cm
2N
OV
AR
TIS
(HE
LLA
S) A
.E27
1590
304
NIC
OTI
NE
LL T
TS (N
CH
)TT
S21
MG
/24h
rsB
T x
28 T
TS x
30
cm2
NO
VA
RTI
S (H
ELL
AS
) A.E
P,
P03
E
,,
P03
A
E,
P03
AC
,P
03A
C03
P
HE
NO
THR
IN19
0740
401
IVA
LITE
NG
EL
0,30
%TU
Bx1
50M
LLA
VIP
HA
RM
AE
19
0740
402
IVA
LITE
NG
EL
0,30
%FL
x125
ML
LAV
IPH
AR
M A
E
1907
405
01IV
ALI
TEN
ME
D.S
HA
MP
0,4%
(W/V
)FL
x150
ML
LAV
IPH
AR
M A
E
1907
405
02IV
ALI
TEN
ME
D.S
HA
MP
0,4%
(W/V
)FL
x125
ML
LAV
IPH
AR
M A
E
1907
406
01IV
ALI
TEN
LOT
0,40
%FL
x150
ML
LAV
IPH
AR
M A
E
1907
406
02IV
ALI
TEN
LOT
0,40
%FL
x125
ML
LAV
IPH
AR
M A
E
2570
601
01P
UB
EX
SH
AM
PO
OM
ED
.SH
AM
P0,
23%
FLX
50M
LTA
FAR
M .
&25
7060
102
PU
BE
X S
HA
MP
OO
ME
D.S
HA
MP
0,23
%TU
BX
20M
LTA
FAR
M .
&25
7060
103
PU
BE
X S
HA
MP
OO
ME
D.S
HA
MP
0,23
% 1
00M
LTA
FAR
M .
&25
7060
104
PU
BE
X S
HA
MP
OO
ME
D.S
HA
MP
0,23
% 1
50M
LTA
FAR
M .
&19
1680
101
VE
NA
TRE
NLO
T &
ME
D.S
HA
MP
0.2%
W/W
& 0
.05%
W/V
FLX
100M
L+FL
X10
0ML
..
P03
AC
04
PE
RM
ETH
RIN
2098
201
01N
IXC
RE
AM
1% (W
/W)
FL x
56
GP
03A
C53
T
ETR
AM
ETH
RIN
,PH
EN
OTH
RIN
1895
201
01C
IF C
AN
DIO
LIM
ED
.SH
AM
P0,
276%
+0,3
68%
FLx1
50M
LIS
TITU
TO P
RO
FILA
TTIC
OP
03A
C54
P
ER
ME
THR
IN,P
IPE
RO
NY
L B
UTO
XID
E,M
ALA
THIO
N20
5100
101
PA
RA
-PLU
SA
ER
.TO
P(0
.5+2
+0.2
5)%
W/W
FLX
90G
OLV
OS
SC
IEN
CE
AE
R
R01
11834 ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ)
ATC R
01A
R01
AA
,R
01A
A05
O
XY
ME
TAZO
LIN
E H
YD
RO
CH
LOR
IDE
2695
301
01E
ZIX
INN
AS
PR
.SO
L22
MC
G/D
OS
EFL
x10
ML
(225
DO
SE
S)
2317
701
01R
ON
AL
M.D
.NA
S.S
P22
MC
G/D
OS
EFL
X10
ML(
225D
OS
ES
)O
LVO
S S
CIE
NC
E A
E
1208
101
01V
ICK
S V
AP
OS
PR
AY
NA
S.S
PR
0,05
%FL
X15
ML
&
1208
101
02V
ICK
S V
AP
OS
PR
AY
NA
S.S
PR
0,05
%FL
X17
.5M
L()
&
1208
101
03V
ICK
S V
AP
OS
PR
AY
NA
S.S
PR
0,05
%FL
X15
ML(
) &
R
01A
A07
X
YLO
ME
TAZO
LIN
E H
YD
RO
CH
LOR
IDE
0055
301
01O
TRIV
INN
AS
.GE
L0,
10%
TUB
X10
GN
OV
AR
TIS
(HE
LLA
S) A
.E00
5530
201
OTR
IVIN
NA
S.S
OL
0,10
%FL
X10
ML
NO
VA
RTI
S (H
ELL
AS
) A.E
0055
303
01O
TRIV
INN
AS
.SO
L0,
05%
FLX
10M
LN
OV
AR
TIS
(HE
LLA
S) A
.E00
5530
401
OTR
IVIN
NA
S.S
PR
0.1%
W/V
FLx1
0ML
NO
VA
RTI
S (H
ELL
AS
) A.E
0055
312
01O
TRIV
IN
MO
ISTU
RIS
ING
FO
RM
ULA
M.D
.NA
S.S
P0,
05%
(0,0
35m
g/D
OS
EFL
X10
ML
NO
VA
RTI
S (H
ELL
AS
) A.E
0055
311
01O
TRIV
IN M
OIS
TUR
ISIN
G F
OR
MU
LAM
.D.N
AS
.SP
0,1%
w/v
(0,1
4mg/
dose
)FL
x10M
L(71
DO
SE
SN
OV
AR
TIS
(HE
LLA
S) A
.E00
5531
401
OTR
IVIN
MO
ISTU
RIS
ING
FO
RM
ULA
NA
S.S
OL
0,1%
W/V
BO
TTLE
X10
ML
NO
VA
RTI
S (H
ELL
AS
) A.E
0055
310
01O
TRIV
IN (M
EN
THO
L P
RE
SE
RV
ATI
VE
FR
M.D
.NA
S.S
P0,
1%W
/VFL
X10
ML(
71D
OS
ES
+N
OV
AR
TIS
(HE
LLA
S) A
.E00
5530
601
OTR
IVIN
(ME
NTH
OL)
NA
S.S
PR
0.1%
FLx1
0ML
NO
VA
RTI
S (H
ELL
AS
) A.E
0055
307
01O
TRIV
IN (M
EN
THO
L)N
AS
.SO
L0.
1%FL
X10
ML
NO
VA
RTI
S (H
ELL
AS
) A.E
0055
313
01O
TRIV
IN (M
OIS
TUR
ISIN
G F
OR
MU
LA)
NA
S.S
OL
0,05
% (W
/V)
BO
TTLE
X10
ML
NO
VA
RTI
S (H
ELL
AS
) A.E
0055
315
01O
TRIV
IN (M
OIS
TUR
ISIN
G F
OR
MU
LA)
NA
SP
R.S
OL
0,1%
(W/V
)B
OTT
LEX
10M
LN
OV
AR
TIS
(HE
LLA
S) A
.E00
5530
801
OTR
IVIN
(PR
ES
ER
VA
TIV
E F
RE
E)
M.D
.NA
S.S
P0,
05%
W/V
BTx
FLx5
ML(
71D
OS
ES
NO
VA
RTI
S (H
ELL
AS
) A.E
0055
309
01O
TRIV
IN (P
RE
SE
RV
ATI
VE
FR
EE
)M
.D.N
AS
.SP
0,1%
W/V
BTX
FLX
10M
L(71
DO
SE
SN
OV
AR
TIS
(HE
LLA
S) A
.ER
01A
B,
R01
AB
01
DIM
ETI
ND
EN
E M
ALE
ATE
,PH
EN
YLE
PH
RIN
E20
5050
101
VIB
RO
CIL
-SN
AS
.SP
R(0
.025
+0.2
5)%
FLX
10M
LN
OV
AR
TIS
(HE
LLA
S) A
.E20
5050
201
VIB
RO
CIL
-SN
AS
.SO
L(0
.025
+0.2
5)%
FLX
15M
LN
OV
AR
TIS
(HE
LLA
S) A
.E20
5050
301
VIB
RO
CIL
-SN
AS
.GE
L(0
.025
+0.2
5)%
TUB
X12
GN
OV
AR
TIS
(HE
LLA
S) A
.E20
5050
401
VIB
RO
CIL
-SM
.D.N
AS
.SP
(0.0
35+0
.35)
MG
/DO
SE
FLX
15M
L(10
7 D
OS
ES
)N
OV
AR
TIS
(HE
LLA
S) A
.ER
01B
R01
BA
R01
BA
52
IB
UP
RO
FEN
,PS
EU
DO
EP
HE
DR
INE
HY
DR
OC
HLO
RID
E23
0550
101
NU
RO
FEN
CO
LD A
ND
FLU
F.C
.TA
B(2
00+3
0)M
G/T
AB
BT
x 12
ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ) 11835
ATC
2305
501
02N
UR
OFE
N C
OLD
AN
D F
LUF.
C.T
AB
(200
+30)
MG
/TA
BB
T x
24R
01B
A52
P
AR
AC
ETA
MO
L,P
SE
UD
OE
PH
ED
RIN
E H
YD
RO
CH
LOR
IDE
2596
701
01P
AN
AD
OL
CO
LD &
FLU
F.C
.TA
B(5
00+3
0)M
G/T
AB
BTx
2 (
BLI
STE
RS
)G
LAX
OS
MIT
HK
LIN
E A
EB
2596
701
02P
AN
AD
OL
CO
LD &
FLU
F.C
.TA
B(5
00+3
0)M
G/T
AB
BTx
5 (
BLI
STE
RS
)G
LAX
OS
MIT
HK
LIN
E A
EB
2596
701
03P
AN
AD
OL
CO
LD &
FLU
F.C
.TA
B(5
00+3
0)M
G/T
AB
BTx
6 (
BLI
STE
RS
)G
LAX
OS
MIT
HK
LIN
E A
EB
2596
701
04P
AN
AD
OL
CO
LD &
FLU
F.C
.TA
B(5
00+3
0)M
G/T
AB
BTx
10 (
BLI
STE
RS
)G
LAX
OS
MIT
HK
LIN
E A
EB
2596
701
05P
AN
AD
OL
CO
LD &
FLU
F.C
.TA
B(5
00+3
0)M
G/T
AB
BTx
12 (
BLI
STE
RS
)G
LAX
OS
MIT
HK
LIN
E A
EB
2596
701
06P
AN
AD
OL
CO
LD &
FLU
F.C
.TA
B(5
00+3
0)M
G/T
AB
BTx
16 (
BLI
STE
RS
)G
LAX
OS
MIT
HK
LIN
E A
EB
2596
701
07P
AN
AD
OL
CO
LD &
FLU
F.C
.TA
B(5
00+3
0)M
G/T
AB
BTx
18 (
BLI
STE
RS
)G
LAX
OS
MIT
HK
LIN
E A
EB
2596
701
08P
AN
AD
OL
CO
LD &
FLU
F.C
.TA
B(5
00+3
0)M
G/T
AB
BTx
24 (
BLI
STE
RS
)G
LAX
OS
MIT
HK
LIN
E A
EB
2596
701
09P
AN
AD
OL
CO
LD &
FLU
F.C
.TA
B(5
00+3
0)M
G/T
AB
BTx
30 (
BLI
STE
RS
)G
LAX
OS
MIT
HK
LIN
E A
EB
2596
701
10P
AN
AD
OL
CO
LD &
FLU
F.C
.TA
B(5
00+3
0)M
G/T
AB
BTx
32 (
BLI
STE
RS
)G
LAX
OS
MIT
HK
LIN
E A
EB
R02 R
02A
R02
AA
R02
AA
03
DIC
HLO
RO
BE
NZY
L A
LCO
HO
L,A
MY
LME
TAC
RE
SO
L00
8560
501
CO
OL-
STR
EP
SIL
S C
OO
LLO
Z(1
,2+0
,6)M
G/L
OZ
BTx
8 (B
LIS
T 1x
8LO
Z)00
8560
502
CO
OL-
STR
EP
SIL
S C
OO
LLO
Z(1
,2+0
,6)M
G/L
OZ
BTx
10(B
LIS
T 1x
10LO
Z)00
8560
503
CO
OL-
STR
EP
SIL
S C
OO
LLO
Z(1
,2+0
,6)M
G/L
OZ
BTx
12(B
LIS
T 1x
12LO
Z)00
8560
504
CO
OL-
STR
EP
SIL
S C
OO
LLO
Z(1
,2+0
,6)M
G/L
OZ
BTx
16(B
LIS
T 2x
8LO
Z)00
8560
505
CO
OL-
STR
EP
SIL
S C
OO
LLO
Z(1
,2+0
,6)M
G/L
OZ
BTx
20(B
LIS
T 2x
10LO
Z)00
8560
506
CO
OL-
STR
EP
SIL
S C
OO
LLO
Z(1
,2+0
,6)M
G/L
OZ
BTx
24(B
LIS
T 2x
12LO
Z)00
8560
401
STR
EP
SIL
S (C
LAS
SIC
)LO
Z(1
,2+0
,6)M
G/L
OZ
BTx
8(1B
LIS
Tx8L
OZ)
0085
604
02S
TRE
PS
ILS
(CLA
SS
IC)
LOZ
(1,2
+0,6
)MG
/LO
ZB
Tx10
(1B
LIS
Tx10
LOZ)
0085
604
03S
TRE
PS
ILS
(CLA
SS
IC)
LOZ
(1,2
+0,6
)MG
/LO
ZB
Tx12
(1B
LIS
Tx12
LOZ)
0085
604
04S
TRE
PS
ILS
(CLA
SS
IC)
LOZ
(1,2
+0,6
)MG
/LO
ZB
Tx16
(2B
LIS
Tx8L
OZ)
0085
604
05S
TRE
PS
ILS
(CLA
SS
IC)
LOZ
(1,2
+0,6
)MG
/LO
ZB
Tx20
(2B
LIS
Tx10
LOZ)
0085
604
06S
TRE
PS
ILS
(CLA
SS
IC)
LOZ
(1,2
+0,6
)MG
/LO
ZB
Tx24
(2B
LIS
Tx12
LOZ)
0085
602
01S
TRE
PS
ILS
(HO
NE
Y+L
EM
ON
)LO
Z(1
,2+0
,6)M
G/L
OZ
x24(
BLI
ST2
x12)
0085
602
02S
TRE
PS
ILS
(HO
NE
Y+L
EM
ON
)LO
Z(1
,2+0
,6)M
G/L
OZ
BTx
8 (B
LIS
T 1x
8)00
8560
203
STR
EP
SIL
S (H
ON
EY
+LE
MO
N)
LOZ
(1,2
+0,6
)MG
/LO
ZB
Tx12
(BLI
ST
1x12
)00
8560
204
STR
EP
SIL
S (H
ON
EY
+LE
MO
N)
LOZ
(1,2
+0,6
)MG
/LO
ZB
Tx36
(BLI
ST
3x12
)00
8560
301
STR
EP
SIL
S (L
EM
ON
SU
GA
R F
RE
E)
LOZ
(1,2
+0,6
)MG
/LO
ZB
Tx8
(BLI
ST
1x8
LOZ)
11836 ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ)
ATC
0085
603
02S
TRE
PS
ILS
(LE
MO
N S
UG
AR
FR
EE
)LO
Z(1
,2+0
,6)M
G/L
OZ
BTx
10(B
LIS
T 1x
10LO
Z)00
8560
303
STR
EP
SIL
S (L
EM
ON
SU
GA
R F
RE
E)
LOZ
(1,2
+0,6
)MG
/LO
ZB
Tx12
(BLI
ST
1x12
LOZ)
0085
603
04S
TRE
PS
ILS
(LE
MO
N S
UG
AR
FR
EE
)LO
Z(1
,2+0
,6)M
G/L
OZ
BTx
16(B
LIS
T 2x
8LO
Z)00
8560
305
STR
EP
SIL
S (L
EM
ON
SU
GA
R F
RE
E)
LOZ
(1,2
+0,6
)MG
/LO
ZB
Tx20
(BLI
ST
2x10
LOZ)
0085
603
06S
TRE
PS
ILS
(LE
MO
N S
UG
AR
FR
EE
)LO
Z(1
,2+0
,6)M
G/L
OZ
BTx
24(B
LIS
T 2x
12LO
Z)00
8560
701
STR
EP
SIL
S S
TRA
WB
ER
RY
SU
GA
R F
RE
LOZ
(1,2
+0,6
)MG
/LO
ZB
Tx8
LOZ
0085
607
02S
TRE
PS
ILS
STR
AW
BE
RR
Y S
UG
AR
FR
ELO
Z(1
,2+0
,6)M
G/L
OZ
BTx
10 L
OZ
0085
607
03S
TRE
PS
ILS
STR
AW
BE
RR
Y S
UG
AR
FR
ELO
Z(1
,2+0
,6)M
G/L
OZ
BTx
12 L
OZ
0085
607
04S
TRE
PS
ILS
STR
AW
BE
RR
Y S
UG
AR
FR
ELO
Z(1
,2+0
,6)M
G/L
OZ
BTx
16 L
OZ
0085
607
05S
TRE
PS
ILS
STR
AW
BE
RR
Y S
UG
AR
FR
ELO
Z(1
,2+0
,6)M
G/L
OZ
BTx
20 L
OZ
0085
607
06S
TRE
PS
ILS
STR
AW
BE
RR
Y S
UG
AR
FR
ELO
Z(1
,2+0
,6)M
G/L
OZ
BTx
24 L
OZ
R02
AA
12
HE
XY
LRE
SO
RC
INO
L29
2800
101
STR
EP
S E
XTR
ALO
Z2,
4MG
/LO
ZB
Tx24
(BLI
ST
2x12
)R
02A
A20
B
EN
ZOC
AIN
E,C
ETY
LPY
RID
INIU
M C
HLO
RID
E07
1950
101
BIS
OR
AL
SO
L.G
A.M
.W0,
066%
+0,0
50%
FL x
100
ML
.&.
/07
1950
301
BIS
OR
AL
LOZ
(0,6
6+5)
MG
/LO
Z x
20
.&.
/R
02A
BR
02A
B
BA
CIT
RA
CIN
,LY
SO
ZYM
E H
YD
RO
CH
LOR
IDE
,PA
PA
IN22
4270
101
SO
PA
IN-P
LUS
SU
BL.
TAB
[200
IU+(
5+2)
MG
]/TA
BB
TX20
ME
DIC
HR
OM
A.E
.
2242
701
02S
OP
AIN
-PLU
SS
UB
L.TA
B[2
00IU
+(5+
2)M
G]/T
AB
BTX
42(B
LIS
T7X
6)M
ED
ICH
RO
M A
.E.
R
02A
B
BA
CIT
RA
CIN
,LY
SO
ZYM
E,P
AP
AIN
0428
601
01LY
SO
PA
INE
SU
BL.
TAB
BTX
20O
LVO
S S
CIE
NC
E A
E
R05 R
05C
-
R05
CB
-
R05
CB
02
BR
OM
HE
XIN
E H
YD
RO
CH
LOR
IDE
0007
902
01B
ISO
LVO
NTA
B8M
G/T
AB
BTx
20 (B
LIS
T 1x
20))
BO
EH
RIN
GE
R IN
GE
LHE
I00
0790
404
BIS
OLV
ON
SY
R4M
G/5
ML
FLx1
00 M
LB
OE
HR
ING
ER
ING
ELH
EI
0007
904
05B
ISO
LVO
NS
YR
4MG
/5M
LFL
x250
ML
BO
EH
RIN
GE
R IN
GE
LHE
I00
0790
603
BIS
OLV
ON
SY
R8M
G/5
ML
FL x
250
ML
BO
EH
RIN
GE
R IN
GE
LHE
I00
0790
701
BIS
OLV
ON
SO
LU.T
AB
8MG
/TA
BB
Tx10
(BLI
ST
1x10
)B
OE
HR
ING
ER
ING
ELH
EI
0007
907
02B
ISO
LVO
NS
OLU
.TA
B8M
G/T
AB
BTx
20 (B
LIS
T 2x
10)
BO
EH
RIN
GE
R IN
GE
LHE
I00
0790
704
BIS
OLV
ON
SO
LU.T
AB
8MG
/TA
BB
Tx16
(BLI
ST
2x8)
BO
EH
RIN
GE
R IN
GE
LHE
I
ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ) 11837
ATC
0856
001
01B
RO
N-H
AL
SY
R4M
G/5
ML
FLX
100M
LH
ELP
17
6330
201
BR
ON
CH
OTU
SS
INE
SY
R4M
G/5
ML
FLX
100M
LA
DE
LCO
A.E
. .
R05
X,
R05
X,
R05
X
CA
MP
HO
R,M
EN
THO
L09
9180
101
VIC
KS
INH
ALE
RIM
P.C
O.C
OT
(0,3
9+0,
39)G
/ &
R
05X
C
AM
PH
OR
,ME
NTH
OL,
ME
THY
L S
ALI
CY
LATE
0527
601
01M
EN
THO
LATU
MO
INTM
EN
TFL
X27
GV
IAN
EX
A.E
.
0527
601
02M
EN
THO
LATU
MO
INTM
EN
TV
AS
EX
30G
VIA
NE
X A
.E.
R
05X
C
AM
PH
OR
,ME
NTH
OL,
THY
MO
L,E
UC
ALY
PTU
S O
IL,T
UR
PE
NTI
NE
OIL
0520
601
01V
ICK
S V
AP
OR
UB
OIN
TME
NT
VA
SE
x 3
8 G
&
0520
601
02V
ICK
S V
AP
OR
UB
OIN
TME
NT
VA
SE
x 9
0 G
&
0520
601
03V
ICK
S V
AP
OR
UB
OIN
TME
NT
VA
SE
x 1
00 G
&
R05
X
CA
MP
HO
R,T
UR
PE
NTI
NE
OIL
,ME
NTH
OL,
EU
CA
LYP
TUS
OIL
,MY
RIS
TIC
A O
IL,C
ED
AR
WO
OD
OIL
,TH
YM
OL
01
1510
101
EK
SO
INTM
EN
TV
AS
EX
40G
ER
FAR
R
05X
E
THA
NO
L,C
AM
PH
OR
,ME
NTH
OL,
ME
THY
L N
ICO
TIN
ATE
,EU
CA
LYP
TUS
OIL
,TU
RP
EN
TIN
E O
IL
1285
301
01FA
RA
GE
L-FO
RTE
GE
LTU
BX
80G
R05
X
ME
NTH
OL
NA
TUR
AL,
EU
CA
LYP
TUS
OIL
2034
501
01E
UC
ALY
PTA
MIN
TO
INTM
EN
T15
%+3
%.
. 160
ML
ME
DIC
HE
M
..
2034
501
02E
UC
ALY
PTA
MIN
TO
INTM
EN
T15
%+3
%.
.1X
120M
LM
ED
ICH
EM
.
.20
3450
103
EU
CA
LYP
TAM
INT
OIN
TME
NT
15%
+3%
..1
240M
LM
ED
ICH
EM
.
.R
05X
M
EN
THO
L,E
UC
ALY
PTU
S O
IL,M
ETH
YL
SA
LIC
YLA
TE,T
UR
PE
NTI
NE
OIL
0527
501
01D
EE
P H
EA
TO
INTM
EN
TTU
BX
67G
VIA
NE
X A
.E.
05
2750
102
DE
EP
HE
AT
OIN
TME
NT
TUB
X10
0GV
IAN
EX
A.E
.
R06 R
06A
R06
AA
()
R06
AA
02
DIM
EN
HY
DR
INA
TE06
0500
101
DR
IME
NTA
B50
MG
/TA
B10
0C
OU
P A
BE
E
0605
001
02D
RIM
EN
TAB
50M
G/T
AB
BTX
10C
OU
P A
BE
E
0605
001
03D
RIM
EN
TAB
50M
G/T
AB
BTX
30(3
BLI
STX
10)
CO
UP
AB
EE
10
0810
101
RE
TAG
ER
CA
P.S
R 7
5MG
/CA
PB
TX60
(10E
NV
X6)
NI-T
HE
.
..
1008
101
02R
ETA
GE
RC
AP
.SR
75M
G/C
AP
BTX
6(E
NV
X6)
NI-T
HE
.
..
11838 ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ)
ATC
1008
102
01R
ETA
GE
RC
AP
.SR
150
MG
/CA
PB
TX40
(10E
NV
X4)
NI-T
HE
.
..
1008
102
02R
ETA
GE
RC
AP
.SR
150
MG
/CA
PB
TX4(
1EN
VX
4)N
I-TH
E
..
.22
1560
101
TRA
VE
LGU
MC
HE
W.G
UM
20M
G/G
UM
BTx
10 (B
LIS
T 2x
5)V
IAN
EX
A.E
.
R06
AA
02
DIP
HE
NH
YD
RA
MIN
E H
YD
RO
CH
LOR
IDE
0746
801
01B
EN
AD
RY
LS
YR
12,5
MG
/5M
LFL
x125
ML
JOH
NS
ON
AN
D J
OH
NS
OS
S01
O
S01
G
AS
01G
AS
01G
A02
T
ETR
YZO
LIN
E H
YD
RO
CH
LOR
IDE
2399
001
01U
RS
A-F
INE
Y.D
RO
.SO
L0,
05%
W/V
BTx
FLx1
0ML
..
2834
101
01V
ISP
RIN
GE
Y.D
RO
.SO
L0,
05%
(W/V
)FL
x 1
5 M
LJO
HN
SO
N A
ND
JO
HN
SO
S01
GA
51
NA
PH
AZO
LIN
E N
ITR
ATE
,BO
RIC
AC
ID04
4770
101
SE
PTO
BO
RE
EY
.DR
O.S
OL
0.1%
+1%
FLX
10M
L.
.S
01G
A51
N
AP
HA
ZOLI
NE
NIT
RA
TE,Z
INC
SU
LFA
TE07
6860
101
OC
ULO
SA
NE
Y.D
RO
.SO
L0,
005%
+0,0
2%FL
x10M
LLA
BO
RA
TOIR
ES
TH
EA
, FS
01G
A51
Z
INC
SU
LFA
TE H
EP
TAH
YD
RA
TE,N
AP
HA
ZOLI
NE
NIT
RA
TE09
6230
101
ZAB
YS
EP
TE
Y.D
RO
.SO
L0.
02%
+0.0
05%
FLX
12M
LR
AFA
RM
A.E
.B.E
.
S01
GA
52
AN
TAZO
LIN
E H
YD
RO
CH
LOR
IDE
,TE
TRY
ZOLI
NE
HY
DR
OC
HLO
RID
E10
0250
101
SP
ER
SA
LLE
RG
EY
.DR
O.S
OL
0,05
%+0
,04%
W
/VFL
x10M
LN
OV
AR
TIS
(HE
LLA
S) A
.ES
01K
X
S01
KA
S01
KA
02
HY
PR
OM
ELL
OS
E25
5830
101
LUB
RIL
AC
EY
.DR
.S.S
D1,
6MG
/0,5
ML
SIN
GLE
DB
TX30
( ZW
ITTE
R P
HA
RM
AC
EU
T22
1000
101
VID
ILA
CE
Y.D
RO
.SO
L0,
32%
FLX
10M
LK
ITE
22
1000
202
VID
ILA
CE
Y.S
OL.
SD
1,6M
G/0
,5M
L S
ING
.DO
SB
TX60
Sin
gle
dose
KIT
E
2210
002
03V
IDIL
AC
EY
.SO
L.S
D1,
6MG
/0,5
ML
SIN
G.D
OS
BTX
120
Sin
gle
dose
KIT
E
2210
002
04V
IDIL
AC
EY
.SO
L.S
D1,
6MG
/0,5
ML
SIN
G.D
OS
BTX
30si
ngle
dos
eK
ITE
S
01X
S01
XA
S01
XA
12
DE
XP
AN
THE
NO
L
" S
JOG
RE
N"
ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ) 11839
ATC
2243
001
01C
OR
NE
RE
GE
LE
YE
.GE
L5%
W/W
BTX
1(TU
BX
5G)
KIT
E
2243
001
02C
OR
NE
RE
GE
LE
YE
.GE
L5%
W/W
BTX
1(TU
BX
10G
)K
ITE
S
01X
A20
C
AR
BO
ME
R20
2640
101
DA
CR
IO G
EL
EY
E.G
EL
0,3%
W/W
TUB
X10
G20
2640
102
DA
CR
IO G
EL
EY
E.G
EL
0,3%
W/W
BTX
10FL
X0.
5GM
ON
OD
OS
E20
2640
103
DA
CR
IO G
EL
EY
E.G
EL
0,3%
W/W
BTX
20FL
X0.
5GM
ON
OD
OS
E20
2640
104
DA
CR
IO G
EL
EY
E.G
EL
0,3%
W/W
BTX
50FL
X0.
5GM
ON
OD
OS
E20
2640
105
DA
CR
IO G
EL
EY
E.G
EL
0,3%
W/W
BTX
100F
LX0.
5GM
ON
OD
OS
2536
401
01LI
PO
SIC
EY
E.G
EL
0.2%
TUB
X5G
KIT
E
2536
401
02LI
PO
SIC
EY
E.G
EL
0.2%
3 TU
BS
X5G
KIT
E
2536
401
03LI
PO
SIC
EY
E.G
EL
0.2%
TUB
X10
GK
ITE
25
3640
104
LIP
OS
ICE
YE
.GE
L0.
2%3T
UB
SX
10G
KIT
E
2008
101
01TH
ILO
GE
LE
YE
.GE
L0,
3% W
/WTU
B x
10
G19
7120
101
VIS
CO
TER
EY
E.G
EL
0,20
%TU
Bx1
0G(
.)
NO
VA
RTI
S (H
ELL
AS
) A.E
S01
XA
20
CA
RB
OM
ER
974
P25
9260
101
SIC
CA
FLU
IDE
YE
.GE
L0,
25%
BTx
1BO
TTLE
x10G
LAB
OR
ATO
IRE
S T
HE
A, F
S01
XA
20
CA
RM
ELL
OS
E S
OD
IUM
2409
801
01C
ELL
UV
ISC
EY
.DR
O.S
OL
1,0%
W/V
BTx
5SD
Cx0
.4M
LA
LLE
RG
AN
PH
AR
MA
CE
U24
0980
102
CE
LLU
VIS
CE
Y.D
RO
.SO
L1,
0% W
/VB
Tx10
SD
Cx0
.4M
LA
LLE
RG
AN
PH
AR
MA
CE
U24
0980
103
CE
LLU
VIS
CE
Y.D
RO
.SO
L1,
0% W
/VB
Tx20
SD
Cx0
.4M
LA
LLE
RG
AN
PH
AR
MA
CE
U24
0980
104
CE
LLU
VIS
CE
Y.D
RO
.SO
L1,
0% W
/VB
Tx30
SD
Cx0
.4M
LA
LLE
RG
AN
PH
AR
MA
CE
U24
0980
105
CE
LLU
VIS
CE
Y.D
RO
.SO
L1,
0% W
/VB
Tx40
SD
Cx0
.4M
LA
LLE
RG
AN
PH
AR
MA
CE
U24
0980
106
CE
LLU
VIS
CE
Y.D
RO
.SO
L1,
0% W
/VB
Tx60
SD
Cx0
.4M
LA
LLE
RG
AN
PH
AR
MA
CE
U24
0980
107
CE
LLU
VIS
CE
Y.D
RO
.SO
L1,
0% W
/VB
Tx90
SD
Cx0
.4M
LA
LLE
RG
AN
PH
AR
MA
CE
U27
8470
101
RE
FRE
SH
PLU
SE
Y.D
RO
.SO
L5M
G/M
LB
Tx5
ALL
ER
GA
N P
HA
RM
AC
EU
2784
701
02R
EFR
ES
H P
LUS
EY
.DR
O.S
OL
5MG
/ML
x30
ALL
ER
GA
N P
HA
RM
AC
EU
2784
701
03R
EFR
ES
H P
LUS
EY
.DR
O.S
OL
5MG
/ML
BTx
90A
LLE
RG
AN
PH
AR
MA
CE
US
01X
A20
D
EX
TRA
N 7
0,H
YP
RO
ME
LLO
SE
1525
602
01TE
AR
S N
ATU
RA
LE (P
HY
SIO
)E
Y.S
OL.
SD
0.1%
+0.3
%B
TX7P
OU
CH
X4F
LX0,
4ML
S01
XA
20
DE
XTR
AN
70,
HY
PR
OM
ELL
OS
E 4
000
MP
AS
1525
601
01TE
AR
S N
ATU
RA
LEE
Y.D
RO
.SO
L0,
1%+0
,3%
FLx1
5 M
L15
2560
102
TEA
RS
NA
TUR
ALE
EY
.DR
O.S
OL
0,1%
+0,3
%B
Tx24
FLx
0,6
ML
1525
601
03TE
AR
S N
ATU
RA
LEE
Y.D
RO
.SO
L0,
1%+0
,3%
BTx
30 F
Lx0,
6 M
L
11840 ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ)
ATC
1525
601
04TE
AR
S N
ATU
RA
LEE
Y.D
RO
.SO
L0,
1%+0
,3%
BTx
50 F
Lx0,
6 M
L15
2560
105
TEA
RS
NA
TUR
ALE
EY
.DR
O.S
OL
0,1%
+0,3
%B
Tx30
FLx
0,4
ML
1525
601
06TE
AR
S N
ATU
RA
LEE
Y.D
RO
.SO
L0,
1%+0
,3%
BTx
32 F
Lx0.
4 M
LS
01X
A20
D
EX
TRA
N,H
YP
RO
ME
LLO
SE
2807
901
01TE
AR
PR
OL
()
EY
.DR
O.S
OL
0,1%
+0,3
% W
/VB
Tx1
FLx1
5 M
LS
01X
A20
P
AR
AFF
IN, L
IQU
ID,W
OO
L FA
T19
0250
101
DU
RA
TEA
RS
EY
E.O
INT
TUB
X3.
5 G
S01
XA
20
PO
LYV
IDO
NE
2325
201
01O
CU
LOTE
CT
EY
.SO
L.S
D20
MG
/0,4
ML
BTX
200,
4ML
NO
VA
RTI
S (H
ELL
AS
) A.E
2325
202
01O
CU
LOTE
CT
EY
.DR
O.S
OL
5%FL
X10
ML
NO
VA
RTI
S (H
ELL
AS
) A.E
S01
XA
20
PO
LYV
IDO
NE
25
2351
601
01P
RO
TAG
EN
TE
Y.D
RO
.SO
L2%
FLx1
0 M
L.
.23
5160
201
PR
OTA
GE
NT
EY
.DR
.S.S
D2%
BTX
20S
DC
X0.
4ML
..
2351
602
02P
RO
TAG
EN
TE
Y.D
R.S
.SD
2%B
TX50
SD
CX
0.4M
L.
.S
01X
A20
P
OLY
VIN
YL
ALC
OH
OL,
PO
LYV
IDO
NE
2460
001
01O
NU
FRID
EY
.DR
O.S
OL
1.4%
+0.6
%B
TX1F
L X
12M
LR
AFA
RM
A.E
.B.E
.
2042
301
01R
EFR
ES
HE
Y.D
R.S
.SD
1,40
%+0
,60%
BTx
30A
LLE
RG
AN
PH
AR
MA
CE
U20
4230
102
RE
FRE
SH
EY
.DR
.S.S
D1,
40%
+0,6
0%B
Tx5
ALL
ER
GA
N P
HA
RM
AC
EU
2042
301
03R
EFR
ES
HE
Y.D
R.S
.SD
1,40
%+0
,60%
BTx
10A
LLE
RG
AN
PH
AR
MA
CE
UV
V03 V
03A
V03
AX
V03
AX
E
LEU
THE
RO
CO
CC
US
SE
NTI
CO
SU
S27
0050
101
KH
ELM
A A
NTI
-STR
ES
SC
AP
S12
0MG
/CA
PFL
x 6
0K
HE
LMA
HE
LLA
S A
.E.
Ο κ
ατά
λογο
ς δύ
νατα
ι να τ
ροποπ
οιηθ
εί α
νάλο
γα μ
ε τι
ς αιτ
ήσει
ς τω
ν κα
τόχω
ν αδε
ίας
κυκλ
οφορ
ίας
ή τη
ν επ
ανα
ξιολ
όγησ
η το
υ τρ
όπου
διά
θεσης
από
τον
ΕΟ
Φ.
Ο π
ροηγ
ούμε
νος
Κατά
λογο
ς μη
συν
ταγο
γραφ
ούμε
νων
φαρμ
άκω
ν (Μ
ΗΣΥΦ
Α) (σ
χετι
κό 7
) παύε
ι να ισ
χύει
με
την
δημο
σίε
υση
της
παρο
ύσης
απόφ
ασης
. Η π
αρο
ύσα ισ
χύει
από
την
επομ
ένη
της
δημο
σίε
υσής
της
στη
ν Εφ
ημερ
ίδα τ
ης Κ
υβερ
νήσεω
ς.Η α
πόφ
αση
αυτ
ή να
δημ
οσιε
υθεί
στη
ν Εφ
ημερ
ίδα τ
ης Κ
υβερ
νήσεω
ς. Αθή
να, 1
1 Μ
αΐο
υ 20
11
Ο Υ
ΠΟ
ΥΡΓ
ΟΣ
ΑΝ
ΔΡΕΑ
Σ Λ
ΟΒ
ΕΡΔ
ΟΣ
ΑΠΟ ΤΟ ΕΘΝΙΚΟ ΤΥΠΟΓΡΑΦΕΙΟΚΑΠΟΔΙΣΤΡΙΟΥ 34 * ΑΘΗΝΑ 104 32 * ΤΗΛ. 210 52 79 000 * FAX 210 52 21 004*02008401205110048*
![ERKOC F TFD Aralik 2010 [Uyumluluk Modu]content.lms.sabis.sakarya.edu.tr/Uploads/52241/54831/çevre... · Çevre Toksikolojisi 2 Araştırma Grubu soldan sağa: Doç. Dr. Aylin Sepici-Dinçel,](https://img.pdfslide.tips/doc/110x75/5c81ea2209d3f263728cf896/erkoc-f-tfd-aralik-2010-uyumluluk-modu-evre-cevre-toksikolojisi-2-arastirma.jpg)
